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Abstract 
 
 
 
The catalytic subunit of telomerase TERT has non-canonical functions, 
which are independent of telomere elongation and sometimes telomerase 
activity. In skin keratinocytes, both TERT expression and anoikis are 
regulated by extracellular matrix molecules and their integrin receptors, 
but the effect of TERT deregulation on anoikis has not been previously 
investigated.  
HaCaT cells expressing wild-type TERT, TERT-HA (non-canonical function 
only) DnTERT (catalytically inactive TERT) and the empty vector (PURO) 
were created by retroviral transduction. HaCaT anoikis was monitored 
after disengagement of integrins following anchorage deprivation by 
nuclear staining and FACS.  The expression of both TERT and TERT-HA, 
and to a lesser extent DnTERT, significantly decreased the appearance of 
apoptotic HaCaT cells in suspension. This showed that TERT could mute 
anoikis even in the absence of telomere lengthening but that it may 
require telomerase activity for optimum effect. TERT/TERT-HA did not 
mute cisplatin-induced HaCaT apoptosis, suggesting that the effects are 
specific to anoikis. 
Telomerase activity in the anchorage-deprived samples significantly 
decreased compared to the controls at time zero in all the samples.  
hTERT mRNA expression dropped in all groups in suspension compared to 
the zero time empty vector controls but the expression was still higher in 
those cells over expressing TERT/TERT-HA  than the controls at zero 
time, suggesting a relationship between TERT/TERT-HA expression and 
resistance to anoikis.  However, TERC expression increased in suspension 
similarly in all experimental groups. Therefore, these results suggest that 
the downregulation of TERT and not TERC contributes to the 
downregulation of telomerase in suspension, although the downregulation 
of ectopically expressed TERT also suggests that post-transcriptional 
mechanisms are involved. TERT splice variants were rare and not 
strikingly regulated in suspended keratinocytes. Western blot and FACS 
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analyses indicated that TERT does not act by affecting integrin expression 
or their density on the keratinocyte surface, suggesting a point of action 
downstream of integrins.  
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Chapter 1: 
Introduction 
 
 
 
 
1.1 The telomere and telomerase: functions and regulation 
 
 
 
1.1.1 The telomere 
 
 
The word “telomere”, derived from the two Greek nouns “telos”, end, and 
“meros”, part, was coined for the first time by Hermann Müller in 1938 to 
describe the extreme part of the chromosome which showed a certain 
level of protection from chromosomal damage induced by X-rays in 
Drosophila (Chuarie 2006).  
 
Later on, the “end of replication problem” aroused new interest about the 
extremity of chromosomes, where DNA polymerase seemed unable to 
complete the replication of the linear DNA molecules because of the lack 
of a DNA template, according to the independent thoughts of Alexei 
Olovnikov in 1971 and James D. Watson the following year (Olovnikov 
1996).  
 
In the majority of eukaryotic organisms, such the protozoan 
Tetrahymena thermophila where telomere sequence was first indentified 
by the Nobel Prize winner Elizabeth Blackburn in 1978, and fungi, insects, 
plants and vertebrates, telomere structure is well conserved in the similar 
composition of short DNA repeats with a sequence of (d[T/A]1–4dG1–8)n 
and a G-rich strand overhanging at the 3’ end. The length of the telomere 
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repeat sequence can vary from few base pairs in yeast to the very long 
murine telomeres (Louis and Vershinin 2005).     
 
In humans, telomeres typically consist of a tandem repeating base 
sequence (TTAGGG) between 3 to 20 kb in length, varying with cell type, 
development and individuals, and decreasing during cell divisions both in 
vivo and in vitro. In skin keratinocytes, for example, mean telomere 
length varies from approximately 10 kb of samples from infant foreskin, 
to approximately 6-7 kb after 30 cell divisions, when the cells started to 
senesce. Keratinocytes from adult foreskin or trunk instead show a much 
more heterogeneous length, from 5 to 10 kb (Krunic, Moshir et al. 2009).   
 
The heterogeneity of telomere fragment length, the continuous erosion of 
this length during cell division, and the different response to telomere 
shortening in different types of cells can be explained by understanding 
the role of the telomere in cells, and what the difference in its length 
means in term of cell survival and behaviour. 
 
A first insight into the role of the telomere was provided in the early 
1970s by Olovnikov, who first proposed a correlation between the end 
replication problem and the Hayflick limit, suggesting a progressive 
shortening at the end of the chromosome at each DNA replication which 
eventually leads to cell senescence. The region of DNA where this 
shortening was supposed to happen was indeed the telomere, as later on 
proved by Harley in 1990 with studies of the telomere length in cultured 
human fibroblasts (Harley, Futcher et al. 1990). 
 
The main (canonical) function of telomeres has been widely studied since 
then. Telomeres ensure that the end of the chromosome is not 
interpreted by the cell as a DNA double-strand break leading to 
chromosomal instability and cell cycle arrest. The key role of the 
extremity of the chromosome must be therefore accurately regulated, so 
that only cells which are supposed to be in a continuous proliferative 
state, such as stem cells or cells in the germ line, will avoid telomere 
shortening and cell death. In these cells telomeres are kept at a certain 
1.1.1- The telomere 
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length by two different mechanisms discussed below. On the contrary, 
somatic cells need final senescence to keep the correct homeostasis of 
the tissue they belong to, and the whole organism (Blackburn 2001). 
Senescence can be also seen as a form of tumour 
suppression, since different studies in vivo and in vitro have detected the 
presence of senescence cells in the premalignant lesions, but not in the 
cancer cells. If also the functions of p16/Rb or p53 is impaired, then the 
premalignant cells will progress to malignancy (Campisi 2005). 
 
Protection of the telomere is achieved by the involvement of a complex of 
six proteins, named shelterin, and a variety of supplementary proteins 
which directly or indirectly binds the telomeric DNA sequence and, 
together with a higher level structure called “t loop”, they provide a 
reversible capping of the telomere. Capping is generally temporally lost 
when the structure of the telomere needs to be accessible for the 
replicating machinery to proceed (Blackburn 2001).  
 
 
 
1.1.2 Telomere lengthening: ALT and telomerase 
 
 
Lengthening of the telomere does not occur just in the germ line and 
stem cells, but also in cancer cells, which manage to escape the 
proliferative block due to telomere shortening in two main ways.  
The majority of cancer cells maintain a certain telomere length by 
reactivation of the enzyme telomerase, which is able to extend the 
telomeric repeats and overcome the loss of those during cell divisions 
(Blackburn 2001). The action of this enzyme will be analyzed in detail in 
the following chapters. 
 
However, a smaller subset of tumours does not show detectable amount 
of telomerase and therefore utilizes an alternative lengthening of 
telomeres (ALT) system to overcome Hayflick limit (Bryan, Englezou et 
al. 1995; Reddel 2003).  
1.1.3- Telomerase 
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This process can proceed in two different ways, which explains the typical 
presence of the highly heterogeneous telomere lengths in cells 
performing ALT (Bryan and Reddel 1997). In the first case there is still a 
small portion of telomeric DNA in the chromosome. This chromosome 
with short telomeres recombines with a complementary telomeric 
sequence in another chromosome where telomeres are still long 
(Dunham, Neumann et al. 2000). This long telomeric sequence can act as 
a primer for the further synthesis of the leading strand of the shorter 
telomere. Finally, the lagging strand will be duplicated as well leading 
lengthening of the previously short telomere. 
 
In case the chromosome has already lost all the telomeric and some 
subtelomeric DNA during cell divisions, a TTAGGG repeat present more 
distantly will recombine to a chromosome with longer telomeres, and 
telomeric elongation will proceed from that point. However, the 
subtelomeric part previously lost will not be regained, leading to a loss of 
genomic material (Dunham, Neumann et al. 2000).  
 
The ALT mechanism has been shown in a small subset of cells derived 
from tumours, such as glioblastoma, osteosarcoma, breast carcinoma, 
and adrenocortical carcinoma. ALT also acts in approximately 28% of 
immortalized cell lines in vitro (Bryan, Englezou et al. 1997).  
 
 
 
1.1.3 Telomerase 
 
 
In the majority of cases, telomere lengthening is carried out by a large 
ribonucleoprotein complex called telomerase. The enzyme was first 
discovered in the ciliated protozoan Tetrahymena thermophila (Greider 
and Blackburn 1985), where it was hypothesized to act with a terminal 
transferase action in its short minichromosomes. 
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The human telomerase complex (figure 1) includes a 451-nucleotide RNA 
molecule, TERC (Telomerase RNA Component, also known as hTR, TRC3, 
SCARNA19), which serves as a template for addition of TTAGGG repeats, 
a catalytic component, TERT (Telomerase Reverse Transcriptase, also 
known as EST2, TCS1, TRT), and numerous other proteins (Collins and 
Mitchell 2002; Keith, Bilsland et al. 2002). 
 
Human TERC is localized on human chromosome 3q26.3 (Soder, Hoare et 
al. 1997). In mouse and human, TERC is a transcribed by RNA 
polymerase II, as demonstrated by the presence of both TATA and CAAT 
boxes in the upstream flanking regions (Hinkley, Blasco et al. 1998), 
whereas in ciliates it is a product of RNA polymerase III (Greider and 
Blackburn 1989). The 5’-end of the template region, longer in the human 
than the murine TERC, is hypothesized to affect the processivity of the 
enzyme, allowing a correct interaction of the DNA substrate with the 
telomerase complex (Hinkley, Blasco et al. 1998).  
 
The group of proteins interacting with the telomere and the two main 
components of telomerase TERC and TERT is quite composite, formed by 
the six-protein “shelterin” complex and probably several unidentified 
proteins.  This highly multifunctional complex of proteins which bind 
double strand or single strand telomeric DNA, or establish protein-protein 
interactions, intervenes in maintaining telomere length, telomere capping 
by formation of the t-loop, and in promoting DNA repair (De Boeck, 
Forsyth et al. 2009) . 
 
TERT is the catalytic core of telomerase. The structure of the 
macromolecule has been investigated with comparative studies, which 
show a general pattern where binding with TERC is possible by the RT 
(retrotranscriptase) domain and the N-terminal domain, and DNA binding 
is promoted by the both C and N-terminal domains. Interaction with 
other proteins of the telomerase complex is instead carried out in other 
regions of the TERT macromolecule (Podlevsky, Bley et al. 2008; De 
Boeck, Forsyth et al. 2009).  
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Figure 1 : Structure of human telomerase  
 
Human telomerase is composed of the reverse transcriptase hTERT 
(yellow and pink, at the centre), and the RNA component TERC (or hTR, 
green). Proteins forming shelterin bind at the N-terminal domain of TERT 
(TEN, in yellow). Some of these proteins directly bind the telomeric DNA, 
such as POT1, which binds single-strand telomeric DNA, and TRF1 and 
TRF2, which bind double-strand telomeric DNA. The other three proteins 
involved in the shelterin complex, among which TPP1 shown here, bind to 
the first set of proteins. In addition, the complex formed by the protein 
dyskerin, which is involved in the binding to TERC by the binding to the 
H/ACA consensus sequence, is shown on the right (figure modified from 
(Podlevsky, Bley et al. 2008)). 
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1.1.4 Functions of telomerase 
 
 
1.1.4.1 Canonical functions of telomerase 
 
 
Telomerase can be detected at high levels in germ line cells, where the 
enzyme is always active and serves its canonical function of lengthening 
chromosome ends, while in most somatic cells telomerase activity is 
almost undetectable. In somatic cells, the progressive shortening of 
telomeres leads to instability of the shelterin complex and DNA damage 
signalling (de Lange 2005). Forced expression of hTERT results in 
reconstitution of functional telomerase activity in normal aging human 
cells (Weinrich, Pruzan et al. 1997) and in vivo this activity leads to 
elongation of telomeric DNA and to extension of cellular replicative life 
span (Bodnar, Ouellette et al. 1998). Other evidence for a possible role in 
cellular homeostasis of telomerase in vivo comes from the study of TERC 
deficient mice (TERC-/- mice). TERC-/- mice show progressive telomere 
shortening with each successive generation. This is associated with age-
related genetic instability, reduced wound healing, deficiency of the 
reproductive and haematopoietic systems, and increased incidence of 
spontaneous malignancies (Blasco, Lee et al. 1997; Lee, Blasco et al. 
1998; Rudolph, Chang et al. 1999). These results prove the need for both 
the RNA and catalytic subunit of telomerase in the execution of its 
canonical function of telomere elongation, but the presence of TERC does 
not seem to be required for the neoplastic transformation of mouse 
embryo fibroblasts in vitro (Blasco, Lee et al. 1997) or cancer formation 
in vivo (Greenberg, Chin et al. 1999) but the tumour yield is reduced 
(Gonzalez-Suarez, Samper et al. 2001) and the tumours show less 
propensity to metastasise (Chang, Khoo et al. 2003). Short telomeres 
have also been shown to suppress cancer by the induction of senescence 
as mediated by p53 (Feldser and Greider 2007).  
 
Finally, it has also been shown that TERC associates with the nuclear 
protein dyskerin through the H/ACA consensus sequence present in both 
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TERC and in the class of small nucleolar RNAs (snoRNAs) processed by 
dyskerin (Mitchell, Wood et al. 1999) in Dyskeratosis congenita (DC). DC 
is a rare inherited bone marrow failure syndrome exhibiting clinical and 
genetic heterogeneity, such as abnormalities of the skin, fingernails, and 
tongue. X-linked recessive, autosomal dominant and autosomal recessive 
forms are recognized and studied (Dokal and Vulliamy 2003; Kirwan and 
Dokal 2008). X-linked DC involves a mutation in DKC1, the gene 
encoding dyskerin, reduced levels of TERC and decrease in telomere 
lengths (Mitchell, Wood et al. 1999), presenting effects which are very 
similar to pathogenic TERC-/- mice (Blasco, Lee et al. 1997; Kipling and 
Faragher 1999).  It has been argued that telomerase effects are 
secondary to the DC phenotype rather than causal (Shay and Wright 
1999). However, definitive evidence that telomere dysfunction was causal 
came from studies of autosomal dominant DC. This form of the disease 
mapped to chromosome 3q (Vulliamy, Marrone et al. 2001), the same 
chromosome arm as TERC (Soder, Hoare et al. 1997), and mutations in 
the TERC gene were also found (Vulliamy, Marrone et al. 2001).  
 
 
1.1.4.2 Non canonical functions of telomerase 
 
 
Telomere lengthening may therefore be defined as the canonical function 
of the telomerase. The catalytic subunit TERT, however, has also been 
investigated for “non-canonical” functions (NC) which are independent 
from telomere lengthening in several studies (figure 2). These functions 
can be divided in two groups, functions requiring the presence of the RNA 
component TERC, and therefore telomerase activity (NC I), and functions 
which do not have this requirement (NC II) (Parkinson, Fitchett et al. 
2008).   
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• Non-canonical functions of telomerase that still require 
enzyme activity (NC I) 
 
Non-canonical functions of telomerase, that require the presence of TERC 
but are independent of telomere lengthening (NC I), have been 
investigated firstly by studies in mice, and subsequently in vitro.  
 
The very long mouse telomeres, reaching up to 150 kb (Kipling and 
Cooke 1990) and therefore the absence of critical telomere shortening 
offered a good system to study the modulation of the two telomerase 
components in a lengthening-independent way.  
 
Subsequent treatment of mice that are highly responsive to the initiating 
and promoting effects of 7,12-dimethylbenz[a]anthracene (DMBA) and 
12-O-Tetradecanoylphorbol-13-acetate (TPA) respectively (referred as 
two-stage chemical tumourigenesis mouse model) leads to formation of 
papillomas, which are hyperplastic skin lesions showing activation of the 
proto-oncogene ras (Balmain, Ramsden et al. 1984). The majority of 
these papillomas and the carcinomas deriving from them induced by 
DMBA initiation possess a mutation in codon 61 of ras (Quintanilla, Brown 
et al. 1986). 
 
Mice treated with the tumour promoting chemical TPA show a high level 
of telomerase activity in the skin papillomas. In particular, the enzymatic 
activity of telomerase was correlated with the progression and the 
genomic instability of the papillomas and couldn’t be attributed to the 
increased proliferation of the cells only (Bednarek, Budunova et al. 
1995). Similarly, mouse mammary carcinomas promoted by a wnt-1 
transgene show increased expression of TERC and a 10-fold higher 
telomerase activity than non-malignant tissues (Broccoli, Godley et al. 
1996).  
 
Furthermore, the necessity of TERC in the progression of carcinogenesis 
is shown by TERC-deficient first generation mice, which are more 
resistant to DMBA and TPA-induced papilloma formation.  However, the 
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tumour suppressor phenotype is more evident in the later generations 
mice, where shorter telomeres are correlated with a near disappearance 
of papillomas and p53 activation (Gonzalez-Suarez, Samper et al. 2000), 
suggesting the importance of canonical and non-canonical functions of 
telomerase in the promotion and progression of skin neoplasias. 
 
Moreover, Tert seems to play an important role for the formation of these 
papillomas independently from its canonical function of telomere 
lengthening, since mice treated with DMBA and TPA and overexpressing 
mTERT, show not only an increase in telomerase activity, but also in skin 
tumourigenesis and wound healing (Gonzalez-Suarez, Samper et al. 
2001). These effects are not seen when the same mice are deprived of 
TERC, demonstrating the requirement for both the telomerase subunits in 
this mouse cancer model (Cayuela, Flores et al. 2005).  
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Resistance to apoptosis
Telomerase
 
Figure 2: Canonical and non-canonical functions of telomerase 
 
In the scheme, the functions of the enzyme are listed together with the 
components required for those functions. Also, the phenotypes which 
were shown in the literature to be correlated with each function are 
shown. As shown, both non-canonical functions are independent from 
telomerase elongation, but can be subdivided in functions requiring the 
presence of TERC (NC I) or functions independent from TERC (NC II).   
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Similarly, the ectopic expression of mTERT in DMBA-treated mice is 
associated with spontaneous development of mammary  carcinogenesis, 
especially in late generation females (Artandi, Alson et al. 2002).  
 
In vitro, ectopic expression of mTERT has been associated with TERC-
dependent increased colony formation and immortalization of mouse 
embryo fibroblasts and with the insensitivity to TGF-β (Geserick, Tejera 
et al. 2006), confirming previous studies showing a  reduced requirement 
for TGF-β in the growth of mammary epithelial cells (Stampfer, Garbe et 
al. 2001). 
 
Ectopic hTERT expression has also been correlated with enhanced DNA 
repair capacity in normal human oral fibroblasts (Shin, Kang et al. 2004) 
and with immortalization of normal human keratinocytes, (Dickson, Hahn 
et al. 2000) and mammary epithelial cells (Smith, Coller et al. 2003) 
after loss of p16INK4a. Furthemore, overexpression of hTERT into the  
latter cell lines promotes the expression of fibroblast and epidermal 
growth factor to stimulate cell proliferation (Smith, Coller et al. 2003).  
 
Down regulation of hTERT with shRNA in different cancer lines has shown 
an association with downregulation at the transcription level of cyclin D1 
(Jagadeesh and Banerjee 2006). The transcription of this cyclin is 
regulated by the pathway regulated by Ras, Src, MEK, AKT, and ERK, 
suggesting a possible regulation of TERT at some point in this oncogenic 
signalling, as well as EGF (Fu, Wang et al. 2004). Therefore, expression 
of cyclin D1 appears to be dependent on the presence of TERT and 
telomerase activity. On the other hand, dependence on the presence of 
TERC for the expression of the cyclin has been recently shown by the use 
of a telomerase inhibitor, which prevents the binding between TERC and 
the telomere, and it is associated with downregulation of the expression 
of cyclin D1 (Tokcaer-Keskin, Dikmen et al. 2010). 
 
Another line of evidence supporting a possible role of telomerase 
independent from telomere-lengthening derives from the genetic 
reconstruction of tumorigenic fibroblasts from their normal counterparts. 
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In this experiment mutant Ras, SV40 T antigen and TERT are required for 
tumorigenesis (Hahn, Counter et al. 1999), but when Ras and SV40 T 
antigen are introduced into fibroblasts maintaining their telomeres by ALT 
(Alternative Lengthening of Telomeres) few tumours result (Stewart, 
Hahn et al. 2002). The addition of TERT, however, restores tumorigenity 
(Stewart, Hahn et al. 2002).  
 
Additional proof that the effect of TERT does not require telomerase 
lengthening comes from the use of TERT-HA  in vitro (Counter, Hahn et 
al. 1998). TERT-HA is a C-terminal hemaglutinin (HA) tagged hTERT 
which is catalytically active but fails to elongate telomeres and to extend 
cellular life span, while the specificity and processivity for an 
oligonucleotide substrate is very similar to wild-type hTERT (Ouellette, 
Aisner et al. 1999). The ectopic expression of TERT-HA can convey a 
tumorigenic phenotype in normal human fibroblasts and in cells that 
maintain telomeres by a telomerase-independent mechanism (ALT, 
Alternative Lengthening of Telomeres)(Stewart, Hahn et al. 2002).  
 
Also, recent findings show that TERT-HA is able to immortalize primary 
human foreskin keratinocytes, when telomerase is interacting with the 
HPV E7 oncoprotein (Liu, Dakic et al. 2009).  
 
These results show that the presence of telomerase activity does not 
necessarily require telomere maintenance and supports a novel telomere 
elongation-independent role for telomerase.   
 
Furthermore, the first discovery of the presence of TERT in normal 
human fibroblasts associated the presence of the enzyme with a delay in 
the entrance in senescence (Bodnar, Ouellette et al. 1998). This effect is 
not due to telomere elongation alone but also to protection of the 
telomere structure (Masutomi, Yu et al. 2003). 
 
Since TERT expression is detected exclusively during the S phase of the 
fibroblast cell cycle, it has been proposed that the increase in DNA 
damage response may be due to modulation of chromatin by TERT due to 
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modification of the histones (Masutomi, Possemato et al. 2005). Normal 
human fibroblasts where TERT is downregulated are less able to repair 
the DNA, and show an increase in radiosensitivity and chromosomal 
disruptions (Masutomi, Possemato et al. 2005). However this proposed 
mechanism does not explain the insensitivity to TGF-β growth inhibition 
cited above, suggesting that there may be other non-canonical 
mechanisms of telomerase.  
 
 
• Non-canonical TERT functions that are independent of catalytic 
activity or TERC (NC II) 
 
 
In other experiments, evidence for a role of TERT in the absence of the 
RNA component TERC and in the absence of changes in telomere length 
have been observed in mice lacking for TERC (TERC-/-). In these mice, 
induction of TERT has been associated with a developmental transition in 
the hair follicle cycle. With ectopic induced mTERT overexpression, stem 
cells of the hair follicle bulb undergo proliferation leading to the anagen 
phase of hair (Sarin, Cheung et al. 2005); these were also associated 
with promotion of hair growth when mice were constitutively 
overexpressing mTERT in a TERC-/- background (Sarin, Cheung et al. 
2005). These effects, therefore, support a function of TERT independent 
from the RNA component (Flores, Cayuela et al. 2005; Sarin, Cheung et 
al. 2005) and from the catalytic activity (reverse transcriptase function) 
of the enzyme (Choi, Southworth et al. 2008) in the promotion of stem 
cell self-renewal and functional maintenance without inducing neoplasia. 
It has also been suggested that regulation of mTERT in the anagen phase 
of the mouse hair cycle is mediated through regulation of Wnt signalling 
(Choi, Southworth et al. 2008). More recently, it has been shown that 
Tert directly associates with the BRG protein to enhance Wnt signalling 
and that the Tert-/- mice have developmental defects that are consistent 
with a physiological role for Tert in this pathway (Park et al Nature 2009). 
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TERT has also been associated with promotion of cell survival of cells 
independent of the presence of the RNA template and therefore telomere 
lengthening. A previous study using the TERT-HA model together with 
wild-type TERT, showed that TERT overexpression has in fact been 
correlated in mouse embryonic fibroblasts and motor neurons with an 
increased resistance to apoptosis initiated by staurosporine and NDMA 
(N-methyl-D-aspartic acid); neither the canonical function of the enzyme 
nor the catalytic activity of TERT was not required (Lee, Sung et al. 
2008). Similar results were also seen in  cortical neurons, where TERT 
overexpression has been associated with resistance to ischaemic brain 
injury and NMDA-Induced neurotoxicity (Kang, Choi et al. 2004). In both 
the cases, it was hypothesised that TERT may protect apoptosis by acting 
at mitochondrial level, but the exact mechanism has not been identified 
yet. 
 
 
• Telomerase and the mitochondria 
 
 
The interplay between telomerase, the mitochondria, apoptosis and 
cellular senescence has been investigated by numerous groups, but it is 
still one of the most discussed topics in the telomerase field. This is due 
to the variety of hypotheses and results that are continuously produced 
and not agreed upon by the whole scientific community. 
 
One of the first studies that demonstrated a possible correlation between 
telomerase and the mitochondria showed that apoptosis induced by 
reactive oxygen species (ROS) was correlated with reduction of the 
mitochondrial transmembrane potential and telomerase shortening in 
HeLa cells; however, no decrease in telomerase activity was observed, 
suggesting a more direct interaction between the ROS and the telomere 
in the specific telomere shortening. On the other hand, if telomerase 
activity was inhibited, the cells became more sensitive to ROS-induced 
apoptosis, which was also shown to be independent from caspase-3 
activation (Ren, Xia et al. 2001).  
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According to another study, also carried out with in HeLa cells, 
overexpression of TERT protects cells from apoptosis due to the DNA 
damaging agent etoposide. Etoposide is a DNA strand breakage agent 
that also involves release of cytochrome c from the mitochondria and 
most importantly the activation of caspase-3; this study has also 
hypothesized a protection by TERT at an early step of the apoptotic 
cascade, before release of the cytochrome c and its dependence on a 
functional RT domain in TERT protein (Zhang, Chan et al. 2003). 
 
A further insight into the mechanism of ROS-induced apoptosis in TERT-
transfected fibroblasts showed increased damage in the mitochondrial 
DNA (mtDNA) compared to the undamaged nuclear DNA in the affected 
cells (Santos, Hunakova et al. 2003), suggesting a more direct 
involvement of telomerase and the organelle. 
 
A possible confirmation of the role of telomerase in the mitochondria 
biology was shown with the colocalization of TERT in the mitochondria, 
due to its N-terminal mitochondrial targeting sequence (Santos, Meyer et 
al. 2006). Recent evidence shows that TERT is indeed localized on the 
membrane of the organelle (Haendeler, Drose et al. 2009). The export of 
TERT from the nuclei to the cytoplasm through the nuclear pores is 
dependent on the presence of ROS. It involves phosphorylation of the 
protein by the Src kinase, and it has been correlated with an increase of 
apoptosis in transformed human embryonic kidney cells (Haendeler, 
Hoffmann et al. 2003). Recently, the same group showed that levels of 
mitochondrial TERT are downregulated by exogenous H2O2 in endothelial 
cells, and that Src kinase is also present in the mitochondria, therefore a 
similar regulation of TERT could be carried out in the nucleus and in the 
organelle (Buchner, Zschauer et al. 2010). 
 
The presence of TERT in the mitochondria was therefore linked with 
increased levels of ROS-induced mtDNA damage, leading to the 
hypothesis that TERT could sensitize the cells to ROS-induced apoptosis 
(Santos, Meyer et al. 2004). For this function, which also extends to 
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etoposide-induced apoptosis, telomerase must be catalytically active 
(Santos, Meyer et al. 2006).  
 
However, the role of telomerase in inducing apoptosis through the 
mitochondrial pathway is not unanimously accepted yet. Different studies 
had observed the opposite situation, since inhibition of hTERT by siRNA in 
HeLa cells induces the mitochondrial apoptotic pathway through  the 
activation of Bax, after cisplatin treatment (Massard, Zermati et al. 
2006), and similarly in a bladder cell line, together with induction of 
cytochrome c release into the cytosol (Park, Kim et al. 2008).  
 
To confirm this, a more recent study showed that ablation of TERT by 
shRNA in endothelial cells also increased the rate of ROS produced by the 
mitochondria, therefore emphasizing the protective effect of the protein 
on this pathway of apoptosis. In vivo, heart mitochondria derived from 
second generation TERT-/- mice show an impaired respiration and lung 
fibroblasts from the same mice are less resistant to UVB radiations. 
Furthermore, the study shows that the protection by TERT against 
damage to the mtDNA is dependent on the RT activity of the enzyme 
(Haendeler, Drose et al. 2009). In these studies therefore, the role of 
telomerase is thought to be protecting cells from mitochondrial cell 
death.  
Other studies support this theory: von Zglinicki’s group (Ahmed et al JCS 
2008) showed a reduction in the damage to the mitochondrial DNA after 
TERT overexpression, correlated with a decrease in the production of ROS 
and an increase of the transmembrane potential (Passos, Saretzki et al. 
2007). Furthermore, expression of a mutant of TERT which cannot be 
exported from the nuclei leads to an increased level of ROS released from 
the mitochondria and, independently from this phenomenon, to an early 
cell senescence in normal fibroblast, and to nuclear DNA damage in 
primary fibroblast, In addition, even if the enzyme is catalytically active 
in vitro, telomerase fails in immortalize the fibroblasts (Kovalenko, Caron 
et al. 2010).  
 
1.1.4- Functions of telomerase 
 
 36
However, stress induced on the cell by ROS is still thought to be an 
essential cause of telomere shortening (Passos and von Zglinicki 2005) 
and to replicative senescence, which in turn is strictly linked with the 
nuclear export of TERT from the nuclei, since antioxidants can inhibit it 
(Haendeler, Drose et al. 2009). 
 
Intracellular levels of ROS could also have a further importance in a 
particular form of cell death due to deprivation of the cells from the 
extracellular matrix, termed anoikis. For further details on this topic, see 
section 1.4.3. 
 
 
1.1.5 Regulation of telomerase activity 
 
 
As explained above, telomerase activity can be detected at very different 
levels amongst different tissues in the body, and therefore the regulation 
of the expression of all the components of the big holoenzyme must be 
coordinated and carried out within multiple stages. Up to date, the 
regulation of telomerase, especially of the catalytic component, has been 
found at transcriptional, post-transcriptional, and post-translational 
levels.  
 
 
1.1.5.1 Regulation at transcriptional level 
 
 
Gene amplification of TERT is the most evident regulation of the level of 
gene expression and therefore telomerase activity. TERT amplification 
has been detected in at least 30% of tumour cell lines and primary 
tumours (Zhang, Zheng et al. 2000). This amplification can be due to 
amplification of the chromosome 5 carrying TERT gene, subregions of the 
chromosome, or amplification of the single gene locus (Cong, Wright et 
al. 2002).  
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• Activators of transcription 
 
Activation of the TERT promoter is one of the most common types of 
gene regulation, thanks to the many binding sites present in the DNA 
sequence (Cong, Wright et al. 2002). c-Myc is one of the most studied 
activators of transcription. This factor has been shown to activate TERT 
transcription and telomerase activity in human mammary epithelial cells 
and normal human diploid fibroblasts by dimerization with Max. (Wang, 
Xie et al. 1998). The regulation of TERT by c-Myc is complex and not fully 
understood yet, but TERT is a direct target of Myc since the activation is 
independent from the synthesis of the TERT protein (Cerni 2000; Kyo, 
Takakura et al. 2008). 
 
Other binding sites in TERT promoter suggests regulation from different 
cellular transcription factors, such as Enhancer-binding Protein-2 (AP-2),  
Hypoxia-inducible factor-1 (HIF-1), and transcription activator protein 
(AP-1), which can also act as a transcription repressor (Kyo, Takakura et 
al. 2008). 
 
The presence of an estrogen-responsive element (ERE) in the TERT 
promoter is associated with regulation of transcription by hormones, in 
particular estrogen, which promotes the nuclear accumulation of TERT in 
an AKT-dependent way (Kimura, Ohmichi et al. 2004). Progesterone 
instead activates TERT transcription through the MAP kinase pathway in 
the malignant cells containing receptor for this hormone (Wang, Kyo et 
al. 2000). 
 
Also oncogenes can have a role in promoting TERT expression. The 
protein E6 of the human papilloma virus (HPV) can induce telomerase 
activity independently from Myc as shown by different studies (Kyo, 
Takakura et al. 2008), as well as Her2/neu, Raf and Ras when expressed 
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together with a protein of the EST family, in a MAP kinase-dependent way 
(Goueli and Janknecht 2004).  
 
Recently, new regulators of telomerase activity have been found by mass 
spectrometry studies (Kang, Chen et al. 2009). This proteins are MutS 
homolog 2 (MSH2), heterogeneous nuclear ribonucleoprotein (hnRNP) D, 
hnRNP K and grainyhead-like 2 (GRHL2), and their expression is 
upregulated in parallel with hTERT in head and neck squamous cell 
carcinoma. MSH2 is a protein involved in the DNA repair machinery, and 
it is necessary for genetic stability, cell proliferation, and maintenance of 
the capping of the telomere. GRHL2 regulates the formation of the 
stratified epithelia, and the two ribonucleoproteins are transcriptional 
regulators that binds to the promoter of the target gene (Kang, Chen et 
al. 2009).  
 
 
• Repressors of transcription 
 
Genes involved in the repression of telomerase activity are mostly 
studied with a chromosomal transfer approach, where regions of a 
chromosome are transferred in a telomerase-positive cell lines, and the 
activity of the enzyme is detected afterwards, indicating if that 
transferred region contains a repressor of telomerase (Cong, Wright et al. 
2002). 
 
A quite predictable repressor of TERT transcription is Mad1, a protein that 
dimers with Max, and competes with the dimer and transcriptional 
activator Myc/Max for its binding with the DNA. The repression induced 
by Mad1 has also been correlated with a decreased acetylation of the 
histones at the TERT promoter (Xu, Popov et al. 2001). 
 
The protein Wilms’ tumour 1 tumour suppressor (WT1), which is essential 
in regulation of differentiation in the kidney and gonad cells, also acts as 
a repressor of TERT transcription (Oh, Song et al. 1999). 
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The tumour suppressor p53 also inhibits TERT transcription, but the 
mechanisms involved are not clarified yet. The repression could act either 
directly or indirectly on TERT promoter, and it may require association 
with Sp1, which is interestingly considered also a weak activator of TERT 
transcription (Cong, Wright et al. 2002). 
 
Moreover, repression on TERT promoter can be carried out by the 
presence of the cytokine Transforming Growth Factor-β (TGF-β), even if 
different studies still debate on the nature (direct or indirect) of its 
interaction with TERT promoter (Kyo, Takakura et al. 2008). 
 
Furthermore, in haemapoietic cells, interferon-α (IFN-α), an inhibitor of 
cellular proliferation, directly acts on TERT promoter to repress gene 
transcription (Xu, Erickson et al. 2000).  
 
In particular, in head and neck squamous cell carcinoma, overexpression 
of p53, E2F1, and p21waf are associated with inhibition of telomerase 
activity (Ying, Randall et al. 2000). In this malignancy, E2F1 acts 
together with retinoblastoma protein (pRB) (Crowe and Nguyen 2001), 
which represses the transcription by modification of the chromatin and 
histone deacetylation (Magnaghi-Jaulin, Groisman et al. 1998). 
 
 
• Epigenetic regulation 
 
 
Apart from specific proteins acting like activators or repressors of 
transcription, modification at transcriptional level of a gene can be carried 
out also by epigenetic regulation, which is modification on the chromatin 
state, DNA methylation and histone de/acetylation.  
 
Many studies have shown that TERT transcription, at least in some cell 
types, can be silenced by methylation of the DNA, consistent with the 
presence of clusters CpG sites in the promoter (Kyo, Takakura et al. 
2008). Also, the recruitment of histone deacetylases by transcription 
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repressors such as Mad1 and Sp1 and use of an inhibitor of histone 
deacetylase showed that modification of the status of the histones around 
TERT promoter is a  mechanism to regulate the transcription of the gene 
(Cong, Wright et al. 2002; Kyo, Takakura et al. 2008).  
 
Recently, a new repressor of transcription has also been identified in the 
protein NFX1. One of the two isoforms of this protein, NFX1-123, 
coactivates TERT promoter if cotransfected with c-Myc, while the isoform 
NFX-91 is a target of ubiquitination in the presence of the HPV protein E6 
(Gewin, Myers et al. 2004). The degradation through deubiquitination is 
carried out by the complex E6-AP, an E3 ubiquitin ligase which is the 
product of the interaction between the viral protein E6 and the cellular 
protein AP. Therefore, activation of TERT promoter by E6 is carried out by 
degradation of NFX1 (Gewin, Myers et al. 2004). A new study by the 
same group have shown that the repression of TERT transcription by 
NFX1 is due to its interaction with the histone deacetylase mSin3A at the 
level of the TERT promotorer (Xu, Luo et al. 2008).  
 
The discovery of this repressor is in agreement with the recent 
observation that TERT activation is dependent on the in vivo tissue 
environment in keratinocytes. In situ-grown epidermis or in organotypic 
cultures activation of transcription of hTERT is active, while in the less 
favourable growth conditions in conventional surface cultures, hTERT is 
silenced through deacetylation of its promoter (Krunic, Moshir et al. 
2009). 
 
Furthermore, other evidence supports the presence of a still unknown 
repressor of telomerase present on chromosome 3p (Cuthbert, Bond et 
al. 1999) and this repressor may act on hTERT by regulating the status of 
chromatin and therefore inhibiting its transcription (Szutorisz, Lingner et 
al. 2003). The mechanisms involved in this repression are still under 
investigation, however it has been shown that the regulation does not 
involve modification of c-Myc activity (Ducrest, Amacker et al. 2001). 
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• Regulation of TERC 
 
Normal human undifferentiated cells express high amount of the RNA 
component of the telomerase, and the expression decreases to almost 
undetectable level in differentiated normal diploid cells (Yashima, Maitra 
et al. 1998); however, cancer cells show a reactivation of TERC 
expression (Avilion, Piatyszek et al. 1996), implying a regulation of the 
transcription of this component as well as of TERT.  The half-life of TERC 
is the highest amongst all RNAs studied up to date, reaching up to 4 
weeks in certain cancer cell lines; this half-life is thought to increase 
through the expression of TERT, without the transcription rate being 
affected (Yi, Tesmer et al. 1999).  
 
Repression of TERC is mainly carried out by methylation of the promoter; 
however, this is not sufficient to completely block transcription in the cell 
lines maintaining telomeres by the ALT mechanism. In this case, TERC 
transcription is effectively blocked by hypermethylation of the promoter 
in more than 90% of its CpG sites (Hoare, Bryce et al. 2001).  
 
In addition, various transcription factors are involved in the regulation of 
TERC promoter: NF-Y interacts with the conserved CCAAT sequence in 
TERC, promoting the transcription of the RNA; also pRb activates the 
promoter, and this effect is inhibited by mutating the CCAAT sequence, 
but the protein does not interact directly with the promoter (Zhao, 
Glasspool et al. 2000).  
 
In addition, Sp1 and Sp3 also interact with different regions in the 
promoter and induce a dose-dependent activation and repression of the 
promoter, respectively (Zhao, Glasspool et al. 2000). Sp1 and Sp3 bind 
to the sites Sp1 in the TERC promoter, and their binding has been shown 
recently to be regulated by JNK (c-Jun-NH2-kinase) (Bilsland, Stevenson 
et al. 2006).  
 
More recently, another activator of transcription has been identified in the 
adenoviral protein E1A, which does not bind directly to the promoter, but 
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to other transcriptional regulators, such as pRb. The mechanisms through 
which E1A activates TERC transcription are not clear yet, however E1A is 
thought to promote transcription by sequestering the corepressor CtBP, a 
protein that binds to the specific Sp1 sites in TERC promoter (Glasspool, 
Burns et al. 2005).  
 
 
 
1.1.5.2 Regulation at post-transcriptional level: mRNA alternative 
splice variants  
 
 
The human TERT gene is localized on the antisense strand of the short 
arm of chromosome 5 (5p15.33), as localized using a probe for 
fluorescence in situ hybridization (Bryce, Morrison et al. 2000). The gene 
is composed of 48881 bp (NCBI Reference Sequence: NG_009265.1), 
formed by 16 exons (from 62 to 1354 bp length) and 15 introns (from 
104 to 8616 bp length) (Wick, Zubov et al. 1999).  
 
The first exon contains the translation start codon, while the end codon is 
localized on exon 16, together with the 3’-untranslated region. The 
telomerase specific motif, or T motif, is localized on the exon 3, while the 
reverse transcriptase (RT) motifs are located on exon 4 (motifs 1 and 2), 
on exon 9 (motif B’, also known as 4), exon 10 (motif C, or 5), exon 11 
(motifs D, or 6, and E, or 7). Motif A, also known as motif 3, is the only 
motif located in two exons, 5 and 6 (Lingner, Hughes et al. 1997; Wick, 
Zubov et al. 1999). 
 
In addition to the full-length mRNA transcript, multiple splice variants 
have been identified, including deletions of part of or whole exons, and 
insertions in the intronic regions (Saeboe-Larssen, Fossberg et al. 2006). 
The result is mostly premature termination of translation due to frame 
shifts. Two different alternative splice variants (ASV), designed α and β 
deletions, have been studied in further detail and cover a role of bigger 
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importance in the possible regulation of telomerase activity by alternative 
splicing (figure 3). 
 
The α splice variant consists in an in-frame deletion of 36 bp, 
corresponding to 12 amino acids, in the reverse transcriptase motif A. 
This is due to the presence of an alternative splice acceptor site in exon 
6. Due to the lack of this essential RT motif, the protein is inactive; it is 
also been shown to act as dominant negative because overexpression of 
this splice variant in cells negative for telomerase activity (where TERC is 
present but TERT is not detectable) cannot reconstitute telomeric activity, 
whereas overexpression of the product from the full length hTERT can 
(Colgin, Wilkinson et al. 2000). Also, exogenous overexpression of the α 
splice variant in cancer cells (where hTERT is already overexpressed) 
reduced the amount of telomerase activity and it was correlated with 
progressive shortening of the telomere and apoptosis (Colgin, Wilkinson 
et al. 2000; Yi, White et al. 2000) 
 
The product of the α splice variant could also inhibit expression of 
telomerase activity in both telomerase-positive fibrosarcoma cells and in 
SV40-immortalized fibroblasts, addressing the cells to senescence or cell 
death, respectively (Colgin, Wilkinson et al. 2000). This observation 
suggests that this splice variant may be generated to cover more 
complex regulatory roles of cell function other than the inhibition of 
telomerase activity. 
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Figure 3: Diagram of the hTERT mRNA alternative splice variants 
 
In the top of the diagram, the schematized structure of hTERT mRNA 
with the conserved domains is shown. The two major splice variants due 
to deleted regions in the mRNA are shown below. A splice variant (α-β+) 
is due to the deletion of 36 bases from the RT motif A. Therefore the 
product will be a shorter protein lacking of catalytical activity. The β 
splice variant (α+β-) is due to the deletion of 182 bases located before 
the motif B, therefore leading to a nonsense mutated product. Another 
nonsense product without RT activity is formed by the combination of the 
two deletion processes during the splicing (α-β-). 
 
 
 
The β splice variant consists in a 182 bp deletion before the B motif which 
results in a nonsense mutation and the creation of a truncated, 
potentially unstable, protein.  A possible role for this splice variant has 
not been identified yet, but its expression seems to vary between cell 
lines and may provide an important role in telomerase regulation. 
 
. 
• The problem of detecting hTERT ASV 
 
To try to investigate the role of the splice variants in telomerase 
regulation, different PCR methods have been utilized to estimate firstly 
the amount of ASVs in different cell types and then to correlate 
telomerase activity with the presence of the splice variants; however, 
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differences between the techniques utilized do not make the comparison 
between studies easy.  
 
Various assays utilized a primer set flanking the regions α and β, 
therefore amplifying all the possible splicing combinations in the same 
polymerase reaction and detecting the different amount of products by 
further electrophoresis on agarose or polyacrylamide gels. This protocol 
can interfere with the nature of the PCR reaction (all the products will be 
amplified after enough number of cycles without reflecting the original 
mRNA amount), therefore it does not seem accurate enough for the 
measurement of five different products (full-length, α, β, and the 
combinations of these). One of these studies (Yi, Shay et al. 2001) 
showed little variation in the ratio of splice variant expression between 
the panel of normal, in vitro immortalized and cancer cell lines, but the 
amount of β deleted variant interestingly represented the majority of the 
transcript in all telomerase-positive cell lines (approximately 80-90% of 
the total amount of hTERT mRNA), compared to the full-length transcript 
(approximately 5%). Correlation with telomerase activity was found only 
with the full-length variant only (in the presence of the RNA component 
TERC which is necessary for the enzymatic activity). On the other hand, a 
more recent study showed an equal presence of all splice variants in 
telomerase-positive lung carcinoids, with a higher presence of full-length 
transcript, but higher expression of the β deleted splice variant was 
detected in telomerase-negative lung carcinoids. Therefore the 
correlation between telomeric activity and the presence of a splice variant 
was not excluded, where the β deleted splice variant could cover a role of 
telomerase negative regulation  (Zaffaroni, Villa et al. 2005). 
 
Other assays utilize real-time methods based on a dual-labelled probe 
system. In this method, primers are designed for each specific splice 
variant and the resulting products given by the amplification of the cDNA 
by the possible primers combinations are detected by a probe which is 
identical for all the splice variants. In the study by Ohyashiki et al., 
hTERT inactive splice variants are expressed in lower amounts in 
leukaemia patients with high telomerase activity, hypothesizing a 
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possible loss of telomerase regulation in the progression of the 
malignancy and confirming a possible role of splice variants as regulator 
of telomerase activity (Ohyashiki, Hisatomi et al. 2005). To confirm this 
observation, a more recent study using the same primers/probe approach 
showed that in non-neoplastic cell lines all hTERT splice variants were 
expressed in a lower amount than in adjacent lung carcinoma samples 
(Mavrogiannou, Strati et al. 2007), confirming the observations made 
previously by Zaffaroni et al. (Zaffaroni, Della Porta et al. 2002) in 
samples taken from a non-neoplastic breast tissue adjacent to the 
neoplastic area.  
 
The difference in the outcome of the splice variant detection after the two 
different techniques is even more relevant if I consider the study by 
Mavrogiannou et al., where it was possible to  detect a higher amount of 
full-length transcript (approximately 50% of the total amount of hTERT 
mRNA) compared to the β deleted splice variant (approximately 4%), in 
contrast to the aforementioned study by Yi et al. (Yi, Shay et al. 2001). 
This could be due the higher specificity of primers/probe assay, which 
permits the unique amplification of each splice variant, in contrast to the 
first method described where all the ASV are detected simultaneously. 
 
Similarly to the primers/probe approach, a new technique using specific 
primer combinations and SYBR green real-time PCR has been developed, 
avoiding the use of probes and allowing the possibility of a melting curve 
analysis to check the specificity of the template. Also, the quantitation of 
the products is more specific because a reference gene analysis is 
included in the assay. Studies on melanoma  cell lines using this 
technique showed a similar expression of all the full-length and splice 
variants in all the samples, where the full-length transcript and β deleted 
splice variant were relatively more expressed then the other variants 
compared to the total amount of hTERT mRNA (approximately 48% and 
44% respectively) (Lincz, Mudge et al. 2008). Also, telomerase activity 
was directly correlated with the presence of the full-length variants and 
inversely correlated with the β deleted splice variant.  
 
1.1.5- Regulations of telomerase 
 
 47
An interesting study by Cerezo et al. (Cerezo, Kalthoff et al. 2002) 
hypothesized a regulation of hTERT splice variant by TGF-β1 signalling 
specifically in skin keratinocytes. The expression of the ASV transcripts 
was measured in this study according to the first protocol mentioned in 
this chapter, which is the detection of all the different ASV after 
amplification with a general primer pair. HaCaT keratinocytes 
overexpressing Myc and treated with TGF-β1 showed a reversible 
decrease of full-length hTERT transcript and an increase of the β splice 
variant. However, the contribution of Myc in this modulation is not fully 
understood. In fact, entire HaCaT sheets (not overexpressing Myc) 
detached from the surface of a culture dishes, and resembling a normal 
tissue disruption and cell differentiation, also show a shift of expression 
from full-length hTERT to the inactive β splice variant. Furthermore, the 
use of organotypic cultures that resemble the opposite phenomenon of 
epidermal re-formation, similar to what happens in vivo showed that 
regeneration of the different layers of epidermis is accompanied with a 
shift from the β splice variant to the full-length variant of hTERT. The 
correlation with TGF-β1 was therefore suggested, since this factor is 
involved in numerous processes involved in wound healing, especially 
during proliferation and mobilization of keratinocytes during tissue re-
epithelialisation (Barrientos, Stojadinovic et al. 2008).  
 
In conclusion, the aforementioned study by Cerezo et al. gives a further 
insight of a possible role of the β splice variant in regulation of 
telomerase activity, and the utilization of an organotypic model seems 
appropriate for a partial correlation with the complex phenomenon of re-
epithelialisation in vivo. However, a more standardized and accurate 
method of detecting the expression of hTERT splice variants is necessary 
before a possible elucidation of the role of the spliced transcript can be 
made.  
 
The utilization of unique primer pairs for each splice variants, the analysis 
of each ASV separately with a real-time PCR protocol and the utilization 
of one or more housekeeping genes as a standard references should 
therefore be considered the method of choice for a reliable quantification. 
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1.1.5.3 Regulation at post-translational level 
 
 
Although TERT regulation is greatly carried out at the transcriptional 
level, some studies have also demonstrated a further level of regulation 
after the synthesis of the protein. Post-translational regulators of 
telomerase activity have revealed different proteins interacting with TERT 
in a direct or indirect way (interaction mediated by the accessories 
protein in the holoenzyme), as shown by several studies both in vivo and 
in vitro.  
 
The overexpression of the protein PinX1, which interacts with Pin2/TRF1,  
a member of the telomeric complex, has been associated with inhibition 
of telomerase activity and telomere shortening, and it has been observed 
that the regulation is due to the direct binding of this PinX1 to TERT 
(Zhou and Lu 2001).  
 
In a similar way, the protein KIP, also known as KIP1, a protein 
mediating the interaction between DNA and DNA-dependent protein 
kinases, directly or indirectly interacts with TERT but the interaction on 
this case stimulates telomerase activity and telomeres lengthening both 
in vivo and in vitro, therefore counteracting somehow the role of PinX1 
(Lee, Yu et al. 2004). 
 
Also the correct assembly of TERT protein is necessary for the function of 
the enzyme. The molecular chaperones p23 and Hsp90 associate with the 
presence of telomerase activity and their inhibition also inhibits the 
telomerase activity (Holt, Aisner et al. 1999). 
 
Furthermore, Ku, an heterodimer involved in DNA repair, contributes to 
telomerase activity also in the absence of TERC, therefore associating 
directly with the catalytic component (Chai, Ford et al. 2002).  
 
Telomerase activity in vitro is also enhanced after phosphorylation of the 
serine/threonine sites present in TERT by the activated Akt kinase (Kang, 
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Kwon et al. 1999). On the other hand, telomerase activity is inhibited by 
the interaction with the tyrosine kinase c-Abl, which is activated by DNA 
double strand breaks (Kharbanda, Kumar et al. 2000) and, reversibly, by 
protein phosphatase 2A (PP2A) (Li, Zhao et al. 1997). 
 
Furthermore, different protein kinase C (PKC) isoforms are involved in 
the cell specific activation of telomerase activity, as demonstrated by the 
use of specific inhibitors of these isoforms (Ku, Cheng et al. 1997). 
  
In addition, phosphorylation may act as a regulatory mechanism in the 
translocation of hTERT from the nucleus to the cytoplasm, which is 
initiated after oxidative stress and it has been correlated with an 
apoptosis.  Components of the Src kinase family, activated by ROS, can 
in fact phosphorylate hTERT and trigger the nuclear export of the 
macromolecule (Haendeler, Hoffmann et al. 2003). 
 
Moreover, the identification of a Makorin RING finger protein 1 (MKRN1) 
showed that TERT can undergo ubiquitination, which is degradation of the 
protein by the proteasome complex. MKRN1 mediates the translocation of 
TERT to the proteasome (Kim, Park et al. 2005), suggesting that further 
ways of regulating telomerase can provide an even wider involvement of 
other cellular processes and pathways. 
 
In particular, in skin keratinocytes, a further way of regulating 
telomerase expression due to differentiation has been hypothesized. 
During differentiation, calcium levels increase in these cells. A parallel 
increase in the two calcium binding proteins S100A8 and S100A9 is also 
shown during this process; therefore it has been hypothesized that when 
level of calcium increase during differentiation, the ion is detected by the 
complex of the two S100 proteins, leading to the temporary release of 
S100A8. This protein in turn will directly interact with telomerase and 
reduce the enzymatic activity; on the other hand, when calcium levels 
are low, S100A9 interacts with S100A8 and prevent its bound with 
telomerase. Therefore, S100A8 and S100A9 have an antagonistic role in 
the regulation of telomerase activity (Rosenberger, Thorey et al. 2007). 
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1.2 The epidermis 
 
 
The epidermis is a stratified epithelium mainly composed of keratinocytes 
organized in multilayers (figure 4). The layer located closer to the 
basement membrane and to the derma is the basal layer (or stratum 
germinativum), composed of nucleated proliferating undifferentiated cells 
which continually migrate to the upper layers. Following an increasing 
gradient of differentiation, the following layer is the prickle cell layer (or 
stratum spinosum), also composed of nucleated and proliferating 
keratinocytes with characteristic spines preventing attacks from bacteria.   
Next is the granular layer (or stratum granulosum), where the cells lose 
the spines and the nuclei, and produce keratin.  On the most external 
surface of the epidermis, the horny (or stratum corneum) layer is 
composed of anucleated dead cells, which will eventually shed and 
desquamate (Fuchs 1995). 
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Figure 4: Structure of the epidermis 
 
The epidermis is the outer surface of the skin, located above the derma, 
and it is composed by several layers of mostly keratinocytes migrating 
upwards during differentiation. The lower layer of the epidermis in 
contact with the dermis is the basal cell layers, where cells are 
continuously proliferating and moving to the next layer, the spinous 
layer. In this layer cells are shaped more irregularly and keep 
proliferating and migrating during skin regeneration. The next layer, 
granular layer, is characterized by an increase flattening of the 
keratinocytes, which also start accumulating keratin. Keratin production 
is maximised in the cells in the outer layer, the stratum corneum, where 
cells are dead, flattened and form overlapping layers to carry on the 
waterproof and barrier function of the skin. Regularly, dead cells are shed 
from the skin surface in the form or squames (figure from (Fuchs 1995)). 
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1.3. Human squamous cell carcinoma and its mouse model 
 
 
1.3.1 Human squamous cell carcinoma 
 
 
Head and neck cancer is the sixth most common cancer worldwide, and 
the majority of these cancers are squamous cell carcinomas (SCCs).  
Head and neck cancer can start in a different set of oral tissues, such as 
oral cavity, pharynx, larynx, salivary gland, tongue, thyroid, affecting the 
treatment and the severity of the disease (Hennessey, Westra et al. 
2009). In the rest of the body, SCC can affect sun-exposed areas like 
part of the trunk or extremities, and genitals (Johnson, Rowe et al. 
1992). 
 
SCC affects mostly older men, and it has been associated directly or 
indirectly with many risk factors, such as UV exposure, 
immunosuppression, tobacco, alcohol use, albinism, genetic skin 
diseases, and chronic inflammation. Also infectious aetiologies, such as 
Epstein-Barr virus (EBV) and human papillomavirus (HPV), represent a 
high risk factor for SCC (Dubina and Goldenberg 2009; Hennessey, 
Westra et al. 2009; Chute and Stelow 2010). 
 
In the skin, SCC can arise in the absence of precursor lesions or after the 
occurrence of actinic keratoses patches, which are premalignant lesions 
due to sun-exposure. In the most common in situ variant of SCC, the 
affected epidermis presents increased thickness, hyperkeratosis and pink 
patches of the epidermis but no invasion into the dermis (Johnson, Rowe 
et al. 1992) . 
 
In the oral cavity, the most common premalignant lesions are leukoplakia 
(adherent white patches on the mucous membranes) and erythroplakia 
(red patch or lesion). The latter, even if less common, is almost always 
correlated with a future transformation into malignancy. These lesions 
histologically are formed of hyperplastic (excessive cell proliferation) or 
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dysplastic (abnormality in the maturation of the cells) cells (Jon and 
Albrecht 2003).  
 
Histological evaluation has allowed investigators to distinguish different 
variants of SCC, such as verrucous carcinoma, papillary SCC, basaloid 
SCC, spindle cell carcinoma, adenosquamous carcinoma, acantholytic 
(adenoid/pseudovascular) SCC, and undifferentiated carcinoma, 
highlighting the difficulty in diagnosing each specific class and the need 
for finding a specific treatment for each one (Chute and Stelow 2010). 
 
 
1.3.1.1 Molecular markers in human SCC 
 
 
A wide variety of molecular markers are used to diagnose SCC in head 
and neck, among which are: epidermal growth factor receptor (EGFR), 
p53 status, cell cycle proteins such as cyclin D and p16INK4a, transcription 
factors and oncogenes such as c-Myc and Ras,  apoptotic proteins such 
as Bax and Bcl-2, presence of HPV, and telomerase activity (Nadal and 
Cardesa 2003; Gold and Kim 2009).  
 
 
• EGFR 
Overexpression of EGFR is found in more than 90% of head and neck 
SCC (Gold and Kim 2009) and it is associated to a poor prognosis, a 
positive nodal stage of the cancer and a lower survival in the patients. 
This receptor, when dimerizing with another subunit or with a receptor of 
the ErbB family like ErbB2, autophosphorylates and activates ERK1 and 
ERK2, part of the MAPK pathway, regulating in turn the growth, 
progression and malignancy of the tumour (Mahmoud, Mehmet et al. 
2008).  
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• p53 
Mutations in the tumour suppressor protein p53 are frequent in various 
human carcinomas. In head and neck SCC, mutations are found in 40% 
to 87% of tumours, depending on the sensitivity of the technique (Boyle, 
Hakim et al. 1993; Waridel, Estreicher et al. 1997). P53 mutations 
increase with the progression of the tumour, and can be found not only at 
the invasive stage of the malignancy, but also at non-invasive stages, 
and in normal tissues adjacent to malignant tissue, indicating that 
mutations in the tumour suppressor are early events in the development 
of SCC (Nees, Homann et al. 1993). However, not all studies agree that 
there is a correlation between p53 mutation and the tumour stage or 
clinical outcome (Gold and Kim 2009).  
 
 
• Cyclin D and p16INK4a 
During tumour progression, the entry into the S phase of the cell cycle is 
essential for the progression and growth of the tumour.  Cyclin D1 is one 
of the essential regulators of this transition, and the amplification of the 
gene for the cyclin is detected in 35-64% of laryngeal SCC 
(Papadimitrakopoulou, Izzo et al. 2001). The gene amplification is 
correlated with protein overexpression and with the progression of the 
disease. Cyclin D overexpression is found on mild and moderate 
dysplasias (Papadimitrakopoulou, Izzo et al. 2001), and in carcinomas at 
invasive stages (Jares, Fernandez et al. 1994; Papadimitrakopoulou, Izzo 
et al. 2001), associating with a lower survival of the patient. This 
suggests that cyclin D is already overexpressed at an early stage of the 
neoplastic transformation, and it increases during the progression of the 
malignancy. Cyclin D is inhibited by p16INK4a via inhibition of the 
phosphorylation of the protein pRb and blockage in the release of E2F. 
Different kinds of alterations on p16INK4a are found in nearly 70% of head 
and neck SCC, with some differences according to the kind of 
modification (such as loss of heterozygosity, point mutations, and 
deletions). Even if no correlation with the outcome of the malignancy has 
been observed, mutation on this key protein may confer an advantage to 
the tumour cells, such as increased growth rate (Hardisson 2003). 
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However, other studies showed a correlation between loss of the p16 and 
tumour progression. A retrospective study found alterations in the two 
tumour suppressor p53 and p16INK4a in premalignant laryngeal lesions 
that later became neoplastic (Gallo, Santucci et al. 1997), and mutation, 
loss of heterozygosity or hypermethylation of p16INK4a and p14ARF 
(encoded by the same locus in the chromosome 9) were also found in 
samples of severe dysplasia (Kresty, Mallery et al. 2002) that 
subsequently progressed to SCC. 
 
 
• c-Myc and RAS 
The role of the transcription factor c-Myc has often been studied in 
parallel with Ras. Mutations in RAS are seen in 35% of oral SCC in the 
Asiatic population (Saranath, Chang et al. 1991), but even if this is 
correlated with different causes, such as the effect of chewing betel quid 
or increased tobacco assumption compared to the Western population 
where RAS mutations are almost undetectable (Hardisson 2003), a 
reason for is still to be defined.  However, since overexpression of Ras is 
found in the dysplastic mucosa as well as in the more advanced stages of 
the tumour (Wendell, Carol et al. 1994; Hardisson 2003) indicating that 
this event, similarly to the expression pattern of cyclin D, is also an early 
event in tumourigenity. 
 
Also c-MYC amplification and the overexpression of the transcription 
factor is found at different levels in head and neck cancer, and, even if 
generally amplification of c-MYC leads to a worse outcome for the patient 
(Wang, Xue et al. 2010), the reason for the variance in the results is not 
fully comprehended yet. One possibility is, that c-MYC is part of an 
amplicon that includes the gene for focal adhesion kinase, FAK, and the 
FAK gene is amplified more often than c-MYC (Agochiya, Brunton et al. 
1999) and so FAK and not c-MYC may account for the poor prognosis of 
the tumours.  In support of this a recent analysis of several microarray 
studies of head and neck SCC revealed a link between FAK and its 
associated focal adhesion pathways and poor prognosis (Thurlow, Peña 
Murillo et al. 2010 (in press)). 
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• Bcl-2 and Bax 
The protein family Bcl covers a mayor role in the apoptotic fate of the 
cells. B-cell leukemia/lymphoma 2 (Bcl-2), of the most important 
member of this family, covers a role as inhibitor of apoptosis which can 
be modulated by its heterodimerization with Bcl-2–associated X protein 
(Bax), a proapoptotic protein (Hardisson 2003). If the apoptotic signalling 
eventually starts, Bcl-2 will start the caspase cascade.  
 
Overexpression of Bcl-2, but also Bax, and of proteins of the same family 
with analogue functions, is found in different amounts in samples from 
head and neck SCC, but even if this suggests that this protein family 
covers an important role in the apoptotic rate of the malignant cells, 
correlation with survival in the patients or with the stage of the cancer 
has not been unequivocally demonstrated (Hotz, Bosq et al. 1999). 
 
 
• HPV 
As mentioned before, HPV is viewed more and more as an etiological 
factor for a defined population of head and neck SCC, also shown by 
recent epidemiologic data (D'Souza, Kreimer et al. 2007), and it 
associates with a better prognosis compared to non-HPV SCC (Psyrri, 
Gouveris et al. 2009; Ha Linh, Andrew et al. 2010). The virus triggers the 
continuous expression of the two viral protein E6 and E7, which in turn 
repress the transcription of both p53 and pRb (Psyrri, Gouveris et al. 
2009).  
 
In particular, in high-risk HPV, E6 accelerates the rate of degradation of 
p53 by promoting the ubiquitin-dependent proteolysis in a ATP-
dependent mechanism (Scheffner, Werness et al. 1990; Munger and 
Howley 2002). Similarly, the viral protein E7 from high-risk HP promotes 
the ubiquitin-dependent proteolysis of the tumour suppressor pRB 
(Munger, Werness et al. 1989; Boyer, Wazer et al. 1996; Munger and 
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Howley 2002) and inhibit p16INK4a-induced cell cycle arrest by G1 block 
(Giarre, Caldeira et al. 2001). 
 
 
• Apoptosis 
In addition, the apoptotic index in SCC is interestingly elevated, and 
correlates with the progression of the disease from mild dysplasia to 
carcinoma. Also proliferation and angiogenesis progressively increase, 
but at a different rate, promoting the progression and invasion of the 
tumour even in presence of high apoptosis (Macluskey, Chandrachud et 
al. 2000). This is being shown also at a more molecular level by studies 
on proteins regulating apoptosis.  
 
The anti-apoptotic protein Bag1 is downregulated in its nuclear 
localization in SCC compared with normal oral epithelium, while the 
amount of protein present in the cytoplasma does not vary in the 
malignancy. This may reflect a different localization of some of Bag-1 
isoforms between nucleus and cytoplasm, and this may be correlated 
with the differentiation of the tumour (Hague, Packham et al. 2002).  
 
Caspase-3 expression, is rare and basilar in normal epithelia, but nuclear 
DNA degradation is found in all the upper layers of the epidermis and 
probably necessary for the frequent turnover of the cells. However, true 
apoptosis, as diagnosed by caspase 3 activation, increases in oral  
squamous cell carcinoma and it is correlated with the differentiation stage 
of the tumour (Hague, Eveson et al. 2004). 
 
 
• Telomerase and its regulators 
Expression of hTERT mRNA and telomerase activity are both elevated in a 
variety of human cancers, as previously stated (Blackburn 2001). 
Telomerase activity is found on approximately 90% of head and neck 
SCC (Hohaus, Cavallo et al. 1996), and it is associated with the stage of 
the malignancy (Kim, Piatyszek et al. 1994; Kang, Chen et al. 2009; 
Strazisar, Mlakar et al. 2009), although increased in many dysplasias 
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(Mao, El-Naggar et al. 1996). However, telomerase activity can be found 
also on the mucosa adjacent to the neoplastic cells, showing a gradient of 
activity that is independent from the presence of dysplasia (Hohaus, 
Cavallo et al. 1996).  
 
Interestingly, hTERT overexpression is associated with the 
overexpression of the regulators of telomerase activity MSH2, hnRNP D, 
hnRNP K and GRHL2, demonstrating the critical role of hTERT in SCC and 
the necessity for a fine regulation (Kang, Chen et al. 2009).  
 
In addition, the expression of the gene coding for the calcium-binding 
protein S100A2 is up-regulated in approximately 80% SCC and parallels 
the up-regulation of hTERT (Strazisar, Mlakar et al. 2009), further 
emphasising the importance of the S100 protein family in the regulation 
of telomerase in squamous tissue (Rosenberger, Thorey et al. 2007), as 
mentioned above in section 1.1.5.3. 
 
 
 
1.3.1.2 The mouse two-stage tumourigenesis system 
 
 
As discussed in the previous sections, the formation and progression of 
squamous cell carcinoma covers a wide variety of proteins and cellular 
pathways, which are complex to identify. For this aim, different groups 
have studied a simpler mouse system, defined as mouse two-stage 
tumourigenesis system, where the tumour formation and progression can 
be analyzed more in detail and under controlled conditions, after 
administering the initiating carcinogen DMBA and the tumour promoter 
TPA.  As already explained briefly in section 1.1.4.2, the first stage is the 
formation from normal skin keratinocytes of a papilloma, and the second 
stage is the progression of the papilloma into squamous cell carcinoma 
(Yuspa 1998). 
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The initiation stage triggered by DMBA consists of the formation of stable 
adducts of the drug with the DNA and it is therefore irreversible 
(Devanesan, RamaKrishna et al. 1993), while the promotion stage 
triggered by TPA, which activates protein kinase C (Kikkawa, Kishimoto 
et al. 1989), is reversible and it is not sufficient to initiate the papillomas. 
The irreversible nature of initiation for at least a year suggests that the 
initiation event takes place in the permanent stem cells of the epidermis 
and recent evidence has shown that these reside in the hair follicle 
(Argyris 1980; Brown, Strathdee et al. 1998; Jaks, Barker et al. 2008). 
 
The initial formation of papillomas in mice after repeated TPA 
administration reflects a change in the keratinocytes, that stop 
differentiating and become hyperplastic (Yuspa 1998).   
 
The most important feature, detected in more than 90% of tumours, is 
however the presence of the mutation in the ras oncogene (Quintanilla, 
Brown et al. 1986), which is followed by the overexpression of Cyclin D 
(Robles and Conti 1995).  
 
Cultured mouse keratinocytes overexpressing an activated ras secrete 
TGFα, which is a ligand for EGFR (Lee, Punnonen et al. 1992). The 
overexpression of TGFα preceeds the overexpression of EGFR in the early 
stages of the tumour (Rubin Grandis, Tweardy et al. 1998), suggesting 
that both these events are necessary for the initial stages of the tumour 
promotion.  EGFR, even if not required for the mitogenic response in in 
vitro v-ras transformed keratinocytes, is necessary for the growth of the 
papillomas in the two-stage tumourigenesis system (Dlugosz, Hansen et 
al. 1997). 
  
The progression of the papillomas towards squamous cell  carcinoma can 
happen spontaneously from a small subpopulation of high-risk 
papillomas, and it is associated with genetic alterations, such as trisomy 
of the chromosome 6 and 7 (carrying ras), and aneuplody, followed by 
progressive absence of differentiation markers (Aldaz, Conti et al. 1988; 
Yuspa 1998).  
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An important oncogene which is essential for the progression into 
carcinoma is fos, which works together with ras in skin carcinogenesis. 
The product of fos is crucial in the transcriptional regulation of many 
genes, since it can dimerize with jun to form the transcriptional factor AP-
1 (Greenhalgh, Welty et al. 1990), which in turn targets several genes 
involved in cell proliferation, differentiation, and tumourigenesis (Saez, 
Rutberg et al. 1995). 
 
High-risk papillomas also show loss of both TGF-β1 and TGF-β2, which 
correlates with hyperproliferation of the basal and suprabasal strata, 
respectively (Glick, Kulkarni et al. 1993).  
 
Increased expression of the integrin α6β4 in the suprabasal strata can 
also be detected (Tennenbaum, Weiner et al. 1993), suggesting the 
importance covered by the interactions between the transforming cells 
and the extracellular matrix in malignant progression.  
 
Furthermore, overexpression of a mouse homolog to the anti-apoptotic 
protein Bcl-2 was detected in the basal layer of papillomas and in most of 
the cells of the carcinomas (Rutberg, Lee et al. 1997).  
 
Correlation between the speed of progression of papillomas to 
malignancy has also been correlated with loss of p53. However, the loss 
of this tumour suppressor does not correlate with the initial promotion 
stage (Kemp, Donehower et al. 1993). Also mutations or deregulation of 
the tumour suppressors p16INK4a and p15INK4b are associated with the 
progression of the malignancy, since these alterations are found only in 
the latest stage of mouse SCC, the spindle carcinoma (Linardopoulos, 
Street et al. 1995).  
 
Interestingly, telomerase does not appear to affect the progression rate 
of papillomas to carcinomas but augments the formation of papillomas 
giving clues as to its mode of action (Gonzalez-Suarez, Samper et al. 
2001) There is abundant evidence that papilloma development is 
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impeded by TGF-β (Cui, Fowlis et al. 1996) and that non-canonical 
functions of telomerase can render cells resistant to the anti-proliferative 
effects of TGF-β.  However, I have not been able to show that TERT 
expression affects TGF-β sensitivity in either normal or HaCaT human 
keratinocytes (E.K. Parkinson, unpublished data). 
1.4- Apoptosis and anoikis 
 62
1.4 Apoptosis and anoikis 
 
 
1.4.1 Apoptosis 
 
 
Apoptosis, also known as "programmed cell death", is an innate response 
of the cell essential for normal development, homeostasis and protection 
of the rest of the organism from potentially damaging agents (Ashkenazi 
2002; Gewies 2004; Jin and El-Deiry 2005). A cell undergoing an 
apoptotic process presents an initial chromatin condensation and 
segregation, cytoplasm condensation and convolution of the cell 
membrane. Later on the surface of the cell will develop buds, originating 
apoptotic bodies which contain pieces of cytoplasm, and fragmented 
chromatin, and later on these cell fragments are phagocytosed. 
 
Apoptosis is activated through two major signalling pathways, which 
create a complex network (figure 5) exhibiting some cross-talk. The 
extrinsic pathway depends on the stimulation of death receptors of the 
TNFR superfamily by a pro-apoptotic ligand, such as endogenous 
Apo2L/TRAIL (apoptosis-inducing ligand 2 or tumour necrosis factor-
related apoptosis-inducing ligand), following the interaction receptor-
ligand, a molecular complex known as DISC is being formed, and 
caspases 8 and 10 are activated. Caspases are proteolytic enzymes which 
degrade endonuclear, stromal and enzymatic proteins important for cell 
viability. Thus activated initiator caspases 8 and 10 activate downstream 
effector caspases 3, 6, and 7, leading to apoptosis (Ashkenazi 2002; 
Gewies 2004; Jin and El-Deiry 2005).  
 
The intrinsic pathway involves mitochondria and the endoplasmic 
reticulum. In this pathway, the tumour-suppressor gene p53 activates 
members of the pro-apoptotic Bcl-2 family, eventually leading to the 
release of cytochrome c and SMAC/DIABLO from the mitochondria. 
Cytochrome c binds APAF-1, forming an “apoptosome” that activates the 
initiator caspase 9. Caspase 9 activates downstream effector caspases, 
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including the same caspases 3, 6, and 7 present in the extrinsic pathway. 
SMAC/DIABLO, interacts with inhibitor of apoptosis (IAP) proteins, 
permitting the apoptotic process (Ashkenazi 2002; Gewies 2004; Jin and 
El-Deiry 2005).    
 
 
Figure 5: Schematic representation of some major apoptotic 
signalling pathways 
 
The two major apoptosis signalling pathways, extrinsic (involving the 
death receptors) and intrinsic (involving the mitochondria) converge at 
the level of the effector caspases 3, 6, and 7. The extrinsic and intrinsic 
pathways can also cross-talk when caspase 8 cleaves the pro-apoptotic 
Bcl-2 family member BID, which leads to activation of caspase 9 via 
mitochondria and further activate caspases 3, 6, and 7. The effector 
caspases can also activate caspase 8 and 10, forming a positive 
amplification loop (Stennicke and Salvesen 2000). Figure from (Gewies 
2004). 
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1.4.1 Anoikis 
 
 
The lack of cell attachment to the extracellular matrix (ECM) can induce 
apoptosis in different systems in vitro, and this process has been 
designated as anoikis (from the Greek term “homelessness”) (Frisch and 
Francis 1994).  Different cell types in vitro present different sensitiveness 
to anoikis, and in particular it has been shown that epithelial cells 
become more resistant to anoikis after oncogenic transformation (Frisch 
and Screaton 2001). Anoikis in vivo therefore may prevent dysplastic 
growth of epithelial cells, by deleting them before they reattach to new 
matrix, but its meaning may be more complex when other cell types are 
considered (Frisch and Ruoslahti 1997). 
 
Different mechanisms, most of them cell type-specific, have been 
hypothesised for anoikis (Frisch and Ruoslahti 1997; Frisch and Screaton 
2001; Stupack and Cheresh 2002). Signalling starting from integrins can 
lead to a cascade of events through the activation of the FAK pathway, 
activating PI3K and Akt, or Ras, Raf and ERK1/ERK2. In both cases, the 
final results will be the expression of the anti-apoptotic proteins Bcl2, Bcl-
xL, or cIAPs (Stupack and Cheresh 2002).  
 
Inhibition of EGF signalling, a modification in the structure of 
cytoskeleton, and a role of death-receptors to understand the initial point 
of activation of caspases have also been investigated (Frisch and 
Ruoslahti 1997; Frisch and Screaton 2001). Some of the pathways 
hypothesized for anoikis are shown in figure 6.  
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Figure 6: Schematic representation of some hypothesized anoikis 
signalling pathways 
 
Autophosphorylation of FAK triggered by activation of integrins leads to 
the Ras-dependent activation of PI3K and further activation of Akt. Akt, 
together with NF-kB (not shown) can target the expression of the anti-
apoptotic proteins of the Bcl family. Alternatively, FAK can activate the 
Raf-MEK-ERK pathway. Erk phosphorylates Bcl-2 inhibiting its 
degradation, and also promote the expression of the anti-apoptotic 
proteins cIAPs.  
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1.4.3 Role of ROS production in anoikis 
 
 
Few studies have shown a role of the production of ROS in anoikis. An 
increase in the production of ROS has been correlated with an augmented 
sensitivity in cell death due to anchorage deprivation in endothelial cells. 
Therefore, antioxidants could be promoting the survival and proliferation 
of these cells in a matrix-deprived environment (Schafer, Grassian et al. 
2009). This would confirm an earlier study showing a rise in ROS 
production from the mitochondria after detachment of endothelial cells 
from the ECM. ROS were hypothesized to intervene at an point upstream 
to caspase activation (Li, Ito et al. 1999). However, another study 
showed that an induced increase the concentration of ROS is followed by 
an increase in the number of cells resistant to anoikis. ROS, in fact, 
activates the Src survival pathway, and ERK and Akt signalling, similarly 
to the pathways triggered by the integrin signalling during cell 
attachment to the ECM (Giannoni, Buricchi et al. 2008).  
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1.5. The extracellular matrix and the role of integrins 
 
 
The extracellular matrix (ECM) is defined as the part of a tissue which is 
external to the cells. ECM is formed by numerous proteins and 
polysaccharides which can vary in amount and type according to the 
adjacent tissue or singular cell, to reflect the individual need of a specific 
tissue or cell shape, development, proliferation or function (Alberts 
2002). Each one of these functions is carried out by a combination of 
different proteins of the ECM, revealing the complex interaction 
happening between the cell and the ECM and how influential a disruption 
of this signalling network can be on the cell behaviour. 
 
As explained above, a lack of interactions between the cell and the ECM 
triggers an apoptotic phenotype known as anoikis. The components of 
the ECM that have been studied more extensively in anchorage 
deprivation-induced cell death are integrins because of the different 
variety of effects initiated by their expression and binding to specific 
ligands. 
 
Integrins are composed by a large number of transmembrane proteins, 
which bind to the cellular cytoskeleton on the cytoplasmic tail, and to 
specific ligands on the ECM on the other end. The affinity with the ligand 
is quite weak, but the concentration of integrins on the cell surface is so 
elevated that it can warrant a highly regulated reversible binding 
between the cell and the ECM (Alberts 2002). Integrins are formed of 
many variants of two distinct subunits, α and β, which then dimerize on 
the cell surface to form a complete receptor. Some of the subunits, such 
as the widely studied β1, are transported to the Golgi complex and is 
glycosylated at the N-terminus, to produce the mature subunit that can 
move to the cell surface and eventually form a receptor (Gu and 
Taniguchi 2004). 
 
Once the ligand is recognized, the activated integrins cluster to form 
defined structures on the cell membrane called focal adhesions, which 
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also encompass a number of accessory proteins, like kinases (such as 
focal adhesion kinase, FAK, or the Src kinases) or scaffolding proteins. On 
the inside of the cell, other proteins are recruited from the active 
integrins, especially with scaffolding and signalling functions 
(Desgrosellier and Cheresh 2010). As detailed in figure 7, the signal 
triggered by integrins is complex and ramified, and involves several 
important transcription factors, such as Jun or NF-kB, different kinases, 
such as ERK, AKT and RAF, and oncogenes such as RAS. The 
combinations of a specific ligand, and the accessory proteins recruited, 
will trigger a specific signal which can result in cell migration, survival, 
proliferation, all of these happening during the cell development, 
differentiation, and transformation. 
 
The role of integrins in cancer has therefore been widely studied by 
numerous groups. Expression of integrins is modified in malignant cells,  
but also in the surrounding tissues and host cells, such as fibroblasts and 
the cells in the vascular system (Desgrosellier and Cheresh 2010), not 
only to confer anti-apoptotic and proliferative advantages to the cancer 
cells, but also to create a favourable environment for these cells to 
proliferate and invade other tissues.  
 
In the neoplastic cells, integrins can cooperate with a variety of 
oncogenes, amplifying the signal triggered by the activation of these. For 
example, the integrin α6β4 works together with EGFR through the Src 
family kinase Fyn to promote migration of SCC cells under EGF 
stimulation (Mariotti, Kedeshian et al. 2001; Mercurio and Rabinovitz 
2001); with ErbB2 in mammary and ovarian human carcinoma, possibly 
to promote invasion (Falcioni, Antonini et al. 1997); and with Met, the 
receptor for the hepatocyte growth factor, even if studies are not 
concordant on this (Trusolino, Bertotti et al. 2001; Chung, Yoon et al. 
2004).  
 
In addition, deregulation of integrin signalling is not always carried out by 
overexpression of the receptor. For example, the expression of integrin 
α2β1 is reduced during the progression of breast adenocarcinoma, and its 
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reintroduction can restore the non-malignant phenotype in breast 
epithelial cells (Zutter, Santoro et al. 1995).  
 
Integrin overexpression is, however, the most frequent case of regulation 
of the signalling during cancer formation and progression. Even if tumour 
cells usually present mutations in oncogenes or loss of heterozygosity of 
other genes, and therefore gaining an increase proliferation, migration, or 
survival, and becoming rather independent from the binding with the 
ECM, it has been proposed that an increased integrin signalling could still 
be an advantage for the malignant cells, conferring extra proliferation 
and other malignant characteristics (Guo and Giancotti 2004).  
 
For example, overexpression or maintenance of the expression level of 
integrin α6β4, important for the formation of hemidesmosomes, can be 
found in several malignancies, among which SCC, and in some of those it 
is correlated with the survival of the patient and the severity of the 
tumour (Mercurio and Rabinovitz 2001).  Also, in SCC, downregulation of 
the integrin αvβ5 is associated with upregulation of the integrin αvβ6 in 
the regulation of anoikis. The two integrins provide antagonistic roles 
since αvβ5 would promote anoikis, while αvβ6 would inhibit it (Janes and 
Watt 2004). 
 
On the other hand, gain of function mutations in the domains of integrins 
in the neoplastic cells are rare events (Wellcome Trust Sanger Institute 
Cancer Genome Project). In a particular cell line derived from SCC from 
the tongue, SCC-4, mutations in the integrin β1 confers an enhanced 
binding affinity for the ligand and eventually a inhibition of differentiation, 
which is associated with a worse prognosis (Evans, Perkins et al. 2003). 
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Figure 7: The integrin pathway 
 
The different pathways initiated by integrins can lead to three different 
cell processes: cell proliferation, cell survival, and cell migration (together 
with cytoskeletal organization).  After dimerization of two α and β 
subunits and binding with the specific ligand, clusters of integrins are 
formed on the surface as focal adhesion, and binding proteins in the 
cytoplasm interact with the cytoplasmatic tail of the integrin receptor and 
the cytoskeleton. This interaction activates the oligomerization and 
autophosphorylation of FAK, and thus the following binding to Src-family 
kinases (SFKs), thanks to the presence of the specific SH2 domain in this 
protein family, and the activation by phosphorylation of a variety of FAK-
associated proteins. Through a cascade signalling, this pathway leads to 
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the activation of Raf, ERK and the regulators of transcription NF-κB and 
Jun to regulate cell growth and differentiation. 
FAK, independently from the interaction with Src, can also activate other 
protein with the SH2 domain, such as Phosphotidyl Inositol-3Kinase 
(PI3K), which eventually leads to the activation of AKT, a regulator of cell 
survival. 
In addition, Src can activate the G-protein Ras through phosphorylation 
of FAK, which bind to the growth-factor-receptor-bound protein 
complex,the GRB2-SOS. Activation of Ras triggers the MAPK pathway, 
eventually promoting cell migration. Figure from (Guo and Giancotti 
2004). 
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1.6 Aim of the thesis: interplay between telomerase and 
extracellular matrix in the modulation of apoptosis and anoikis in 
skin 
 
 
A possible involvement of telomerase in the mechanism of apoptosis and 
the regulation of the enzyme by loss of attachment with the extracellular 
matrix has firstly been suggested by observations in anchorage-deprived 
normal human epidermal keratinocytes and squamous cell carcinoma 
lines. In these cell lines, anchorage deprivation inhibits telomerase 
activity, while increasing ERK1 activity and leading the cells to cell cycle 
arrest. Re-adhesion to type IV collagen via specific integrin subunits α2β1 
inhibits ERK1 activity and telomerase repression (Crowe, Nguyen et al. 
2005).  
 
Decreased ß1 integrin expression has also been associated with loss of 
basement membrane attachment and terminal differentiation of these 
same cell types (Jones and Watt 1993). A study from Tiberio et al. 
(Tiberio, Marconi et al. 2002) indicates that keratinocytes enriched for 
stem cells are protected from anoikis via β1 integrin, in a Bcl-2 
dependent manner, and that disruption of β1 integrin activates the 
extrinsic apoptotic pathway.  
 
Secondly, the importance of the pathway involving the focal-adhesion 
kinase FAK has also been correlated with cell survival, being able to 
suppress suspension-induced cell death (anoikis) and transform kidney 
epithelial (MDCK) cells (Frisch and Francis 1994). Also, FAK is activated 
by autophosphorylation upon integrin-mediated cell attachment and the 
signalling which follows FAK activation leads to the activation of the MAP 
kinases ERK1 and ERK in human kidney epithelial cells and mouse 
fibroblasts (Schlaepfer and Hunter 1996). 
 
Thirdly, in the same two-stage chemical carcinogenesis mice model cited 
above, a reduction in FAK protein expression in the epidermis has been 
directly associated with a reduction in the acquisition of malignancy and 
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an increase keratinocyte cell death (McLean, Brown et al. 2001; McLean, 
Komiyama et al. 2004), leading to investigate the role of FAK in the 
progression of these tumours. FAK is known to be involved in signalling 
from growth-factor receptors and to influence the adhesion mechanics 
regulated by integrins, working together with the Src-family kinases 
(McLean, Carragher et al. 2005). 
 
Collectively from these data and from what I already know about anoikis, 
I can say that there is considerable experimental support that telomerase 
is regulated by ECM; a possible survival mechanism involving integrins 
and FAK/Src kinases, Ras and ECM; a confirmation of this pathway in the 
survival of skin cancer cells, since FAK (Frisch and Ruoslahti 1997), Src 
(Frisch and Francis 1994) and Ras all mute anoikis (Frisch and Francis 
1994).  
 
The first aim of the study was to establish that my chosen model of 
immortal HaCaT keratinocytes did show a down regulation of telomerase 
activity in anchorage-deprived conditions and if so how this down 
regulation occurred. 
 
The second aim of this study is to investigate whether telomerase could 
augment neoplasia in human squamous epithelia and in mouse models of 
this tumour such as the two stage epidermal tumourigenesis by 
protecting keratinocytes from anoikis.  
 
The final aim of the project was to begin to investigate how telomerase 
was able to mute anoikis and in particular whether telomere lengthening 
or catalytic functions of the enzyme were required.  
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Chapter 2:  
Materials and methods  
 
 
 
2.1 Cell culture 
 
 
HaCaT cells expressing wild-type TERT (possessing both canonical and 
non-canonical function), TERT-HA (non canonical function only), DnTERT 
(double negative TERT) and the empty vector (pBabePuro) were created 
by retroviral transduction in our group by Dr. Fitchett and Dr. Bergin. 
HaCaT are immortalized skin keratinocytes and they were maintained  at 
37ºC in 5% CO2 in RPMI 1640 medium (Invitrogen, Paisley, UK) 
containing 10% v/v Fetal Clone II, 2 mM L-glutamine, 25 mM HEPES. 
SVFN, a clone of SvpgC2a, was kindly donated by Dr. Muy-Teck Teh and 
used as a positive control for hTERT mRNA expression level. SvpgC2a are 
pre-malignant oral keratinocytes infected with SV40 virus (Kulkarnl, 
Sundqvist et al. 1995) and maintained at 37ºC in 5% CO2 in DMEM 
medium (Lonza Biologics, Slough, UK) containing 10% v/v bovine serum, 
2 mM L-glutamine.  
 
VA13 was used as a negative control for hTERC expression level and are 
lung fibroblasts lacking detectable amounts of the RNA component of 
telomerase and elongate telomeres via the ALT mechanism (Bryan, 
Marusic et al. 1997; Atkinson, Hoare et al. 2005). Cells were maintained 
at 37ºC in 5% CO2 in DMEM medium (Lonza Biologics, Slough, UK) 
containing 10% v/v bovine serum, 2 mM L-glutamine. 
 
GM847 was used as a negative control for telomerase activity and are 
SV40-immortalized skin fibroblast line, which maintains telomere length 
via ALT (Bryan, Marusic et al. 1997). It presents almost undetectable 
amount of TERC (Atkinson, Hoare et al. 2005) Cells were maintained at 
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37ºC in 5% CO2 in DMEM medium (Lonza Biologics, Slough, UK) 
containing 10% v/v bovine serum, 2 mM L-glutamine. 
 
SCC-25 and NHEK were used as a positive control for integrin expression. 
SCC-25 (squamous cell carcinoma line) cells were maintained at 37ºC in 
5% CO2 in DMEM medium containing 10% v/v bovine serum, 2mM L-
glutamine. NHEK (normal human epidermal keratinocytes) were 
maintained at 37ºC in 5% CO2 in Keratinocyte basal medium (KBM) 
(Cambrex) supplemented with bulletkit (hydrocortisone, insulin, bovine 
pituitary extract, EGF, antibiotics, Cambrex) to make Keratinocyte growth 
medium (KGM). 
 
All cells were cryopreserved in liquid nitrogen in a freezing medium (10% 
DMSO, 20% serum, 70% complete culture medium), after a gradual 
dropping in temperature at -80°C overnight. This was done by placing 
the cells in ampoules at 1-2x106 cells/ml and wrapping them in cotton 
wool in a plastic box. All cells were routinely subcultured by rinsing briefly 
with 0.02% EDTA and then incubating in 0.05% trypsin/0.01% EDTA at 
37oC until the cells completely detached from the culture vessel.  To 
obtain single HaCaT cell suspensions for experiments the HaCaT cells 
were incubated for 10 mins in 0.1% EDTA at 37oC and then 
disaggregated by incubation in 0.05% trypsin and 0.05% EDTA for 30-40 
mins.   
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2.2 Quantitative real-time PCR 
 
 
 
2.2.1 RNA extraction and cDNA synthesis 
 
 
Total RNA from HaCaT-PURO, HaCaT-TERT, HaCaT-TERT-HA, VA13, SFVN 
at time 0, and after 20 hr in suspension for HaCaTs, was extracted using 
an RNA RNeasy Mini Kit (Qiagen, Crawley, UK) and the concentration 
evaluated with a NanoDrop spectrophotometer (Thermo Fisher Scientific, 
Loughborough, UK). First strand cDNA was synthesized DyNAmo™ cDNA 
Synthesis Kit (Finnzymes, via New England Biolabs, Hitchin, UK) 
according to the manufacturer’s instructions.  
 
 
2.2.2 Creation of standard curve  
 
 
The expression of hTERT and hTERT splice variants (alpha deletion or α-
β+, beta deletion or α+β-, alpha/beta deletion or α-β-) and TERC was 
compared to the expression of a set of the two housekeeping genes 
HPRT1 and ESD. For the creation of housekeeping gene standards, the 
PCR reaction was additionally performed on the cDNA samples derived 
from the HaCaT-TERT cell line, using TITANIUM Taq DNA Polymerase 
(Takara Bio Europe/Clontech, Saint-Germain-en-Laye, France) and gene 
specific primer pairs (table 1), which were previously analysed with a 
BLAST search of GenBank to ensure specificity, and the presence of a 
single specific PCR band was verified by electrophoresis on a 2% agarose 
gel. Real-time PCR conditions were as follows: denaturation at 95°C for 1 
min; amplification of 40 cycles at 95°C for 30 sec, 60°C for 1 min, 
annealing at 65°C for 3 min. 
 
PCR products were purified using a Qiagen spin column (Qiagen, Crawley, 
UK) and eluted in dH2O. The DNA concentration was measured with a 
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NanoDrop spectrophotometer (Thermo Fisher Scientific, Loughborough, 
UK) and the total number of gene copies was measured according to the 
equation: 
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The initial stock of 1011 copies/2 µl was subsequently diluted using 25 
µg/ml tRNA (Sigma-Aldrich, Poole, UK) as carrier nucleic acid to give a 
dilution series of 109, 107, 106, 105, 104, 103, 102 copies/2 µl. 
 
 
2.2.3 mRNA expression analysis with real-time qPCR 
 
 
For real-time qPCR analysis, 2 µl of cDNA derived from the samples or 
from each standard dilution was used in a 10 µl reaction in a real-time 
PCR Roche LightCycler system (Roche Diagnostics, Burgess Hill, UK). 
dH20 was used as a negative control. PCR reactions were carried out with 
the SYBR Green I Master Mix (Roche Diagnostics, Burgess Hill, UK) and 
the specific primer sets (table 1), and melting curve analysis of products 
was additionally performed to ensure specificity. All primers were used at 
a concentration of 5 µM. 
 
For HPRT1, ESD and TERC mRNA quantification, real-time PCR conditions 
were as follows: denaturation at 95°C for 5 min; amplification of 45 
cycles at 95°C for 10 sec, 60°C for 10 sec, 72°C for 10 sec; melting 
curve at 95°C for 5 sec, 65°C for 1 min; cooling down at 40°C for 30 sec. 
Acquisition time for the detection of the fluorescence corresponded to the 
last step of the amplification stage.  
 
For hTERT mRNA quantification, the real-time PCR conditions were as 
follows: denaturation at 95°C for 5 min; an amplification of 45 cycles at 
volume required to dilute 
original stock DNA to give 1011 
per 2µl concentration 
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95°C for 10 sec, 60°C for 10 sec, 72°C for 10 sec; a melting curve at 
95°C for 5 sec, 65°C for 1 min; cooling down at 40°C for 30 sec. 
Acquisition time for the detection of the fluorescence was performed at 
88°C for 1 sec. The higher acquisition temperature for hTERT mRNA 
expression was chosen to minimize the acquisition of primer dimers 
which are easy to form due to the length of the template (182 bp). 
 
For hTERT splice variant mRNA quantification, real-time PCR conditions 
were as follows: denaturation at 95°C for 5 min; amplification of 55 
cycles at 95°C for 10 sec, 67°C for 10 sec, 88°C for 10 sec; melting 
curve at 95°C for 5 sec, 65°C for 1 min; cooling down at 40°C for 30 sec. 
Combinations of four primers are required for the detection and analysis 
of all the splice variants (see section 1.1.5.2). Blast analysis was 
performed to identify the correct position of the primers in the total 
hTERT mRNA and to predict the length of the amplicons (see table 2). 
 
 
2.2.4 Data analysis 
 
 
The samples were analysed in triplicate, and absolute quantification of 
the gene of interest and the single housekeeping genes was possible with 
comparison with a standard curve using standard dilution of the same 
gene. Relative amount of the copy number of the gene of interest of the 
unknown sample was calculated by normalizing the absolute 
quantification of the gene of interest with the normalization factor based 
on the geometric mean of multiple housekeeping genes. The geNorm VBA 
applet for Microsoft Excel (http://medgen.ugent.be/~jvdesomp/genorm/) 
was used to determine the stability of expression of the selected 
housekeeping genes and to calculate the normalization factor used to 
estimate the mRNA expression of the genes of interest. The result was 
proven to be statistically significant by one way ANOVA test and Tukey-
Kramer multiple comparisons test, with different levels of significativity 
(***: highly significant, p<0.001; **: very significant, p<0.01; * 
significant, p<0.05; ns: non significant).  
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Genes Sequence (5’-3’) Position on 
gene 
(BLAST 
alignment) 
Product 
size 
(bp) 
HPRT1-F 
HPRT1-R 
TGACACTGGCAAAACAATGCA 
GGTCCTTTTCACCAGCAAGCT 
496-516 
589-569 
93 
ESD-F 
ESD-R 
TCAGTCTGCTTCAGAACATGG   
CCTTTAATATTGCAGCCACGA 
387-407 
458-438 
71 
hTERT-F 
hTERT-R 
AGAGTGTCTGGAGCAAGTTGC 
CGTAGTCCATGTTCACAATCG 
1791-1811 
1973-1953 
183 
α+ TGTACTTTGTCAAGGTGGATGTG 2175-2197  
α- CTGAGCTGTACTTTGTCAAGGAC 2169-2188, 
2226-2227 
 
β+ GTACGGCTGGAGGTCTGTCAA 2373-2354  
β- GGCACTGGACGTAGGACGTGG 2346-2341 
2543-2529,  
 
hTR-F1 
hTR-R1 
ACCCTAACTGAGAAGGGCGTAG 
GTTTGCTCTAGAATGAACGGTG 
49-70 
170-149 
121 
 
Table 1: Primer sets for real-time PCR 
 
For amplicon length of splice variants, see table 2.  
HPRT1: Homo sapiens hypoxanthine phosphoribosyltransferase 1 (Lesch-
Nyhan syndrome), NM_000194.1  
ESD: Homo sapiens esterase D/formylglutathione hydrolase, 
NM_001984.1  
hTERT: Homo sapiens telomerase reverse transcriptase (TERT), transcript 
variant 1, NM_198253.2   
hTR: Homo sapiens telomerase RNA component (TERC), telomerase RNA 
NR_001566.1  
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NCBI Reference Sequence: NM_198253.2 
Homo sapiens telomerase reverse transcriptase (TERT),  
transcript variant 1, mRNA, 4018 bp 
 
[…] 
1501 gcacaacgaa cgccgcttcc tcaggaacac caagaagttc atctccctgg ggaagcatgc 
1561 caagctctcg ctgcaggagc tgacgtggaa gatgagcgtg cgggactgcg cttggctgcg 
1621 caggagccca ggggttggct gtgttccggc cgcagagcac cgtctgcgtg aggagatcct 
1681 ggccaagttc ctgcactggc tgatgagtgt gtacgtcgtc gagctgctca ggtctttctt 
1741 ttatgtcacg gagaccacgt ttcaaaagaa caggctcttt ttctaccgga agagtgtctg 
1801 gagcaagttg caaagcattg gaatcagaca gcacttgaag agggtgcagc tgcgggagct 
1861 gtcggaagca gaggtcaggc agcatcggga agccaggccc gccctgctga cgtccagact 
1921 ccgcttcatc cccaagcctg acgggctgcg gccgattgtg aacatggact acgtcgtggg 
1981 agccagaacg ttccgcagag aaaagagggc cgagcgtctc acctcgaggg tgaaggcact 
2041 gttcagcgtg ctcaactacg agcgggcgcg gcgccccggc ctcctgggcg cctctgtgct 
2101 gggcctggac gatatccaca gggcctggcg caccttcgtg ctgcgtgtgc gggcccagga 
2161 cccgccgcCT GAGCTGTACT TTGTCAAGgt ggatgtgacg ggcgcgtacg acaccatccc 
2221 ccaggACagg ctcacggagg tcatcgccag catcatcaaa ccccagaaca cgtactgcgt 
2281 gcgtcggtat gccgtggtcc agaaggccgc ccatgggcac gtccgcaagg ccttcaagag 
2341 CCACGTctct accttgacag acctccagcc gtacatgcga cagttcgtgg ctcacctgca 
2401 ggagaccagc ccgctgaggg atgccgtcgt catcgagcag agctcctccc tgaatgaggc 
2461 cagcagtggc ctcttcgacg tcttcctacg cttcatgtgc caccacgccg tgcgcatcag 
2521 gggcaagtCC TACGTCCAGT GCCaggggat cccgcagggc tccatcctct ccacgctgct 
2581 ctgcagcctg tgctacggcg acatggagaa caagctgttt gcggggattc ggcgggacgg 
2641 gctgctcctg cgtttggtgg atgatttctt gttggtgaca cctcacctca cccacgcgaa 
[…] 
 
 
α- β+
α+ β-
α- β-
α del
α del β del
β del
primer β-
primer β+primer α-
primer α+
 
 
 
 
Table 2: Blast analysis of primers used for the detection of hTERT 
and hTERT splice variant mRNA expression 
 
Expression of hTERT mRNA was performed on real-time qPCR using the 
reverse and forward primers for hTERT (highlighted in yellow in the 
table).  
Expression of hTERT splice variants was performed using a combination 
of primers α+, α-, β+, β-. In the table, the 36 bp deletion called the  
“alpha deletion” is highlighted in green; the 182 bp deletion called the 
“beta deletion” is highlighted in light blue. The same deletion sites are 
marked as a dotted line in the lower graph. To analyze all the possible 
scenarios, one primer is located entirely, or partly, on the deletion site 
(underlined primers, primers α+ and β+), and one primer is flanking the 
deletion site (primers in bold, uppercase font, α- and β-).  
Primer combinations and amplicons obtained are as follows: 
α+/β-, beta deleted mRNA variant: 187 bp 
α-/β+, alpha deleted mRNA variant: 169 bp 
α-/β-, alpha and beta deleted mRNA variant: 156 bp 
α deletion 
β deletion 
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2.3 Telomere Repeat Amplification Protocol (TRAP) 
 
 
 
2.3.1 Conventional TRAP assay 
 
 
The Telomeric Repeat Amplification Protocol, or TRAP, is a two-step PCR-
based methodology to determine the telomerase activity in vitro, 
originally developed by Kim et al. (Kim, Piatyszek et al. 1994). In the first 
step of the assay, telomerase, if present in the sample lysate, adds 
telomeric repeats (GGTTAG) to a template substrate.  In the second step, 
amplification of these adducts is performed with specific forward and 
reverse primers, together with amplification of an internal standard PCR 
control (with separate forward and reverse primers). The amount of the 
internal control product detected is inversely correlated with the amount 
of telomeric product, and can be utilized to check the equal loading of the 
lysates, hence normalize the results, and identify false-negative samples 
due to Taq polymerase inhibitors. 
 
In a conventional TRAP assay, telomeric repeats, representing the 
enzymatic activity, are subsequently shown on a polyacrylamide gel as a 
ladder pattern of PCR products with a spanned size of 6 bp, starting from 
a size of 50 bp. The internal control band is shown at 36 bp. The higher 
the telomerase activity, the stronger the signal of the ladder will be.  
A non-radioactive TRAP assay was utilized in our study, adapted from the 
protocol of  Herbert et al. (Herbert, Hochreiter et al. 2006). 
 
 
• Preparation of samples 
 
Half a million cells were pelleted, washed twice with PBS, and stored at -
80°C in RNAse-free tubes until further usage. After thawing, cell pellets 
were immediately resuspended in 200 µl of CHAPS Lysis Buffer (from 
TRAPeze Kit, Chemicon Europe Ltd, Chandlers Ford, UK) and incubated 
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on ice for 30 min. The suspension was then spun at 12,000 g for 20 min 
at 4°C to remove cell debris, and 160 µl of the supernatant were used to 
determine the protein concentration. Protein determination was 
performed with DC protein assay (BIO-RAD, Hemel Hempstead, UK), 
according to the manufacturer’s instructions. A standard curve calculated 
with a known BSA concentration, using the CHAPS Lysis Buffer was first 
established. Following this, the protein concentration in the samples was 
estimated according to the standard. Optimization of the amount of 
protein required was first established by serial titrations of the lysates, so 
that the assay could be sensitive over the broad activity of our samples. 
Aliquots of the lysates were stored at -80°C in RNAse-free tubes until 
subsequent use and from which appropriate dilutions were made..The 
optimal protein concentration was estimated to be 100 ng/µL. 
 
 
• Positive and negative controls 
 
The positive control cell pellet (106 cells) provided in the Chemicom 
TRAPeze kit (Chemicon Europe Ltd, Chandlers Ford, UK) was suspended 
in 200 µL of CHAPS Lysis Buffer and the same procedure of sample 
preparation was followed. The lysate was diluted 1:1 with RNase-free 
water before loading in the assay to avoid overloading of the system.   
 
A specific negative control for the absence of telomerase activity was 
obtained by cell lysate of GM847 cells, which possess ALT phenotype and 
lacks detectable telomerase activity.  
 
A negative control was performed to check the presence of primer-dimer 
PCR artefacts or the presence of PCR contamination by substitution of the 
cell extract with the same amount of CHAPS Lysis Buffer. 
 
Heat treatment of each sample was also used as a third negative control, 
as telomerase is heat sensitive. Every sample extract was incubated at 
85°C for 10 minutes prior to the assay to inactivate telomerase. 
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• Cy5 fluorescent-based PCR reaction 
 
Two µl of sample lysates (100 ng/µl) were used in each 50 µl PCR 
reaction, according to table 3. The fluorescent dye Cy5, fluorescent in the 
red region (~650 nm excitation/670 nm emission), was attached to the 
5’-end of the primer TS to permit final quantification of the PCR products 
on the gel. Primers details are shown in table 3.  
 
 
• Visualization of PCR products 
 
After PCR, 5 µl of loading dye (0.25% bromophenol blue, 50% glycerol, 
50 mM EDTA) were added to the samples, and 25 µl of this mix were 
loaded to a 12% non denaturing PAGE gel. 
 
12% polyacrylamide gel was cast in a disposable plastic cassette 
(Invitrogen, Paisley, UK) by mixing 12% of PolyPAGE-40 Acrylamide/Bis 
(19:1) (Polysciences, Eppelheim, Germany), 6% of 1X TBE (89 mM Tris 
base, 89 mM boric acid, 2 mM EDTA), 0.01% of 10% ammonium 
persulfate, 0.001% of TEMED and dH2O. 
 
The gel was run on a XCell SureLock™ Mini-Cell vertical electrophoresis 
system (Invitrogen, Paisley, UK), in 0.5X TBE for approx. 1 hour at 140-
160 V, protected from the light. Subsequent fixation of the gel to avoid 
DNA diffusion was performed by incubation of the gel in 0.5 M NaCl, 50% 
(vol/vol) ethanol and 40 mM sodium acetate (pH 4.2) for 15 min at room 
temperature (RT) in the dark. 
 
Visualization of the TRAP ladder on the gel was performed using a 
Phosphorimager (Typhoon 9400 scanner, GE Healthcare, Chalfont, UK) 
reading Cy5 fluorescence at 633 nm. The intensity of the 6 bp ladder 
representing telomerase products and the 36 bp IC band was estimated 
with ImageQuant software (Molecular Dynamics Inc., Sunny Vale, CA) on 
the 4th smallest band in the ladder. The relative telomerase activity (RTA) 
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was calculated as the ratio of the intensity of the TRAP ladder to the 
intensity of the internal control.  
 
The extension products were created and amplified by PCR in a five-stage 
reaction: incubation at 30°C for 1 hour, where telomerase is allowed to 
add repeats to the substrate; telomerase inactivation at 95°C for 5 min; 
24 cycles at 95°C for 30 sec (denaturation), 52°C for 30 sec (annealing) 
and 72°C for 30 sec (extension); final elongation at 72°C for 2 min; hold 
at 4°C.  
 
 
2.3.2  Real-time TRAP assay 
 
 
A modification of the conventional TRAP assay using a real-time qPCR 
technique allows a faster and more accurate quantification of the 
telomerase activity in the samples. Despite the similarity between the 
real-time and non real-time methods, the real-time protocol is adjusted 
to permit the relative quantification of the activity compared to a 
standard curve of known concentrations of adducts, and the fluorometric 
detection of the products labelled with fluorescein (485 nm excitation/535 
nm emission). In our study, I have used a commercial kit called 
TRAPEZE® RT (Chemicon Europe Ltd, Chandlers Ford, UK, catalogue No. 
S7710). The increase of fluorescence in the PCR reaction is due to the 
presence of Amplifluor® primers (included in the kit) in the reaction and 
the concept of energy transfer. In this technique, the fluorophore and 
quencher molecules are spatially close due to the hairpin structure of the 
primer itself; therefore the fluorescence emission is constantly quenched. 
However, during PCR amplification, the hairpin is unfolded by the 
polymerase causing fluorescence emission. This fluorescence is therefore 
correlated with the amount of accumulation of telomeric products in the 
reaction. 
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Component Supplier Concentration Volume (µl) 
per reaction 
Total 50 µl 
RNase-free 
H2O 
Qiagen, Crawley, 
UK 
- 37.7 
TRAP buffer 
* 
- 10X 5 
dNTP mix  New England 
Biolabs, Hitchin, UK 
10 mM each 
primer 
0.5 
Cy5-TS  Eurofins MWG 
Operon, London, UK 
100 ng/µl 1 
NT primer  Eurofins MWG 
Operon, London, UK 
100 ng/µl 1 
ACX primer  Eurofins MWG 
Operon, London, UK 
100 ng/µl 1 
TSNT 
template 
Sigma-Aldrich, 
Poole, UK 
10-20 mol/µl 1 
BSA  Ambion, 
Huntingdon, UK 
50 mg/ml 0.4 
Taq 
polymerase 
New England 
Biolabs, Hitchin, UK 
5 U/µl 0.4 
Sample - 100 ng/µl 2 
 
Table 3: Components of PCR reaction for TRAP assay 
 
The main components of the PCR reaction of the TRAP assay are the 10X 
TRAP buffer (200 mM Tris-HCl pH 8.3, 15 mM MgCl2, 630 mM KCl, 10 mM 
EGTA, 0.5% Tween-20) to lyse the cells of the sample and collect TERT; 
the different primers, the function of which is shown in table 4; the 
substrate TS to which telomerase adds the telomeric repeats; and the 
Taq polymerase to amplify the product added by telomerase in the first 
step of the reaction. 
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Primer 
name 
Sequence Function 
Cy5-TS 5’-Cy5-AATCCGTCGAGCAGAGTT-3’ Substrate 
oligonucleotide/ 
forward primer 
ACX 5’-GCGCGGCTTACCCTTACCCTTACCCTAACC-3’ Reverse primer 
TSNT 5’-AATCCGTCGAGCAGAGTTAAAAGGCCGAGAAGCGAT-3’ template for 
internal control 
NT 5’-ATCGCTTCTCGGCCTTTT-3’ Reverse primer 
for internal 
control 
 
Table 4: Role of the primers used in the PCR reaction for TRAP 
assay 
 
The four primers utilized in the PCR reaction have got specific function 
that allows the addition of the telomeric repeat and the following 
amplification for further detection of their amount and correlation with 
telomerase activity. Active telomerase binds to the TS substrate and a 
number of telomeric repeats (GGGTTA) are added to TS according to the 
degree of activity of the enzyme. In the PCR step of the assay, the 
products generated, formed of TS and AG(GGGTTA)n, are amplified with 
the TS primer, that is attached to a fluorophore for the following 
detection, and with the reverse primer ACX. In addition, the sequence 
TNST serves as a template for an internal control which is amplified with 
the reverse primer NT and the forward primer TS. Therefore, using the 
same TS primer, this internal control competes with the telomeric repeats 
in the amplification process. Its expression will be inversely correlated 
with the amount of telomeric products, thus with the activity of the 
telomerase. 
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• Preparation of samples and controls 
 
The lysates, sample preparation and controls are identical to those of the 
conventional TRAP assay (see section 2.3.1). 
 
• Generation of TSR8 Standard Curve 
 
TSR8 is an internal control included in the kit that allows the creation of a 
standard curve to calculate the amount of adducts extended by 
telomerase in the different samples. The TSR8 sequence is composed of 
the TS primer sequence extended with 8 telomeric repeats AG(GGTTAG)7. 
The stock TSR8 concentration (20 amoles/µL) was serially diluted 1:10 
with CHAPS Lysis Buffer to obtain TSR8 concentrations of 2 amoles/µL, 
0.2 amoles/µL and 0.02 amoles/µL. Two µL of each of the four TSR8 
dilutions were used per assay.  
 
 
• Real-time qPCR reaction 
 
Two µl of sample lysates (100 ng/µl) were used in each 25 µl PCR 
reaction, according to table 5.   
 
The extension products were created and amplified using a real-time PCR 
Roche LightCycler system (Roche Diagnostics, Burgess Hill, UK) in a four-
stage reaction: initial denaturation at 37°C for 30 min; telomerase 
inactivation at 95°C for 2 min; 45 cycles at 94°C for 15 sec 
(denaturation), 59°C for 1 min (annealing) and 45°C for 10 sec 
(extension); cooling down at 37°C for 30 sec. Acquisition time for the 
detection of the fluorescence corresponded to the last step of the 
amplification stage. 
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• Data analysis 
 
The logarithmic plot of the standard curve was created by calculating the 
log10 of the amoles per well for each reaction (see table 6). The 
logarithmic value was plotted against the Cp measurement (second 
derivative cycle-threshold) at the corresponding standard as detected by 
the qPCR machine using Microsoft Excel®. A linear regression plot was 
then calculated and utilized to extrapolate the arbitrary telomerase units 
of the unknown samples from the known Cp measurement. The result 
was proven to be statistically significant by one way ANOVA test and 
Tukey-Kramer multiple comparisons test, with different levels of 
significativity (***: highly significant, p<0.001; **: very significant, 
p<0.01; * significant, p<0.05; ns: non significant). 
 
 
Component Supplier Concentration Volume 
(µl) per 
reaction 
Total 25 µl 
TRAPEZE® 
RT Reaction 
Mix* 
Chemicon Europe Ltd, 
Chandlers Ford, UK 
5X 5 
Titanium Taq 
Polymerase 
Takara Bio 
Europe/Clontech, Saint-
Germain-en-Laye, 
France 
5 U/µl 0.4 
Nuclease 
Free Water 
Chemicon Europe Ltd, 
Chandlers Ford, UK 
- 17.6 
Sample** - 100 ng/µl 2 
 
Table 5: Components of real-time qPCR reaction for real-time 
based TRAP assay 
 
*5X TRAPEZE® RT Reaction Mix is composed of  TS primer, RP tailed 
primer, Amplifluor® primer dA, dC, dG and dTTP, diluted in 10X Reaction 
Buffer S Plus, 10 mM MgCl2 with 0.5 mg/ml BSA 
**Samples included were: TSR8 dilutions, positive and negative controls, 
and experimental samples 
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Like in a conventional TRAP assay, the two major primers are TS, acting 
also like a substrate for the addiction of telomeric repeats, and RP 
(corresponding to the primer ACX in the conventional TRAP assay). In 
this real-time qPCR-based TRAP, the internal control is missing, because 
of the impossibility to quantify two distinct products, but the control is 
provided by independent amplification of a serial dilution of the sequence 
TSR8, composed of 8 telomeric repeats, which creates a standard curve 
for the quantification of the number of repeats added by telomerase. 
 
 
TSR8 
dilution 
Correspondent 
copies of TSR8 
Log10 Experimental 
average Cp 
40 amoles 24088000 7.381800743 25.75 
4 amoles 2408800 6.381800743 28.13 
0.4 amoles 240880 5.381800743 29.97 
0.04 
amoles 24080 4.381656483 31.9 
 
Table 6: Data for generation of a TSR8 standard curve 
 
One complete standard curve was taken as reference for samples 
repeats. Accuracy of the efficiency was confirmed by correspondence of 
the Cp from the second and third dilution in the subsequent run. 
Telomerase activity extrapolated in this way was then subtracted from 
the water sample. 
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2.4 Anoikis assay 
 
 
This assay permits the analysis of the cell behaviour in a environment 
where the cell-matrix engagement is disrupted. For this aim, I have used 
bacteriological dishes coated with PolyHEMA (poly(2-
hydroxyethylmethacrylate),  Sigma-Aldrich, Poole, UK), an non-ionic 
hydrogel that, at a concentration of 10 mg/ml (1 mg/cm2) precludes 
matrix deposition and therefore cell attachment (Bretland, Lawry et al. 
2001). 
 
 
2.4.1 Coating of the dishes and cell seeding 
 
 
PolyHEMA (Sigma-Aldrich, Poole, UK) was firstly dissolved 10% (w/v) in 
95% acetone to obtain the stock solution. One ml of working solution 
(0.4% (v/v) in acetone:90% alcohol) was then homogenously applied to 
a petri dish and let it dry in the tissue culture hood before adding the cell 
suspension.  
 
Adapting from Frisch’s protocol (Frisch and Francis 1994), cell lines were 
grown to different confluences: 20%, 70% and  100% confluence. Single 
cells were obtained by treatment with 0.1% EDTA for approx. 3 mins and 
trypsinization with 0.05% trypsin/ 0.05% EDTA. Two x 106 cells were 
counted and plated onto 100-mm diameter petri dishes coated with 
polyHEMA in duplicate, and in parallel the same number of cells were 
used as a control at time 0.  
 
To analyze the hallmarks of apoptosis, DNA content was measured by 
Hoechst staining and morphological characterization of the nuclei or 
independently by propidium iodide (PI, Sigma-Aldrich, Poole, UK) staining 
and fluorescence activate cell sorting (FACS). After 20 hrs, cells can be 
seen floating in the medium or loosely attached to the surface of the 
dishes, still as single cells. Both these type of cells were combined 
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together in a single tube by gently scraping the dish and pipetting the 
floating cells before further fixation. 
 
 
2.4.2  Morphological characterization of the apoptotic nuclei 
 
 
For morphological characterization of the nuclei at the microscope, cells 
at 0 hr and 20 hrs were fixed with 3.7% paraformaldehyde for 15 mins at 
4°C, washed in sterile PBS and dropped on microscope slides to let air-
dry at 60°C for 2 hr. Cells were then stained with or 0.1 µg/ml Hoechst 
33258 (Sigma-Aldrich, Poole, UK), and washed twice in PBS 1X before 
the coverslip was applied. Stained cells were then blindly counted and 
photographed on a Nikon Eclipse TE200-S. Blindness of the experiment 
was achieved by covering the sample names with removable tape and 
randomizing the slides before the count. 
 
 
2.4.3 Analysis of the sub-G1 peak by fluorescence-activated cell 
sorting for fluorescence-activated cell sorting (FACS) 
 
 
Cells at 0 hr and 20 hrs were fixed with ice cold absolute ethanol while 
gently vortexing to avoid clustering, and washed twice with 100 mM 
sodium citrate (Sigma-Aldrich, Poole, UK). The cells were suspended in PI 
RNAse mix, (500 µg/ml propidium iodide (Sigma-Aldrich, Poole, UK), 5 
mg/ml RNase A (Sigma-Aldrich, Poole, UK), 100 mM sodium citrate, 1X 
PBS) and filtered through a 100 µm cell strainer. Analysis of the PI 
staining in the sub-G1 peak, corresponding to the percentage of dead 
cells in the sample, was performed by the Flow Cytometry Core Facility, 
at the Institute of Cell and Molecular Sciences, Bart’s and the London 
School of Medicine and Dentistry, by Dr. Gary Warnes. A minimum of 
25000 cells were analyzed by LSRII system (BD Biosciences, Oxford, UK) 
at a wavelength of 585 nm. 
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For detection of cisplatin-induced apoptosis, cells were treated with 0 µM, 
10 µM, 20 µM and 35 µM cisplatin (Sigma-Aldrich, Poole, UK) before 
plating in regular tissue culture dishes. After 0 h and 20 hrs, cells were 
collected from the dishes by gently scraping and pipetting. Adherent cells 
were combined with floating cells before fixation and analysis of the sub-
G1 peak was performed as cited above.  
 
 
2.4.4 Data analysis 
 
 
For morphological characterization of apoptotic nuclei, blind scoring of 
>300 nuclei per sample was used to detect membrane blebbing, cellular 
shrinkage, chromatin condensation and nuclei fragmentation, hallmarks 
of anchorage deprivation induced cell death, as reported (Frisch and 
Francis 1994). The statistical significance of the differences were 
analyzed using one way ANOVA test and Tukey-Kramer multiple 
comparisons test, with different levels of significativity (***: highly 
significant, p<0.001; **: very significant, p<0.01; * significant, p<0.05; 
ns: non significant). 
 
For FACS analysis, a minimum of 25000 events was measured for each 
sample and percentage of apoptotic cells were calculated after analysis of 
Sub-G1 peak. The statistical significance of the differences were analyzed 
using Anova test as above mentioned. 
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2.5 Western blotting 
 
 
Western blotting, or protein immunoblot, is a technique used to detect 
the expression and localization of specific proteins in a sample of tissue 
homogenate or cell extract. Proteins are first separated by 
electrophoresis in denaturing or native conditions before being 
immobilized on a membrane and detected using specific antibodies 
against the target protein.  
 
 
2.5.1 Sample preparation 
 
 
Whole cell lysates were obtained by washing the cells growing in the 
flask/dish from medium with sterile PBS 1X and incubation with RIPA 
buffer (1% NP-40, 0.1% SDS, 50 mM Tris pH 7.3, 150 mM NaCl, 
protease inhibitors (Complete Mini EDTA-free tablets, Roche Diagnostics, 
Burgess Hill, UK) for 20 min at 4°C.  
 
The lysates were then spun at 12,000 g for 20 min at 4°C to remove cell 
debris, and 160 µl of the supernatant were used to determine the protein 
concentration. Protein determination was performed with the DC protein 
assay (BIO-RAD, Hemel Hempstead, UK), according to the 
manufacturer’s instructions. A standard curve was calculated with a 
known BSA (New England Biolabs, Hitchin, UK) concentration using the 
sample lysis buffer. Following this, the protein concentration in the 
samples was estimated according to the standard.  
 
 
2.5.2 Preparation of controls  
 
 
NHEK and SCC-25 were chosen as positive control for integrin expression 
Positive controls were performed by culturing the cells to 70% confluence 
2.5 – Western blotting 
 95 
in their specific growth medium, and cell lysates were obtained as above 
mentioned. 
  
 
2.5.2 Preparation of SDS-PAGE gels 
 
 
Proteins were separated on either  precast 4-12% resolving gels under 
denaturing and reducing conditions (NuPAGE Novex Bis-Tris Pre-Cast 
Gels, Invitrogen, Paisley, UK) in MES SDS Running Buffer (NuPAGE, 
Invitrogen, Paisley, UK), or on a hand-made 8% gel. 
 
The hand-made 8% separating gel (0.25 M Tris pH 8.8, 26% of (30% 
acrylamide/0.8% bis-acrylamide) 0.4% SDS, 1% ammomium persulfate, 
0.06% TEMED) was allowed to polymerized before topping with stacking 
gel (0.1 M Tris pH 6.8, 17% of (30% acrylamide/0.8% bis-acrylamide) 
0.4% SDS, 1,2% ammomium persulfate, 0.3% TEMED). The running 
buffer for this gel was composed of 25 mM Tris, 192 mM glycine, 0.1% 
SDS, pH 8.3. 
 
 
2.5.3 Protein separation and detection 
 
 
Total cellular proteins (10 µg) from the samples were boiled for 5 min in 
SDS sample buffer (2X, 0.5 M Tris HCl, pH 6.8, 10% SDS, 20% glycerol, 
10% 2-mercaptoethanol, 0.1% bromophenol blue) and separated on the 
precast or hand-made gel in the appropriate running buffer at 100-130 V. 
Six µl of ladder (Dual colour, BIO-RAD, Hemel Hempstead, UK) were also 
separated as reference for the protein molecular weight.  
 
Separated proteins were electroblotted to 0.45 µm PVDF membranes 
(Immobilon, Millipore, Watford, UK) at 30 V at 4°C for 90 min using a 
chilled transfer buffer (25 mM Tris, 190 mM glycine, 20% methanol).  
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The membrane was then blocked in 5% low fat (<1.5%) milk in TBS-T (1 
M TRIS pH 8.0, 5 M NaCl, 0.05% Tween-20) at RT for 1 hr. 
 
Primary antibody was added at the appropriate dilution in milk/TBS-T. 
The membrane was incubated at 4°C overnight and then washed 
extensively with TBS-T.  
 
The corresponding horseradish peroxidase-conjugated secondary 
antibody was added at appropriate dilution in milk/TBS-T. The membrane 
was incubated at room RT for 1 h and then washed extensively with TBS-
T. Antigen-antibody complexes were detected using ECL system for 
medium-strong signals, or SuperSignal West Femto Maximum Sensitivity 
Substrate for weak signals (Pierce, Thermo Fisher Scientific, 
Loughborough, UK), according to the manufacturer’s instructions. The 
antibodies used are shown in table 7. 
 
 
 
2.5.4 Data analysis 
 
 
Estimation of the difference the level of protein expression in each 
sample was evaluated by Labworks 4.6 software (UVP Bioimaging 
System) or with ImageJ software and amount of proteins were 
normalized with the estimated amount of expressed GAPDH in the 
loading control. 
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2.6 Integrin analysis by FACS 
 
 
Cells from an approximately 70% confluent plate were trypsinized using 
0.05%/0.25% trypsin/EDTA. After neutralization of trypsin with 
DMEM/0.1% BSA/0.1% sodium azide (Wash Buffer, WaB), the cells were 
spun and washed with WaB at 1200rpm for 3 mins. Cells were then 
resuspended to get a concentration of 4x106 cells/ml in WaB and kept on 
ice. 
 
In 15 ml tubes, 50 µl of cells (2x105) were aliquoted and 50 µl of the 
primary antibody of the appropriate dilution were added to the sample. 
The cells are mixed by gently flicking the tube and kept on ice to incubate 
for 45-60 min. Specification of the antibodies and the optimal dilutions 
are shown in table 7. 
 
After incubation, the cells were washed twice with 2 ml of WaB and spun 
at 300 g for 3’. The supernatant was discarded both times in one flick of 
the tube, leaving approximately 50 µl on the cell pellet. 50 µl of second 
antibody at the appropriate dilution were added to the sample.  The cells 
were mixed by gently flicking the tube and kept on ice to incubate for 30 
min. Specification of the antibodies and the optimal dilutions are shown 
in table 7. Cells were washed twice in WaB as above. After the final wash, 
cells were transferred in a total suspension of 500 µl in WaB in 
appropriate FACS tubes (BD Biosciences, Oxford, UK).   
 
 
2.6.1 Data analysis 
 
 
Flow cytometry was performed in the Core Cell Sorting Facility 
laboratory, at the John Vane Science Centre, Bart’s and the London 
School of Medicine and Dentistry, by Dr. Linda Hammond (Tumor Biology, 
Institute of Cancer) on a BD FACSCalibur platform (BD Biosciences, 
Oxford, UK). Data analysis was performed using Cell Quest software. 
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Primary antibodies for FACS, Western blot and anoikis assay 
Antibody 
name 
Supplier and cat 
no. 
Type Host Dilution 
and 
application 
Integrin α1 
(clone FB12) 
 
Chemicon Europe 
Ltd, Chandlers 
Ford, UK 
# MAB1973Z 
Primary 
monoclonal 
mouse 1:1000 
FACS 
Integrin α2 
(clone P1E6) 
 
Chemicon Europe 
Ltd, Chandlers 
Ford, UK 
# MAB1950Z 
Primary 
monoclonal 
mouse 1:1000 
FACS 
Integrin α3 
(clone P1B5) 
Chemicon Europe 
Ltd, Chandlers 
Ford, UK 
# MAB1952Z 
Primary 
monoclonal 
mouse 1:1000 
FACS 
Integrin α5 
(clone P1D6) 
Chemicon Europe 
Ltd, Chandlers 
Ford, UK 
# MAB1956Z 
Primary 
monoclonal 
mouse 1:1000 
FACS 
Integrin α6 
antibody 
(clone GoH3) 
Abcam, Cambridge, 
UK 
# Ab19765 
Primary 
monoclonal 
rat 1:1000 
FACS 
Integrin α9β1 
(clone Y9A2) 
Chemicon Europe 
Ltd, Chandlers 
Ford, UK 
# MAB2078Z 
Primary 
monoclonal 
mouse 1:1000 
FACS 
Integrin αVβ5 
(clone 15F11) 
Chemicon Europe 
Ltd, Chandlers 
Ford, UK 
# MAB2019Z 
Primary 
monoclonal 
mouse 1:1000 
FACS 
Integrin αVβ6 
(clone 10D5) 
Chemicon Europe 
Ltd, Chandlers 
Ford, UK 
Primary 
monoclonal 
mouse 1:1000 
FACS 
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# MAB2077Z 
integrin β4 Abcam, Cambridge, 
UK 
# ab29042 
 
Primary 
monoclonal 
mouse 1:1000 
WB 
FACS 
integrin β1 
(CD29) 
Abcam, Cambridge, 
UK 
# ab30394 
 
Primary 
monoclonal 
mouse 1:1000 
WB 
FACS 
integrin αV 
(CD51) 
Abcam, Cambridge, 
UK 
# ab55991 
 
Primary 
polyclonal 
rabbit 1:500 
WB 
GAPDH Abcam, Cambridge, 
UK 
# ab9485 
Primary 
polyclonal 
rabbit 1:2000 
WB 
integrin β1 
(clone 6S6) 
Millipore, Watford, 
UK 
#MAB2253Z 
Primary 
monoclonal 
Mouse 1:250 
anoikis 
assay  
 
Table 7: Primary antibodies utilized in western blot and FACS 
analysis and anoikis assay 
 
In the table, appropriate dilutions for the different techniques are shown. 
The only blocking antibody was against β1 integrin used on the anoikis 
assay.  
WB : western blot 
FACS: fluorescence-activated cell sorting 
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Isotype controls and secondary antibodies for FACS and Western 
blot 
Antibody 
name 
Supplier and 
cat no. 
Type Host Dilution and 
application 
Mouse IgG1 
Negative 
Control  
(clone Ci4) 
 
Chemicon 
Europe Ltd, 
Chandlers Ford, 
UK 
# MABC002 
Primary 
monoclonal 
mouse 1:1000 
FACS 
Rat IgG2b 
(kappa 
[RTK4530]) 
Abcam, 
Cambridge, UK 
# Ab18536 
Primary 
monoclonal 
rat 1:1000 
FACS 
Alexa Fluor® 
488 anti-
mouse IgG 
 
Invitrogen, 
Paisley, UK 
# A-21121 
Secondary goat 1:250 
FACS 
Alexa Fluor® 
488 anti-rat 
IgG 
 
Invitrogen, 
Paisley, UK 
# A-21208 
Secondary donkey 1:250 
FACS 
HRP-
conjugated  
anti-mouse 
IgG 
Pierce, Thermo 
Fisher Scientific, 
Loughborough, 
UK 
#31430 
Secondary goat 1:2000 
WB 
HRP-
conjugated 
anti-rabbit  
IgG 
Pierce, Thermo 
Fisher Scientific, 
Loughborough, 
UK 
#31460 
Secondary goat 1:2000 
WB 
 
Table 8: Isotype controls and secondary antibodies utilized in 
western blot and FACS analysis and anoikis assay 
 
In the table, appropriate dilutions for the different techniques are shown.  
WB : western blot 
FACS: fluorescence-activated cell sorting 
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Chapter 3: 
Results 1 
 
 
 
 
3. Characterization of telomerase components in the model cell 
lines 
 
 
The aim of this project is to determine a possible new role of telomerase 
in the protection from anoikis in HaCaT skin keratinocytes. To do this, I 
decided to use as a model immortalized human skin keratinocytes 
(HaCaT) overexpressing the following constructs: wild type TERT, the 
flagged TERT-HA, which has telomerase activity in vitro but cannot 
lengthen telomeres in vivo, the catalytically dead dominant-negative 
TERT mutant, DnTERT, which has neither catalytic activity nor the ability 
to lengthen telomeres and as a control HaCaT carrying an empty vector.  
 
To adopt this model as a good system to identify exclusively non-
canonical functions of telomerase, I investigated the ability to elongate 
telomeres in vitro, the activity of the enzyme in vitro, the presence of the 
two main components TERT and TERC.  In addition, as the splice variants 
of TERT have been reported to regulate telomerase activity (Ulaner, Hu 
et al. 1998; Colgin, Wilkinson et al. 2000; Cerezo, Kalthoff et al. 2002), I 
investigated the three most common forms, the α variant, the β variant 
and the αβ variant. 
 
Additionally, to determine the relationship between telomerase regulation 
in my model system and in intact epidermis in vivo I also tested the 
above in anchorage deprived conditions that is designed to simulate the 
earliest events in squamous differentiation. 
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3.1 Characterising telomere length in HaCaT 
 
 
The HA-flagged TERT construct, TERT-HA, has previously been reported 
to be incapable of extending the length of telomeres and immortalising 
human cells, despite possessing telomerase activity in vitro (Counter, 
Hahn et al. 1998). To evaluate the adequacy of the system used to 
distinguish between canonical (dependent from telomere lengthening) 
and non-canonical functions (independent from telomere lengthening) of 
telomerase, the inability in lengthening telomeres by the flagged protein 
TERT-HA was tested in HaCaT cells overexpressing the corresponding 
gene, and compared with HaCaT overexpressing wild-type hTERT, HaCaT 
carrying the empty vector, and with untransduced HaCaT. This 
experiment was carried out by the group of Professor Petra Boukamp on 
cells that were prepared by our group and sent to her (unpublished 
data).  
 
Telomere Restriction Fragment Length (TRF) analysis permits the 
evaluation of telomere length in the  samples carrying different hTERT 
constructs, according to a previous study (Gordon, Ireland et al. 2003). 
Briefly, genomic DNA is digested using the restriction enzymes HinF1 and 
Rsa1. Telomeric and subtelomeric regions lack of the restriction sites 
from these enzymes, therefore those regions of DNA will not be affected 
by the enzymatic digestion and will produce a long smear when the 
digested DNA is resolved by gel electrophoresis and detected by Southern 
blotting.   
 
The average telomere repeat fragment length increases in HaCaT-TERT 
cells from an average of 4 kb to 6.5 kb in 5 weeks in vitro, whereas 
HaCaT, HaCaT-Puro (empty vector) and HaCaT-TERT-HA showed no 
telomere extension (figure 8) showing that the fusion protein hTERT-HA 
is incapable of lengthening telomeres in intact cells as previously shown 
for fibroblasts (Counter, Hahn et al. 1998).  
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Figure 8: Variation in Repeat Fragment Lengths (TRF) between 
different hTERT constructs in HaCaT grown for 5 weeks in vitro 
 
This experiment was carried out by the group of Professor Petra Boukamp 
(unpublished data). Telomere repeat fragment length increases in HaCaT-
TERT cells from an average of 4 kb to 6.5 kb after 5 weeks in vitro, 
whereas HaCaT-TERT-HA shows no telomere extension and the telomere 
length in these cells is comparable to the untransduced HaCaT and the 
empty vector control HaCaT-Puro.  
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3.2 Characterising telomerase activity in HaCaT following 
anchorage deprivation 
 
 
To confirm and extend previous observations that telomerase activity in 
keratinocytes is dependent on anchorage and attachment to the 
extracellular matrix (Crowe, Nguyen et al. 2005), I measured the activity 
of TERT in HaCaT-Puro, HaCaT-TERT, HaCaT-TERT-HA, HaCaT-DnTERT at 
time 0 (referred in the graph as 0 hr), and after the cells were cultured in 
suspension for 20 hrs (referred in the graph as 20 hrs).  
 
The activity of the enzyme can be measured in vitro by introducing a 
primer that acts as a substrate for telomerase-mediated addition of 
TTAGGG repeats in a PCR reaction. Two methods, both defined as the 
Telomeric Repeat Amplification Protocol (TRAP), may be used for this 
aim: a conventional PCR followed by resolving the telomerase products 
on a polyacrylamide gel (figure 9), and a real-time qPCR (figure 10). 
  
Even if the outcome of telomerase activity among the samples is similar 
between the two techniques, there is a difference in detection and 
sensitivity between them. Real-time qPCR TRAP assay is not as routinely 
used as conventional TRAP (in our case a Cy5-based TRAP), however the 
sensitivity of the assay is much higher and the quantitation is more 
accurate than the analysis of the band intensity derived from a 
conventional TRAP. 
 
However, since conventional TRAP is still the method of choice in the 
detection of telomerase activity, I decided to perform both the techniques 
to get a reliable and accurate measure of the enzymatic activity. 
 
Conventional PCR-based TRAP did not show any detectable telomerase 
activity in GM847, as expected from previous studies (Bryan, Marusic et 
al. 1997); however, TRAP performed with real-time qPCR method show a 
minor amount of activity in this cell line. This is in line with recent 
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findings of a low amount of TERT expression in this cell line (Atkinson, 
Hoare et al. 2005). 
  
On a Cy5-TRAP plot (figure 9) at the control time (0 hr, as shown in the 
graphs) HaCaT-Puro showed nearly half the amount of telomerase 
activity compared to the telomerase-positive cells used as a control in the 
commercial TRAPeze Kit (Chemicon Europe Ltd, Chandlers Ford, UK), and 
to the activity of HaCaT cells overexpressing TERT and TERT-HA. HaCaT 
cells expressing a dominant-negative version of TERT, DnTERT, showed a 
three fold reduction of telomerase activity compared to HaCaT-Puro, as 
expected from previously published work on other cell lines (Hahn, 
Counter et al. 1999).  
 
When the cells are placed for 20 hrs in suspension (20 hrs, as shown in 
the graphs) and undergoing anoikis, telomerase activity decreases in a 
similar fashion in all the cell lines, with an average of a 1.8 fold reduction 
compared to the corresponding cell lines at time 0.  However, telomerase 
activity in the HaCaT-TERT and HaCaT-TERT-HA in the cells at 20 hrs 
remains higher than or comparable to the HaCaT-Puro cells at zero time, 
where the level of anoikis is low.  
 
A similar pattern of enzymatic activity but more striking differences 
between positive and negative values are also shown by real-time qPCR-
based TRAP (figure 10). Also in this case, telomerase activity drops 
dramatically when the cells are placed in suspension and undergo anoikis, 
but in the HaCaT-TERT and HaCaT-TERT-HA the activity is still more 
elevated than in HaCaT-Puro under the same experimental conditions and 
comparable to HaCaT-Puro at zero time. 
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c) 
Cell lines  
Average of telomerase 
activity (%) 
Standard deviation 
 
 0 hr 20 hrs 0 hr 20 hrs 
GM847 0 - 0 - 
positive control 9255.80 - 620.06 - 
HaCaT-Puro 4620.48 2707.78 783.63 1354.41 
HaCaT-TERT 8064.62 3598.54 592.39 2138.03 
HaCaT-TERT-HA 7853.23 5076.38 1582.11 2081.82 
HaCaT-DnTERT 1562.98 806.03 220.48 697.40 
 
d) HaCaT cells: significance P value 
TERT 0 hr - TERT 20 hrs P<0.05 * 
Puro 20 hr – TERT-HA 0hr P<0.01 ** 
Puro 20 hr – TERT 0hr P<0.01 ** 
TERT 0 hr - DnTERT 0 hr P<0.001 *** 
TERT 0 hr - DnTERT 20 hrs P<0.001 *** 
TERT 20 hrs - TERT-HA 0 hr P<0.05 * 
TERT-HA 0 hr - DnTERT 0 hr P<0.001 *** 
TERT-HA 0 hr - DnTERT 20 hrs P<0.001 *** 
TERT-HA 20 hrs - DnTERT 20 hrs P<0.05 * 
 
Figure 9: Analysis of telomerase activity using Cy5-TRAP 
 
a) Example of polyacrylamide gel after Cy5-TRAP for detection of 
telomerase activity in HaCaT cells at control times (0 hr) and after 20 hrs 
in suspension during anoikis assay (20 hrs). Positivity for telomerase 
activity is shown by the 6-bp incremental TRAP ladder. A positive control 
available with TRAPeze kit (Chemicon Europe Ltd, Chandlers Ford, UK) 
were used as a negative and positive control, respectively.  The 36-bp 
internal standard control (IC) is indicated by an arrow at the bottom of 
the gel to confirm equal loading of the samples. 200 ng of cell lysates 
were used in the assay, after previous optimization by serial dilutions 
(not shown).  
b) and table c) Quantification of telomerase activity using Cy5-TRAP. The 
absolute intensity of the fourth band of the ladder in each sample, 
obtained by graphic software, was divided by the intensity of the IC 
band. Average of the values of three independent repeats and standard 
deviation (SD) are shown. ***: highly significant; **: very significant; * 
significant; ns: non significant. 
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b) 
cell lines 
Average activity of 
telomerase 
 (arbitrary units relative to 
TSR8 amplification) standard deviation 
 0 hr 20 hrs 0 hr 20 hrs 
HaCaT-Puro  450310.98 34395.65 335386.71 31702.63 
HaCaT-TERT  5777341.78 307299.82 5434091.96 373521.71 
HaCaT-TERT-HA  3865639.63 194612.53 2129273.10 148708.96 
HaCaT- DnTERT  19149.47 -1128.86 17253.62 6739.04 
H2O 0.00 - 0.00  - 
GM847 57440.71 - -  - 
chaps buffer 9006.62 - -  - 
HaCaT-TERT HI -5071.81  -  -  - 
c) 
0
2000
4000
6000
8000
10000
12000
T
h
o
u
s
a
n
d
s
a
r
b
it
ra
r
y
 t
e
lo
m
e
r
a
s
e
 u
n
it
s
 
re
la
ti
v
e
 t
o
 T
S
R
8
  
a
m
p
li
fi
c
a
ti
o
n
HaCaT-Puro HaCaT-TERT HaCaT-TERT-HA 
cell lines
Quantification of telomerase activity by TRAPeze kit
0hr
20hrs
T
h
o
u
s
a
n
d
s
a
r
b
it
ra
r
y
 t
e
lo
m
e
r
a
s
e
 u
n
it
s
 
re
la
ti
v
e
 t
o
 T
S
R
8
  
a
m
p
li
fi
c
a
ti
o
n
 
3.2 Telomere activity in HaCaT 
 
 110 
d)  
-10
0
10
20
30
40
50
60
70
T
h
o
u
s
a
n
d
s
a
r
b
it
r
a
ry
 t
e
lo
m
e
ra
s
e
 u
n
it
s
 
r
e
la
ti
v
e
 t
o
 T
S
R
8
  
a
m
p
li
fi
c
a
ti
o
n
0hr
20hrs
cell lines
Quantification of telomerase activity by TRAPeze kit
HaCaT-
Puro 
HaCaT-
DnTERT
H2O GM847 chaps
buffer
HaCaT-
TERT HI
T
h
o
u
s
a
n
d
s
a
r
b
it
r
a
ry
 t
e
lo
m
e
ra
s
e
 u
n
it
s
 
r
e
la
ti
v
e
 t
o
 T
S
R
8
  
a
m
p
li
fi
c
a
ti
o
n
 
 
Figure 10: Analysis of telomerase activity using TRAPeze-RT 
detection kit 
 
a) and more in detail in c) and d) Detection of telomerase activity in 
HaCaT cells at control times (0 hr) and after 20 hrs in suspension during 
anoikis assay (20 hrs). The mean ratio of telomerase activity relative to 
the empty vector HaCaT-Puro at time 0 is shown. The assay was 
performed in triplicate samples with 200 ng of total cell lysate, and four 
negative controls were performed (water, GM847, lysis buffer (chaps 
buffer), and a heat-inactivated lysates (HaCaT-TERT HI). The data are 
presented as means of three independent repeats and SD, and the values 
are reported in table b).  Between each comparison group (comparison at 
different time points and between different cell lines), the p value is < 
0.0001, considered extremely significant. 
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3.3 Detection of hTERT mRNA expression 
 
 
Normally, somatic cells express almost undetectable amounts of TERT, 
however a basal level of mRNA expression should always be detectable 
as shown in normal fibroblasts during their passage through the S phase 
of the cell cycle (Masutomi, Yu et al. 2003). On the other hand, cells 
expressing a construct with hTERT or hTERT-HA should highly express 
the corresponding mRNA. Therefore, I investigated hTERT and hTERT-HA 
mRNA expression in HaCaT carrying the empty vector and carrying hTERT 
and hTERT-HA by real-time PCR. 
 
Quantitative real-time qPCR requires normalization of cDNA to reflect the 
same amount of initial RNA in each reaction, which may easily vary due 
to the high sensitivity of the method and the difficulty in quantifying with 
the same sensitivity, the amount of the starting material (Vandesompele, 
De Preter et al. 2002). Also, the difference in the expression in different 
cell lines illustrates the need for a standard for mRNA expression to use 
as a normalization tool. To increase the accuracy of the normalization, at 
least two control genes should be used, and their stability in the studied 
sample should be evaluated before proceeding with the gene of interest. 
mRNA levels of 4 housekeeping genes (YAP1, POLR2A, HPRT1, ESD, see 
Table 1, in the Materials and Methods section) were chosen from previous 
studies (Saviozzi, Cordero et al. 2006; Allen, Winters et al. 2008) and 
analysed using real-time PCR. Evaluation of the stability (M) of the gene 
expression profiles for each of the housekeeping genes was carried out 
using geNORM (Vandesompele, De Preter et al. 2002). M is a measure of 
how stable each housekeeping gene is with respect to the other 
housekeeping genes in the data set. A lower M value corresponds to a 
bigger stability; therefore that housekeeping gene is more suitable for 
normalization. All the 9 possible combinations of normalization using 4, 3 
or 2 housekeeping genes (YAP1-POLR2A-HPRT1-ESD; YAP1-POLR2A-
HPRT1; POLR2A-HPRT1-ESD; POLR2A-ESD etc.) were performed and the 
groups presenting the lowest average of M value were considered. 
However, YAP1 was eventually removed form data analysis, since a 
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recent study has shown the involvement of this protein in apoptosis 
(Danovi, Rossi et al. 2007), which may interfere with our results. 
Therefore, the pair of housekeeping genes ESD-HPRT1 (average 
M=0.668) was chosen for further normalization of hTERT mRNA 
expression in HaCaT cell lines and in the positive control (SVFN4 cells) 
(figure 11). As shown in figure 4, table b), at time 0, hTERT gene 
expression is approximately 30-fold and 43-fold increased in hTERT or 
hTERT-HA overexpressing HaCaT keratinocytes compared to control 
(HaCaT-Puro) cells, respectively.   
 
After 20 hrs in suspension, anchorage-deprived cells show a lower 
amount of exogenous hTERT (or hTERT-HA) mRNA, corresponding to an 
average 1.6-fold decrease in hTERT or hTERT-HA. However, there was a 
non significant difference in the endogenous hTERT mRNA expressed by 
HaCaT-Puro at zero time and after 20 hrs of anchorage deprivation. 
Significantly, in anchorage-deprived cells, hTERT and hTERT-HA gene 
expression is still more abundant than in the empty vector control cells at 
zero time. The mRNA relative expression is approximately 21-fold and 
25-fold increased in hTERT or hTERT-HA overexpressing HaCaT 
keratinocytes compared to control (HaCaT-Puro) cells, respectively. 
Results portrayed represent the means and standard deviations from 3 
independent experiments.  
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b)  
cell lines 
relative hTERT mRNA 
expression compared to 
housekeeping genes standard deviation 
 0 hr 20 hrs 0 hr 20 hrs 
positive control 704.58 - 0.00 - 
HaCaT-Puro  334.51 284.73 165.07 82.50 
HaCaT-TERT 10224.22 6997.85 2128.07 793.12 
HaCaT-TERT-HA  14460.60 8398.19 964.51 1358.98 
 
g) HaCaT cells: groups for comparison P value 
Puro 0 hr - Puro 20 hrs p>0.05 ns 
Puro 0 hr - TERT 0 hr P<0.001 *** 
Puro 0 hr - TERT 20 hrs P<0.001 *** 
Puro 0 hr - TERT-HA 0 hr P<0.001 *** 
Puro 0 hr - TERT-HA 20 hrs P<0.001 *** 
Puro 20 hrs - TERT 0 hr P<0.001 *** 
Puro 20 hrs - TERT 20 hrs P<0.001 *** 
Puro 20 hrs - TERT-HA 0 hr P<0.001 *** 
Puro 20 hrs - TERT-HA 20 hrs P<0.001 *** 
TERT 0 hr - TERT 20 hrs P<0.05 * 
TERT 0 hr - TERT-HA 20 hrs P<0.01 ** 
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TERT 20 hrs - TERT-HA 0 hr P<0.001 *** 
TERT 20 hrs - TERT-HA 20 hrs p>0.05 ns 
TERT-HA 0 hr - TERT-HA 20 hrs P<0.001 *** 
 
Figure 11: Quantification of hTERT mRNA expression by real-time 
qPCR in HaCaT cells at control times (0 hr) and after 20 hrs in 
suspension during anoikis assay (20 hrs) 
 
In graph a) and table b), relative amount of hTERT mRNA expression 
compared to HaCaT-Puro at time 0. Absolute values of mRNA copy 
numbers were normalized with the two set of housekeeping genes ESD 
and HPRT1. In the inner graph, inset of the relative amount of hTERT 
mRNA expression in HaCaT-Puro. SVFN (SV40-infected premalignant oral 
keratinocytes) were used as a positive control for hTERT expression.  
The data are presented as means of three independent repeats and SD, 
and the values are reported in table b). ***: highly significant; **: very 
significant; * significant; ns: non significant. 
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3.4 Detection of hTERT splice variants mRNA expression 
 
 
As explained in the introduction, section 1.1.5.2, alternative splice 
variants (ASV) of hTERT have been identified in numerous cell lines. A 
possible role in regulation of telomerase due to these ASV was therefore 
hypothesized by a number of studies. In particular, a study by Cerezo et 
al. (Cerezo, Kalthoff et al. 2002) suggests a possible implication of the 
beta (β) splice variant in regulation of telomerase activity in HaCaT cell 
lines.  
 
Therefore, to investigate a possible role of alternative splice variants in 
our cell lines undergoing anoikis in an accurate way, I developed a real-
time qPCR protocol that utilizes unique primer pairs for each splice 
variant. The expression of each variant is detected independently and 
quantified against the pair of housekeeping genes ESD and HPRT1. It is 
however necessary to consider that a precise quantification of hTERT 
splice variants is difficult considering the very low amount of these 
transcripts. Also, HaCaT-TERT and HaCaT-TERT-HA do not show any 
exogenous ASV, due to the presence of a constitutive promoter in the 
retrovirally-transduced vector. 
 
As shown in figure 12, all HaCaT cells show a reduction in the alpha (α) 
splice variants (dominant negative variant) when deprived of anchorage. 
However, the decrease is not significant, and since this splice variant 
represents less than 2% of the endogenous hTERT transcript in HaCaT-
Puro at time 0, it is possible to exclude a regulatory role of this ASV in 
hTERT expression.   
 
The beta (β) splice variant represents 4.4% of the total endogenous 
hTERT transcript in HaCaT-Puro at time 0, but its expression does not 
significantly change at 20 hrs, or in the TERT/TERT-HA overexpressing 
cells.  
 
3.4 hTERT splice variants mRNA expression 
 
 116 
The alpha/beta (αβ) deletion contributes minimally to hTERT gene 
expression (less than 0.5% in HaCaT-Puro at time 0) and it is not 
significantly altered in any cell lines.    
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expression of hTERT splicing variants mRNA
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b) Each splice variant expression is calculated as concentration 
relative to the pair of housekeeping genes 
cell lines 
average of alpha deletion 
expression  standard deviation 
 0 hr 20 hrs 0 hr 20 hrs 
HaCaT-Puro  6.46 0.21 5.56 0.18 
HaCaT-TERT 9.23 0.29 0.46 0.50 
HaCaT-TERT-HA  13.73 2.66 15.61 4.39 
cell lines 
average of beta deletion 
expression standard deviation 
 0 hr 20 hrs 0 hr 20 hrs 
HaCaT-Puro  14.82 28.71 1.70 16.57 
HaCaT-TERT 15.31 16.77 6.89 9.02 
HaCaT-TERT-HA  19.70 29.95 10.25 20.06 
cell lines 
average of alpha/beta 
deletion expression standard deviation 
 0 hr 20 hrs 0 hr 20 hrs 
HaCaT-Puro  0.68 0.99 0.39 0.47 
HaCaT-TERT 0.99 0.26 0.29 0.23 
HaCaT-TERT-HA  0.37 2.26 0.25 1.79 
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c)
Contribution of the ASV in the hTERT
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d)
Contribution of the ASV in the hTERT mRNA 
expression
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e) 
 
cell lines 
% total 
hTERT 
mRNA 
% alpha 
del ASV 
% beta del 
ASV 
% 
alpha/beta 
del ASV 
HaCaT-Puro 0 
hr 93.43 1.93 4.43 0.20 
HaCaT-Puro 
20 hr 89.50 0.07 10.08 0.35 
HaCaT-TERT 
0 hr 99.75 0.09 0.15 0.01 
HaCaT-TERT 
20 hrs 99.75 0.00 0.24 0.00 
HaCaT-TERT-
HA 0 hr 99.77 0.09 0.14 0.00 
HaCaT-TERT-
HA 20 hrs 99.58 0.03 0.36 0.03 
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Figure 12: Quantification of hTERT splice variants mRNA 
expression by real-time qPCR in HaCaT cells at control times (0 
hr) and after 20 hrs in suspension during anoikis assay (20 hrs) 
 
In graph a) and table b), relative concentration of hTERT splice variants 
normalized to the pair of housekeeping genes ESD and HPRT1. The data 
are presented as means and SD and average of three independent 
experiments.  
In graphs c), d) and table e), relative contribution in percentage of each 
splice variant to the correspondent total (endogenous and exogenous) 
amount of hTERT mRNA is represented. In graph d), inset of TERT and 
TERT-HA expressing cells is shown. Variations in the mRNA amount 
between the gropus is not statistically significant (p>0.05). Contribution 
of ASV in the total hTERT mRNA is so low that a possible regulative role 
may be excluded in our cell lines. 
 
3.5 TERC RNA expression 
 
 119 
3.5 Detection of TERC RNA expression 
 
 
Non-canonical functions of telomerase can be divided into two subgroups: 
the one requiring the presence of the RNA component TERC or the one 
which is independent from it (Parkinson, Fitchett et al. 2008).  
 
As I showed above, exogenously-expressed telomerase is highly active 
even when the cells are deprived of anchorage, but to further categorize 
any observed phenotype in TERT/TERT-HA overexpressing HaCaT and 
relate it to a defined subgroup in the range of non-canonical functions, it 
is necessary to measure TERC expression in the cell at control time (0 hr, 
as shown in figure 13) and undergoing anoikis (20 hrs).  
 
The expression of TERC was normalized against the pair of housekeeping 
genes ESD and HPRT1. HaCaT cells expressing the different constructs do 
not show a significant difference in TERC expression at control time, but 
show an increase when deprived of anchorage. The increase could be due 
to the stability of the TERC mRNA, which is known to have one of the 
longest half-lifes of all human mRNAs (Yi, Tesmer et al. 1999), or 
possibly to an unidentified stabilizing mechanism operating under 
conditions of anchorage deprivation.  
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a)
TERC expression by qPCR
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b) 
cell lines 
average of TERC 
expression standard deviation 
 0 hr 20 hrs 0 hr 20 hrs 
VA13 48.21 - 0.00 - 
HaCaT-Puro 452813.18 1459167.49 288817.24 398974.75 
HaCaT-TERT 610826.61 1824166.86 177486.55 838392.54 
HaCaT-TERT-HA 916887.20 1602932.45 910882.48 647018.22 
 
Figure 13: Quantification of TERC expression by Real-time qPCR in 
HaCaT cells at control times (0 hr) and after 20 hrs in suspension 
during anoikis assay (20 hrs) 
 
In graph a) and table b), relative amount of TERC expression compared 
to HaCaT-Puro at time 0. Absolute values of RNA copy numbers were 
normalized with the two set of housekeeping genes ESD and HPRT1. 
VA13 was used as a negative control for TERC expression, as VA13 is 
known to use the ALT system and lacks the RNA component of 
telomerase (Atkinson, Hoare et al. 2005).  
The data are presented as mean of three independent repeats and SD, 
and the values are reported in table b). Variation among the samples is 
not statistically significantly (p>0.05). 
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3.6 Summary of results part 1 
 
 
As explained in the section 1.1.4 of the introduction, telomerase has been 
involved in a variety of functions in germs, stem, cancer and even 
somatic cells. The main (canonical) function of telomerase is the ability to 
elongate the telomeres, however the enzyme has got other non-canonical 
functions, which are independent from telomere lengthening and can be 
either dependent on, or independent from, the RNA component TERC.   
 
A study on the two-stage chemical epidermal tumourigenesis mouse 
model, showed the mice were more prone to form papillomas and show 
increased wound healing when TERT was overexpressed in the basal 
keratinocytes (Gonzalez-Suarez, Samper et al. 2001). This could be 
explained by a new function of TERT, independent of telomere 
lengthening (mice already having long telomeres), in the promotion of 
tumour formation. However, TERT overexpression did not affect the 
malignant conversion of the papillomas (Gonzalez-Suarez, Samper et al. 
2001). In particular, TERT could act by giving the malignant cells an 
increased resistance towards a form of cell death specific to anchorage 
deprivation, termed anoikis. This is supported by a possible regulation of 
ras, which has been shown to be involved  both in the two-stage 
chemical tumourigenesis model, where a mutation on the gene is 
necessary for the initiation of carcinogenesis and papilloma formation 
(Brown, Quintanilla et al. 1986), and in anoikis, where it inhibits the 
cascade leading to cell death (Frisch and Francis 1994).  
 
To identify the role of telomerase in the protection against anoikis in skin 
keratinocytes, and define this function as novel and independent from 
telomere lengthening, different aspects of telomerase activity and the 
main components of this enzyme were measured. 
 
The system I used permits the investigation of non-canonical functions of 
telomerase only thanks to the expression of a modified form of hTERT, 
TERT-HA. The  influenza virus haemagglutinin (HA) epitope tag added at 
the carboxy-terminus does not affect the telomerase activity in vitro but 
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annuls the ability to elongate telomeres, as also shown by Counter’s 
group (Counter, Hahn et al. 1998).  
  
The drop in telomerase activity occurred in all HaCaT lines when cultured 
for 20 hrs in suspension, but the higher activity retained in TERT and 
TERT-HA overexpressing cells at this time point compared to the empty 
vector at time 0 suggests the necessity of an active TERT in protection 
against anoikis that I later observed (see result chapter 2, section 4.1). 
However, the ability of telomerase to elongate the telomere is not 
necessary in the protective function, as the same function also is 
observed in HaCaT-TERT-HA, whose telomerase cannot carry out its 
canonical function of telomere elongation. 
 
The expression of the RNA component TERC has also been investigated to 
determine if TERT regulates TERC expression during anoikis. TERC was 
interestingly elevated in the cells that undergo anoikis after 20 hrs in 
suspension, demonstrating that the lack of telomere lengthening is not 
due to the lack of the RNA component but of a different function of the 
telomerase when cells are deprived of anchorage. It also confirm a 
previous study showing a possible stabilization of TERC due to the 
overexpression of the catalytic component (Yi, Tesmer et al. 1999).  
 
Therefore, the catalytic component TERT seems to be the only direct 
candidate in the protection against anoikis observed in HaCaT 
keratinocytes overexpressing TERT/TERT-HA. In fact, although hTERT 
expression decreases after 20 hrs in suspension, it is still higher than the 
control.  
 
The hypothesis that hTERT expression was regulated at transcriptional 
level was rejected because TERT was not downregulated in the HaCaT 
Puro controls in suspension. In addition the alternative splice variants in 
our cells were shown not to play a major role as had been suggested by 
previous semi-quantitative studies (Cerezo, Kalthoff et al. 2002). This 
would seem to be in contrast with what was shown in a previous study, 
which showed an increase in the inactive β splice variant when HaCaT cell 
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sheets are detached from the basement membrane (Cerezo, Kalthoff et 
al. 2002), and such a manipulation would trigger anoikis (Marconi, Atzei 
et al. 2004). However, I believe that the methods I have used to 
determine the expression of the splice variants, using independent 
primers for each splice variant, is more accurate than the one used by 
Cerezo et al., where all splicing patterns were identified by a single pair 
of primers and the products quantified by densitometry following gel 
electrophoresis.  Furthermore, the β splice variant produces an out-of-
frame protein that may be recognised as foreign and not expressed at 
high enough levels to be a functional dominant-negative as suggested 
(Cerezo, Kalthoff et al. 2002). There is fact no evidence that any of the 
splice variants are naturally expressed as proteins at significant levels. 
  
From my results, it is suggested that some post-transcriptional and post-
translational mechanisms may regulate TERT mRNA and telomerase 
expression respectively during HaCaT anoikis. 
 
Indeed there is evidence that a balance between the calcium-binding 
proteins S100A8 and S100A9 controls telomerase activity at the post-
translational level (Rosenberger, Thorey et al. 2007) in differentiating 
keratinocytes.  Furthermore, it has been shown that telomerase activity 
is not regulated by TERT mRNA levels in cervical cancer in vivo 
(Matthews, Shera et al. 2000), and TERT and TERC mRNA levels do not 
decrease immediately upon detachment from the basement membrane in 
epidermis whereas telomerase activity does (Harle-Bachor and Boukamp 
1996). 
 
My results from the enzymatic assay show telomerase activity in HaCaT 
cells at control times, confirming earlier findings detecting telomerase 
activity in the epidermis (Taylor, Ramirez et al. 1996). In addition, the 
drop of telomerase activity that I could detect when HaCaT are 
anchorage-deprived for 20 hrs is comparable with the results in vivo by 
Boukamp’s group, where telomerase activity is detected in the 
regenerative basal layer of the skin but it is absent in the upper layers, 
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where keratinocytes differentiate and lose contact with the extracellular 
matrix (Harle-Bachor and Boukamp 1996).  
 
The presence of telomerase activity in the epidermis, however, is not 
fully correlated with the expression of the mRNA for the two telomerase 
components TERT and TERC. In fact, both TERT and TERC can be 
detected not only in the basal layer of the epidermis, where telomerase 
activity is present, but also in the suprabasal of the epidermis, and the 
expression of TERT, in particular, follows a gradient of expression as 
detected by in situ hybridization (Nakano, Watney et al. 1998). These 
studies confirm my results, showing an invariant expression of TERT 
mRNA when control HaCaT are anchorage-deprived for 20 hrs compared 
to the time zero, and a decrease, but not annulment, of TERT expression 
in HaCaT overexpressing exogenous TERT or TERT-HA. I also detected 
the expression of TERC both when HaCaT are growing anchored to the 
ECM and when they grow detached from it. The increase of TERC in 
HaCaT after 20 hrs in suspension has been previously discussed in this 
section. 
 
My results partly contradict the previous study by Crowe (Crowe, Nguyen 
et al. 2005), where telomerase activity is undetectable at time 0, then is 
suddenly detected at 8 hrs in suspension, and again is undetected at 24 
hrs in suspension in NHEK. The levels of TERT mRNA measured by 
reverse transcription-PCR and not real-time qPCR, vary between 
undetectable at time 0, to high levels at 2 hrs in suspension, to a 
complete drop at 4 hrs, and a peak in expression at 8 hrs, followed by a 
lack of activity in the expression at 24 hrs. These results are not 
accompanied by an analysis of the expression of TERC, so it is difficult to 
determine a correlation between the variation in TERT mRNA levels and 
the telomerase activity found by this group. In addition, the detection of 
TERT protein by western blot cannot be evaluated, since a later study 
highlighted the inefficiency and non-specificity of the antibody use by 
Crowe (Wu, Dudognon et al. 2006).   
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4. The role of TERT expression in the protection against anoikis 
(apoptosis in anchorage-deprived cells)  
 
 
As more extensively explained in the introduction, a possible involvement 
of telomerase in the mechanism of apoptosis and the regulation of the 
enzyme by loss of attachment has been shown in normal human 
epidermal keratinocytes and squamous cell carcinoma lines, where 
anchorage deprivation inhibits telomerase activity, while increasing ERK1 
activity in this setting contributes to cell cycle arrest. Re-adhesion to type 
IV collagen via specific integrin subunits α2β1 inhibits ERK1 activity and 
telomerase repression (Crowe, Nguyen et al. 2005).  
 
Decreased ß1 integrin receptor density also been associated with loss of 
basement membrane attachment and terminal differentiation of these 
same cell types (Jones and Watt 1993). Also, keratinocytes enriched for 
stem cells are protected from anoikis via β1 integrin, in a Bcl-2 
dependent manner, and disruption of β1 integrin activates the extrinsic 
apoptotic pathway (Tiberio, Marconi et al. 2002).  
 
The importance of the pathway involving the focal-adhesion kinase FAK 
has also been correlated with cell survival, being able to suppress anoikis 
and transform kidney epithelial cells (Frisch and Francis 1994). Also, FAK 
activation is dependent on integrin-mediated cell attachment and the 
following signalling cascade leads to the activation of the MAP kinases 
ERK1 and ERK in human kidney epithelial  and mouse fibroblast 
(Schlaepfer and Hunter 1996). Additionally, there is evidence that 
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epidermal growth factor (EGF) and its downstream effectors mitogen 
activated protein kinase (MAPK) and ERK can mute anoikis in HaCaT 
keratinocytes (Jost, Huggett et al. 2001).  
 
FAK is known to be involved in signalling from growth-factor receptors 
and to  influence the adhesion mechanics regulated by integrins, working 
together with the SRC-family kinases (McLean, Carragher et al. 2005). 
 
Moreover, reduction in FAK protein expression in the epidermis has been 
directly associated with a reduction in the acquisition of neoplasia and 
malignancy and an increase keratinocyte cell death in the same two-
stage chemical carcinogenesis mouse model (McLean, Brown et al. 2001; 
McLean, Komiyama et al. 2004) where a Ras mutation is known to be the 
initiating event (Brown, Quintanilla et al. 1986; Quintanilla, Brown et al. 
1986). FAK is overexpressed in a number of human cancers, including 
squamous cell carcinoma (Agochiya, Brunton et al. 1999), as is the 
upstream effector of Ras, the EGF receptor (Gusterson, Cowley et al. 
1985). 
 
Telomerase is also over-expressed in papillomas and carcinomas 
generated by the mouse epidermal two-stage tumourigenesis protocol 
(Parkinson, Fitchett et al. 2008) and forced expression of TERT in the 
epidermis leads to improved wound repair and an increase in the number 
of papillomas but not carcinomas (Gonzalez-Suarez, Samper et al. 2001).  
Thus TERT promotes neoplasia rather than malignancy in this model. 
Telomerase is also expressed in human squamous dysplasias and 
carcinomas (Mao, El-Naggar et al. 1996). 
 
Collectively current data support hypotheses encompassing telomerase 
regulation by ECM and a possible survival mechanism involving integrins 
and FAK/SRC kinases, HRAS and ECM. The involvement of these 
pathways in the survival of skin cancer cells is strongly indicated, since 
FAK (Frisch and Ruoslahti 1997), Src (Frisch and Francis 1994), EGFR 
(Jost, Huggett et al. 2001), and HRAS all mute anoikis (Frisch and Francis 
1994).  
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Therefore the aim of this part of my study was to test the hypothesis that 
TERT mutes anoikis to enhance two-stage epidermal tumourigenesis. 
Moreover, protection against anoikis, if shown in the cell line model of 
HaCaT cells over expressing TERT and TERT-HA characterized above, 
would be a novel non-canonical function of telomerase. 
 
To this hypothesis, I set up an experimental assay where I analyzed the 
behaviour of the HaCaT-Puro, HaCaT-TERT, HaCaT-TERT-HA, and HaCaT-
DnTERT when they are deprived from anchorage for 20 hours. I 
determined the specificity of cell death (anoikis rather than general 
apoptosis) after treatment of HaCaT cells in surface cultures with 
cisplatin, and two independent methods were utilized to confirm the 
results, studying two different sets of cells derived from two 
independently-transduced HaCaT populations.  
4.1 Anchorage deprivation and apoptosis 
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4.1 The effect of disruption of cell-matrix interactions on 
phenotypic features of apoptosis 
 
 
According to Frisch’s protocol (Frisch and Francis 1994), HaCaT-Puro, 
HaCaT-TERT, HaCaT-TERT-HA cells were plated on petri dishes that had 
been coated with polyhydroxyethylmethacrylate (polyHEMA). PolyHEMA is 
in fact known to prevent cell attachment because its uniformly nonionic 
nature prevents matrix deposition (Folkman and Moscona 1978). Live 
and apoptotic cells were harvested for further analysis at time 0 (right 
after trypsinization) and at 20 hr. At this final time, some cells were 
loosely attached to the bottom of the coated dish, however these cells 
remained as single round cells and did not spread on the dish. Other cells 
were floating in the medium but all the cells were collected for the 
analysis. 
 
The percentage of apoptotic cells was quantified by two independent 
methods, by morphological analysis of the nuclei, and by flow cytometry, 
as described in Materials and Methods. The results have been statistically 
analyzed independently with one way analysis of variance (ANOVA) test. 
 
 
• Morphological evaluation of the apoptotic nuclei 
 
Firstly, classical hallmarks of apoptosis, such as membrane blebbing, 
cellular shrinkage, chromatin condensation and nuclei fragmentation, 
have been detected by Hoechst staining of the nuclei in at least 300 
nuclei per sample (figure 14). Blind analysis of 19 independent 
experiments was performed, and the results were subjected to the 
statistical test. All HaCaT samples harvested at time 0 present a minimal 
percentage of apoptotic cells (less than 1%), which is normally expected 
in recently trypsinized cells. On the other hand, HaCaT cells that 
underwent anchorage deprivation and overexpress hTERT (canonical 
function of telomerase) or hTERT-HA (non-canonical function of 
telomerase) show an average percentage of apoptotic cells of 
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approximately 19 and 16-fold higher than the control at 0 hr, 
respectively, compared to an approximately 34-fold higher rate of 
apoptotic cells seen in the same suspended HaCaT-Puro compared to the 
same control at 0 hr. Therefore, hTERT overexpression was shown to 
increase resistance to apoptosis in HaCaT cells by an average of 
approximately 1.9 fold compare to HaCaT-Puro, and the result was 
proven to be statistically significant by one way ANOVA test and Tukey-
Kramer multiple comparisons test (figure 14, table g).  
 
 
• Detection of the apoptotic nuclei by FACS 
 
Secondly, flow-cytometric analysis of propidium iodide-stained cells was 
performed to detect the percentage of apoptotic cells present in sub-G1 
peak of cell cycle analysis (figure 15) in 10 independent experiments, 
sorting at least 25000 cells. The bigger number of events analysed with 
FACS permitted a more accurate detection of apoptotic cells, and 
therefore there was no need for a bigger number of experiments to be 
performed to acquire a significant result. All HaCaT samples harvested at 
time 0 showed a minimal percentage of apoptotic cells (maximum 2%). 
On the other hand, HaCaT cells that underwent anchorage deprivation 
and overexpressed hTERT or hTERT-HA showed an average percentage of 
apoptotic cells that was approximately 8 and 6-fold that of the control at 
0 hr respectively, compared to approximately 11-fold in the HaCaT-Puro 
controls. Therefore, hTERT overexpression was shown to increase 
resistance to anoikis in HaCaT cells by an average of approximately 1.6 
fold compared to HaCaT-Puro, and the result was proven to be 
statistically significant compared to HaCaT-TERT-HA (p < 0.05) by one 
way ANOVA test and Tukey-Kramer multiple comparisons test (figure 15, 
table d).  
 
It should be noted that different percentages of apoptotic cells were 
detected by the two methods used above. The bigger percentage of 
apoptosis estimated by morphological evaluation of the cells could be due 
to the inferior accuracy of the method and to the smaller number of cells 
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analyzed compared to FACS analysis. However, it is also possible that the 
visual observation method can detect cells in an earlier stage of apoptosis 
and can detect nuclei which are highly reduced in size, which the FACS 
method could mistakenly detect as debris. Furthermore, the level of 
significance in the rate of apoptotic cells between HaCaT-Puro and 
HaCaT-TERT after 20 hrs after detection of apoptosis by FACS is not as 
high as after morphological evaluation. This may due to the smaller 
sample size, the bigger variability of the assay and, as said before, the 
different amount of apoptotic cells detected by this method.  
Nevertheless, the significance of the results is shown at least with one 
sample, HaCaT-TERT-HA, making the pattern of the results obtained by 
both methods consistent, and strengthening the conclusions drawn. 
Therefore, I believe that a reduction in the variability of the assay (see 
section 4.4) and a bigger sample size would prove that the same pattern 
of resistance towards anoikis could be shown with FACS as well as with 
morphological evaluation of the nuclei. 
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f) 
Cell lines 
Average of cell death 
(%) Standard deviation 
 0 hr 20 hrs 0 hr 20 hrs 
HaCaT-Puro 0.82 27.49 0.82 27.49 
HaCaT-TERT 0.63 15.87 0.63 15.87 
HaCaT-TERT-HA 0.59 13.10 0.59 13.10 
 
g) HaCaT cells: groups for comparison P value 
Puro 0 hr - Puro 20 hrs P<0.001 *** 
TERT 0 hr - TERT 20 hrs P<0.001 *** 
4.1 Anchorage deprivation and apoptosis 
 
133 
TERT-HA 0 hr - TERT-HA 20 hrs P<0.01 ** 
TERT 20 hrs - Puro 20 hrs P<0.01 ** 
TERT-HA 20 hrs - Puro 20 hrs P<0.001 *** 
TERT 20 hrs - TERT-HA 20 hrs p>0.05 ns 
 
Figure 14: Effect of disruption of cell-matrix interactions on 
phenotypic features of apoptosis by Hoechst staining of nuclei 
 
HaCaT cells (approximately 2 million cells) were plated onto petri dishes 
which had been coated with polyHEMA and after 20 hrs hallmarks of 
apoptosis in the nucleus were detected in the fixed cells and compared 
with cells fixed at time 0, as described in Materials and Methods.  
Top picture: Comparison between a normal nuclei of an unaffected cell 
(a, b) with an apoptotic nucleus, showing membrane blebbing, cellular 
shrinkage, chromatin condensation and nuclei fragmentation (c, d).  
e), table f) and table g). Anchorage-deprived HaCaT cells expressing 
exogenous TERT or TERT-HA are approx 1.9 fold more resistant to 
apoptosis than HaCaT expressing the empty vector. Results portrayed 
represent mean and standard deviation (SD) for 19 independent 
experiments and significance is shown as follows; p value showing no 
significant difference between the wild-type TERT construct and HA-
flagged TERT in the response to anoikis after 20 hours of growth in 
suspension. ***: highly significant; **: very significant; * significant; ns: 
non significant. 
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c)  
Cell lines 
Average of cell death 
(%) Standard deviation 
 0 hr 20 hrs 0 hr 20 hrs 
HaCaT-Puro 1.32 14.52 1.32 14.52 
HaCaT-TERT 1.08 10.06 1.08 10.06 
HaCaT-TERT-HA 2.13 8.05 2.13 8.05 
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d) HaCaT cells: groups for comparison P value 
Puro 0 hr - Puro 20 hrs P<0.001 *** 
TERT 0 hr - TERT 20 hrs P<0.001 *** 
TERT-HA 0 hr - TERT-HA 20 hrs P<0.05 * 
TERT 20 hrs - Puro 20 hrs P>0.05 ns 
TERT-HA 20 hrs - Puro 20 hrs P<0.05 * 
TERT 20 hrs - TERT-HA 20 hrs p>0.05 ns 
 
Figure 15: Effect of disruption of cell-matrix interactions on 
phenotypic features of apoptosis analysed by FACS 
  
a) HaCaT cells (approximately 2 million cells) were plated onto petri 
dishes which had been coated with polyHEMA and after 20 hrs PI staining 
analysis to determine the percentage of apoptotic cells (Sub-G1 phase) 
was performed and compared with cells fixed at time 0, as described in 
Materials and Methods. In the left panel; representative FACS analysis of 
HaCaT-Puro (empty vector, P0), HaCaT-TERT (T0) and HaCaT-TERT-HA 
(H0) at time 0. Apoptotic cells are in P3 sector, corresponding to SubG1 
peak; G1 cells in sector P4; S-phase cells in sector P5; M phase cells in 
sector P5. Apoptotic cells are less than 3% of the total events sorted. In 
the right panel, representative FACS analysis of HaCaT-Puro (empty 
vector, PS), HaCaT-TERT (TS), and HaCaT-TERT-HA (HS) harvested after 
20 hr in suspension in polyHEMA coated dishes. 
b) and table c). Anchorage-deprived HaCaT cells expressing exogenous 
TERT or TERT-HA are approximately 1.9 fold more resistant to apoptosis 
than HaCaT cells expressing the empty vector. Results portrayed 
represent mean and SD for 10 independent experiments and significance 
is as follows; p value showing no significant difference between the wild-
type TERT construct and HA-flagged TERT in the response to anoikis after 
20 hours of growth in suspension. ***: highly significant; **: very 
significant; * significant; ns: non significant.  
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4.2 Determination of nature of cell-death: general apoptosis or 
anoikis? 
 
 
To test whether the resistance to cell death due to hTERT or hTERT-HA 
overexpression was directly correlated with anchorage-deprivation and 
was not a general form of apoptosis, treatment with non toxic doses (0 
µM, 10 µM, 20 µM and 35 µM) of cisplatin was performed on HaCaT cells 
growing in adherence to tissue culture dishes (figure 16). Most forms of 
apoptosis are induced by drugs such as cisplatin, which cross-links DNA 
in several different ways, interfering with cell division in mitosis, although 
the mechanism has not yet been fully elucidated (Gonzalez, Fuertes et al. 
2001)  
 
In surface cultures cisplatin-treated hTERT or hTERT-HA overexpressing 
cells do not show any protection in drug-induced cell death compared to 
the corresponding control carrying the empty vector; therefore I can 
deduce that hTERT or hTERT-HA overexpression did not protect HaCaT 
cells against apoptosis induced by cisplatin.  This suggests that the 
anoikis resistance phenotype induced by TERT is independent of apoptotic 
mechanisms associated with DNA damage. 
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b) 
Dose cisplatin Average of cell death (%) 
 
HaCaT-Puro 
 
HaCaT-TERT 
 
HaCaT-
TERT-HA 
0 µM  (0 hr) 0.40 0.40 0.40 
0 µM (0.01% DMSO, 20 hrs)  1.23 1.23 1.23 
10 µM (20 hrs)    2.50 2.50 2.50 
20 µM (20 hrs)   3.43 3.43 3.43 
35 µM (20 hrs)  2.43 2.43 2.43 
    
Dose cisplatin Standard deviation 
 
HaCaT-Puro 
 
HaCaT-TERT 
 
HaCaT-
TERT-HA 
0 µM (0 hr) 0.35 0.35 0.35 
0 µM (0.01% DMSO, 20 hrs)  0.45 0.45 0.45 
10 µM (20 hrs)    0.69 0.69 0.69 
20 µM (20 hrs)   1.47 1.47 1.47 
35 µM (20 hrs)  0.76 0.76 0.76 
 
Figure 16: Effect of TERT on apoptosis analysed by Hoechst 
staining of nuclei in cisplatin-treated cells 
 
 
HaCaT cells (approx 2 million cells) were plated onto tissue culture 
control dishes. Cells were treated with 0 µM, 10 µM, 20 µM and 35 µM of 
cisplatin and after 20 hrs hallmarks of apoptosis in the nucleus were 
detected in the fixed cells and compared with cells fixed at time 0, as 
described in Materials and Methods. Exogenous hTERT or hTERT-HA 
expression do not protect cells from cisplatin-induced cell death in HaCaT 
cells.   Results portrayed represent mean and SD for 2 independent 
experiments. 
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4.3 The effect of the dominant negative (catalytically dead) TERT 
overexpressing HaCaT on anoikis  
 
 
As some non-canonical functions of telomerase require the catalytic 
activity of telomerase (Gonzalez-Suarez, Samper et al. 2001), and some 
do not (Sarin, Cheung et al. 2005; Choi, Southworth et al. 2008; Park, 
Venteicher et al. 2009), I additionally tested whether telomerase activity 
was required to mute HaCaT anoikis.  The catalytically-dead, dominant-
negative TERT mutant, DnTERT, which has neither catalytic activity nor 
the ability to lengthen telomeres, was included in a second set of anoikis 
assays, together with a second population of transduced HaCaT-Puro, 
HaCaT-TERT, HaCaT-TERT-HA cells.  
 
As shown in figure 17 (black bars), due to the modest difference in the 
percentage of apoptotic cells between the samples, a bigger sample size 
would be required to repeat exactly the result as before, where the 
protection due to TERT and TERT-HA expression was estimated 
approximately 1.9 fold compared to HaCaT-Puro. However, the same 
trend can be seen also in this experiment, where HaCaT-TERT and 
HaCaT-TERT-HA are on average 1.7 fold more resistant to anoikis than 
the control HaCaT-Puro at time 0.  
 
The presence of the dominant negative version of TERT did not show the 
same level of protection, since anoikis resistance can be quantified as 
approximately 1.4 fold higher than HaCaT-Puro. This may suggest that 
the lack of a catalytic activity of TERT reduces the protection against 
anoikis and that catalytic activity is required for the observed phenotype 
even in the absence of telomere lengthening. However, the results may 
be confounded by the inhibition of the canonical functions of telomerase 
in telomerase-positive HaCaT cells and the DnTERT-HaCaT cells do show 
evidence of increased anaphase bridge formation, which is consistent 
with telomere shortening and dysfunction (E. K. Parkinson – unpublished 
data). The last hypothesis is further supported by the observation that 
the DnTERT-expressing HaCaT cells were not sensitised to anoikis, which 
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would be predicted if the DnTERT had no protective functions and that 
the protective function of TERT against anoikis required telomerase 
activity. 
 
 
 
4.4 The Role of Cell Density on the Effect of TERT on Anoikis 
 
 
Although the data showing TERT-induced protection is significant, the 
anoikis assay on HaCaT cells show great variability, and the reasons for 
this were not initially clear. Maintaining the same experimental conditions 
is essential as in any other study, but identifying the reason for a major 
variability in this assay could be useful for future work. 
 
The possible role of cell culture confluence in modulating the rate of 
apoptotic cells during the assay was hypothesized during routine cell 
culture. HaCaT cells with the different TERT constructs behave differently 
during routine culture, as it has been observed by my colleagues in our 
group: HaCaT-TERT and HaCaT-TERT-HA seem to undergo a faster 
proliferation when the cells are at a higher confluence, while HaCaT-Puro 
and HaCaT-DnTERT seem to proliferate quicker at a lower confluence. 
Also, other experiments undertaken by my colleagues have shown a 
possible dependence of cell confluence. These hints prompted me to 
perform the same anoikis assay with cells growing under different levels 
of confluence. The experiment was repeated three times and significance 
was evaluated by two-tailed ANOVA test. 
 
When all our experimental groups are harvested for the anoikis assay at 
low density (20% confluent), so that in the flask the interaction between 
the still small colonies is minimized, the resistance to anoikis is very high 
(figure 17). More than 90% of HaCaT are still alive after 20 hrs in 
suspension, and the presence of any TERT transgene in the cells does not 
significantly influence the apoptotic rate. 
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On the other hand, when cells were harvested at full confluence (100%), 
prior to being placed in suspension, so that in the culture flask HaCaT 
form a multilayer of cells and the interaction between the cells is 
maximal, the resistance to anoikis significantly decreases compared to 
the lowest confluence. Approximately 77% of HaCaT are still alive after 
20 hrs in suspension, and also in this case the presence of any TERT 
transgene expressed in the cells does not significantly influence the 
apoptotic rate. Also, at this confluence variability between the experiment 
in the same cell line is greater than at the lowest confluence. To confirm 
that cell death of HaCaT at this confluence wasn’t related to the depletion 
of the nutrients in the culture media, fresh medium was added the day 
before the experiment.  
 
However, when the density of the cell culture (approximately 70% 
confluence) permits the cells to be in a proliferating state but also to gain 
inter-cellular interactions, an effect of TERT overexpression on cell 
apoptosis can be more reproducibly seen. As shown by section 4.1 and 
4.3 of this result chapter, TERT expression confers significant resistance 
to anoikis after 20 hrs in suspension to HaCaT-TERT and HaCaT-TERT-
HA, while HaCaT-DnTERT is less effective. 
 
From this data I can conclude that one aspect to consider when 
performing this kind of anoikis assay is the cell density prior to the 
experiment. Variation depending on density could be due to the 
increasing inter-cellular interactions within the culture, which promotes 
anoikis in an overconfluent culture (Frisch and Francis JCB 1994), or to 
the different cell-cycle and density-dependent expression of the proteins 
targeted by TERT to confer protection against anoikis.  
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b) 
Effect of confluence on anoikis assay 
cells at 0 hr
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c)  
Cell lines 
Average  (%) of apoptotic cell death after 
20 hrs in suspension 
 Cell confluence before assay 
 20% 70% 100% 
HaCaT-Puro 6.49 23.36 20.33 
HaCaT-TERT 6.15 13.49 20.09 
HaCaT-TERT-HA 12.52 13.73 24.16 
HaCaT-DnTERT 8.16 18.02 26.03 
 
Cell lines Standard deviation 
 Cell confluence before assay 
 20% 70% 100% 
HaCaT-Puro 0.86 6.66 6.34 
HaCaT-TERT 1.62 4.27 10.19 
HaCaT-TERT-HA 3.44 3.59 9.73 
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HaCaT-DnTERT 2.46 4.48 16.12 
 
d) HaCaT cells: groups for comparison P value 
  
20% confluence  
Puro 20 hrs – TERT 20 hrs P>0.05 ns 
TERT 20 hrs – TERT-HA 20 hrs P<0.05 * 
Puro 20 hrs - TERT-HA 20 hrs P<0.05 * 
Puro 20 hrs - DnTERT 20 hrs P>0.05 ns 
TERT 20 hrs - DnTERT 20 hrs P>0.05 ns 
TERT-HA 20 hrs - DnTERT 20 hrs P>0.05 ns 
  
70% confluence  
Puro 20 hrs – TERT 20 hrs P<0.05 * 
TERT 20 hrs – TERT-HA 20 hrs P<0.05 ns 
Puro 20 hrs - TERT-HA 20 hrs P<0.05 * 
Puro 20 hrs - DnTERT 20 hrs P>0.05 ns 
TERT 20 hrs - DnTERT 20 hrs P>0.05 ns 
TERT-HA 20 hrs - DnTERT 20 hrs P>0.05 ns 
  
100% confluence P=0.89 ns 
 
e)  
Cell lines 
Average  (%) of apoptotic cell death 
at 0 hr  
 Cell confluence before assay 
 20% 70% 100% 
HaCaT-Puro 0.33 0.26 0.33 
HaCaT-TERT 0.33 0.33 0.25 
HaCaT-TERT-HA 0.44 0.33 0.33 
HaCaT-DnTERT 0.22 0.33 0.58 
 
Cell lines Standard deviation 
 Cell confluence before assay 
 20% 70% 100% 
HaCaT-Puro 0.00 0.15 0.27 
HaCaT-TERT 0.00 0.00 0.17 
HaCaT-TERT-HA 0.19 0.23 0.00 
HaCaT-DnTERT 0.38 0.23 0.17 
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Figure 17: Effect of confluence of the cell culture in the rate of 
apoptotic assay performed with the anoikis assay 
 
As in fig. 14, HaCaT cells (approximately 2 million cells) were plated onto 
petri dishes which had been coated with polyHEMA and after 20 hrs 
hallmarks of apoptosis in the nucleus were detected in the fixed cells and 
compared with cells fixed at time 0, as described in Materials and 
Methods.  
Differently from fig. 14, these are a new population of cells transduced 
with the different transcripts. Also the new transcript DnTERT has been 
included in the cell line HaCaT-DnTERT, characterized by the expression 
of a catalytically inactive TERT which is unable to elongate telomeres.  
Before plating the cells in the polyHEMA dishes, HaCaT were cultured at 
different confluences: low density (20% confluent), medium density 
(70% confluent) and high density (100% confluent).  
a), b), table b), c) and d) Anchorage-deprived HaCaT cells expressing 
exogenous TERT or TERT-HA are respectively approximately 1.7 fold 
more resistant to apoptosis than HaCaT expressing the empty vector and 
compared to HaCaT-DnTERT, but this effect is seen just when the cells 
derive from 70% confluence. At the lowest confluence, the percentage of 
apoptotic cells is approximately 6%, and it is not significantly affected by 
the presence of TERT. At full confluence, the percentage of apoptotic cells 
approximately 23%, and it is not affected by the presence of TERT either. 
Results portrayed represent mean and SD for 3 independent experiments 
for 20% and 100% confluence, and 5 repeats for 70% confluence. In the 
table c), the significance values are shown for each relevant groups of 
comparison. Significance is as follows; p value showing no significant 
difference between the wild-type TERT construct and HA-flagged TERT in 
the response to anoikis after 20 hours of growth in suspension. ***: 
highly significant; **: very significant; * significant; ns: non significant. 
The significance of the cells growing at 70% confluence prior to the 
anoikis assay is concordant to the results shown in figure 14, confirming 
once more the phenotype observed. It was not possible to perform Anova 
test on the last set of experimental group (100% confluence prior to the 
anoikis assay) because of the big variation and the sample size.  
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4.5 Summary of results part 2 
 
 
Normal human epidermal keratinocytes and squamous cell carcinoma 
(SCC) lines have been shown to be sensitive to programmed cell death 
when deprived from anchorage to the ECM (Tiberio, Marconi et al. 2002), 
although SCC cells are more resistant than normal keratinocytes 
(Rheinwald and Beckett 1980). This particular form of apoptosis has been 
termed anoikis and it can be distinguished from other forms of apoptosis 
by treating cells with cisplatin, a DNA damaging agent that induces 
apoptosis initially through the release of cytochrome c from the 
mitochondria and only later through the exogenous pathways mediated 
by caspase 8.  
 
The regulation of anoikis by extracellular molecules has been already 
proved by several studies and pathways deriving from FAK/SRC kinases 
and therefore HRAS have been involved as well in the phenomenon.  
 
Since TERT expression has been shown to be regulated by integrin 
expression in keratinocytes, it could be hypothesised that telomerase 
covers a role in the apoptotic phenotype by regulation of integrin 
expression of the downstream derived pathway. In particular, considering 
the involvement of the various abovementioned kinases not only in 
anoikis but also in the two-stage chemical tumourigenesis mouse model, 
TERT may act in promoting neoplasia and malignancy in this model by 
protecting the cells towards anoikis by regulating HRAS and FAK/SRC 
kinases pathway.  
 
HaCaT cells are spontaneously immortalized but non-transformed human 
keratinocytes that have been widely used as a model for studies on 
keratinocytes differentiation. As explained in results part 1, wild-type 
hTERT, TERT-HA (active in vitro but unable to elongate telomeres of 
cultured HaCaT cells) and DnTERT (dominant negative TERT) were 
transduced into the cells, and the rate of cells undergoing anoikis, after 
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disruption with the matrix, was evaluated in the three cell lines and 
compared with HaCaT-Puro (empty vector, control).  
 
After 20 hrs in suspension, when integrins are disengaged from the ECM, 
cells die at a different rate; hTERT and TERT-HA overexpression was 
shown to significantly increase resistance to anoikis in HaCaT cells by an 
average of approx 1.9 fold compared to HaCaT-Puro, however this 
protection was not seen in HaCaT-DnTERT. This particular form of cell 
death was exclusive to anchorage deprivation and TERT overexpression 
did not protect adherent HaCaT cells treated with subtoxic doses of 
cisplatin, confirming that the observed phenomenon is anoikis and not 
general apoptosis.  
 
The data suggest that TERT must be catalytically active to optimally 
promote resistance to anoikis in HaCaT, and the resistance effect is 
independent of telomere lengthening but dependent on density in cell 
culture.  
 
The protection against anoikis due to TERT overexpression could be 
argued to be subtle, but it was observed over a big number of repeats 
(19 repeats), with two different methods and in some cases with two 
different batches of retrovirally-transduced HaCaT cells. 
 
First, the variability of the anoikis assay needs to be considered: 
difference in the cell density before the experiment was shown to 
influence greatly the amount of apoptotic cells, and the protection to 
anoikis was particularly observed when the cells before the experiment 
were growing in the exponential phase, up to 70% confluence. Also, TERT 
is not completely repressed in HaCaT-Puro, as shown in results part 1, so 
its expression could attenuate the difference between the cell lines.  
Finally, my anoikis assays showed a lower rate of apoptotic cells 
compared to a different anoikis assay in polypropylene tubes performed 
in a previous study (Marconi, Atzei et al. 2004), which showed up to 60% 
of HaCaT undergoing anoikis against 30% in my experiment after 
microscopic evaluation of the nuclei. 
4.5 Summary of results part 2 
 
146 
Therefore it can be concluded that TERT may provide a new role in the 
promotion of neoplasia and malignancy, protecting the cells that 
overexpress it against anoikis, therefore making them more resistant and 
potentially able to migrate and invade other tissues. This phenomenon is 
independent from telomere lengthening, therefore this role may be part 
of the reason by which mice treated with DMBA and TPA and 
overexpressing TERT in the basal keratinocytes are more prone to skin 
carcinogenesis in spite of the murine long telomeres, as shown by a 
previous study (Gonzalez-Suarez, Samper et al. 2001). 
 
The effects of TERT on anoikis are similar to those reported by Lee et al. 
(Lee, Sung et al. 2008) for motor neurones in that the effects of 
telomerase in muting anoikis do not absolutely require telomerase 
catalytic activity.  As TERT requires TERC (and hence telomerase activity) 
to enhance wound healing and the production of papillomas in the two-
stage carcinogenesis system, this suggests that the muting of anoikis 
may not be sufficient for these phenotypes although it is still possible 
that it is essential. 
 
Furthermore, the observation that anoikis resistance induced by TERT can 
be affected by the state of confluence in the cells before the experiment 
could be related to recent studies on a relation between TERT and Wnt 
pathway.  
 
Recently, an involvement of TERT in the Wnt/β-catenin signalling has 
been shown and correlated with transition from telogen to anagen in the 
hair follicle of mice conditionally expressing TERT; in addition, this 
function does not require RT activity of the enzyme (Sarin, Cheung et al. 
2005; Choi, Southworth et al. 2008). In this animal model, TERT 
expression regulates the expression of a series of genes involved in 
development, signal transduction and adhesion, which are closely related 
to the genes similarly regulated by Myc and Wnt pathways (Choi, 
Southworth et al. 2008). Further studies have shown that TERT occupies 
position in the promoters of genes targeted by Wnt, and can therefore 
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coact with β-catenin to regulate transcription in these genes (Park, 
Venteicher et al. 2009).  
 
β-catenin is a multifunctional protein that changes localization 
dependently on the presence of Wnt signal. In the absence of Wnt, β-
catenin binds to cadherin and it becomes part of the complex of adherens 
junctions, necessary for adhesion and growth of epithelial cells. The free 
β-catenin that is not bound to cadherin is subject to degradation after the 
binding with the protein GSK3. In the presence of a Wnt signal, a cascade 
of events leads to the inhibition of GSK3, and therefore β-catenin, not 
degraded, can enter the nucleus and bind to specific factors to activate 
the transcription of Wnt target genes, among which Myc to promote 
proliferation (Alberts 2002). In addition, Wnt has been shown to protect 
cells against chemotherapy-induced apoptosis by recruiting β-catenin for 
the activation of transcription of its target genes in human colorectal 
cancer cells (Chen, Guttridge et al. 2001).  
 
Therefore, for my observation on the state of confluence of HaCaT cells, 
it is possible to speculate the presence of a fine balance between the rate 
of β-catenin involved in adherence junctions (in bigger number when the 
cells are confluent) and free β-catenin involved in the Wnt pathway. If 
TERT is able to coact with β-catenin in the Wnt signalling, to produce an 
anti-apoptotic signal, then cells at a lower confluence which have a 
higher amount of free cytoplasmic β-catenin, would also possess an 
increased resistance towards apoptosis, consistent with my results. This 
hypothesis is testable in a number of ways, such as western blot, 
immunoprecipitation, or reporter assays. 
 
However, the pathways through which TERT regulates the apoptotic fate 
of the cells are under investigation. Since anoikis involves a complex 
cascade of protein starting from interaction with the ECM, integrins are 
the first choice for targeting the pathway and to indentify exactly at 
which point TERT acts, so this was investigated in the next result chapter.  
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5. Testing the regulation of integrin expression by TERT 
overexpression in the protection against anoikis 
 
 
Human keratinocytes located in the basal layer of the epidermis are still 
undifferentiated and express different type of integrins (see Table 9). All 
the receptors studied up to date are expressed in the basal layer of the 
epidermis, with the only exception being  the receptor for vitronectin 
αvβ8, that is expressed in the suprabasal layer (Watt 2002). 
 
The correct balance between cell proliferation and terminal differentiation 
(homeostasis) is maintained by the regulated expression of these 
receptors for extracellular matrix molecules, as confirmed by a variety of 
malignancies showing a deregulation of integrin receptors, such as 
squamous cell carcinoma, where α6β4 is expressed in the suprabasal 
level of the epidermis and promotes the progression of the malignancy 
from the initial benign papilloma (Tennenbaum, Weiner et al. 1993).  
 
In keratinocytes, integrin expression has been correlated with adhesion 
to the substrate, migration, motility, wound healing, and with progression 
to malignancy (Watt 2002).  
 
However, the main function of integrin expression in neoplasia and 
malignancy is in the process known as terminal differentiation, where the  
keratinocytes migrate from the basal layer to the outer surface and 
acquire a cornified envelope (Adams and Watt 1990). During this 
process, the maturation and transport of integrin β1 is inhibited (Hotchin, 
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Gandarillas et al. 1995) and therefore the presence of the receptors 
associated with this integrin in the cell membrane is reduced. The 
importance of the specific integrin β1 has been confirmed after showing 
that terminal differentiation can be inhibited with the addition of 
fibronectin (Adams and Watt 1989) or with an antibody against the β1 
subunit (Watt, Kubler et al. 1993).  
 
 
Table 9: Expression of integrins in skin keratinocytes 
Receptor specificity Integrin dimer 
collagen and laminin α2β1 
epiligrin and laminin α3β1 
fibronectin α5β1 
fibronectin αvβ1 
tenascin α9β1 
tenascin, fibronectin and vitronectin α8β1 
vitronectin αvβ5 
fibronectin and tenascin αvβ6 
vitronectin αvβ8 
associated with hemidesmosomes 
and intermediate filament system 
α6β4 
 
Table 9: Integrins detected in skin keratinocytes 
 
Integrins are receptors formed by the interaction of two subunits, α and 
β. The specificity of the ligand recognized by integrins depends on the 
subunits forming the receptor. Integrins are cell and tissue specific; in 
this table, the receptors expressed in skin keratinocytes are shown. 
 
 
Different studies have compared anoikis and terminal differentiation in 
keratinocytes (Gandarillas 2000) and have found parallels in the level of 
importance of integrins and other pathways in the two processes. 
However, there are also many differences between anoikis and terminal 
differentiation, such as the lifetime of the cell undergoing the process 
(which is as long as weeks in differentiation compared to hours in 
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anoikis) and the cell morphology before anucleation (Gandarillas, 
Goldsmith et al. 1999).  
 
As explained in the introduction of this chapter, β1 integrin in particular is 
crucial in the apoptotic destiny of different types of cells, not only 
keratinocytes, but in a variety of different cell types. Reduced expression 
of this integrin in subclones of pancreatic cancer cells confers a resistance 
in anoikis. This resistance is specific to β1 integrin, and independent from 
the reduction of the α5 and α6 integrins (Walsh, Clynes et al. 2009). 
Anchorage deprivation-induced apoptosis is also inhibited in islets of 
Langerhans after treatment with an anti-β1 integrin antibody or RGD 
peptides (that mimic the ECM molecules) by preventing the activation of 
caspase-3 (Pinkse, Bouwman et al. 2006). Also in endothelial cells 
growing in suspension, anoikis (in this paper from 1993 anoikis was still 
defined as programmed cell death) is inhibited when cells are plated on 
dishes coated with a β1 integrin antibody (Meredith, Fazeli et al. 1993). 
In fibroblasts β1 integrin has been implicated in the survival pathway 
when the cells are growing in collagen matrix, by regulating the 
(PI3K)/Akt pathway and triggering apoptosis (Tian, Lessan et al. 2002; 
Xia, Nho et al. 2004).   
 
Specifically, α3β1 integrin is shown to be necessary and sufficient in 
protecting from apoptosis in MK cells, a keratinocyte cell line derived 
from wild-type and α3-knockout mice, via FAK and ERK activation and 
through inhibition of caspase-3 activation (Manohar, Shome et al. 2004). 
In addition, skin keratinocytes enriched for stem cells are protected from 
anoikis via β1 integrin in a Bcl-2 dependent manner, and disruption of β1 
integrin activates the extrinsic apoptotic pathway (Tiberio, Marconi et al. 
2002). 
 
In a different study Janes and colleagues showed that in squamous cell 
carcinoma, a change in the expression of integrin from avβ5 to avβ6 is 
related to an increased protection against anoikis. In particular, anoikis is 
promoted by avβ5 by inhibition of Akt; Akt activation is increased when 
caspase-8 is inhibited, but the apoptotic pathway does not involve signals 
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from the death receptors, that is the most common feature of the 
caspase-8 –related intrinsic apoptotic pathway (Janes and Watt 2004). 
 
From these observations, it is possible to hypothesise a possible 
involvement of integrins in the resistance to anoikis shown in my 
experimental HaCaT cell lines overexpressing TERT and TERT-HA.  
I therefore analyzed the expression of a panel of surface integrins in 
HaCaT-Puro, HaCaT-TERT, HaCaT-TERT-HA and HaCaT-DnTERT by FACS 
analysis, and the expression of the total amount of integrins from whole 
cell lysates in the same cell lines, at control time (0 hr) and after the cells 
were cultured in suspension for 20 hrs. 
 
 
5.1 Analysis of integrin expression on the cell surface of HaCaT 
cells after TERT and TERT-HA overexpression 
 
 
To investigate the involvement of integrins in the resistance of HaCaT cell 
lines overexpressing TERT and TERT-HA to anoikis, I first tested whether 
there was a correlation between TERT overexpression and integrin 
expression in normal surface cell culture conditions.  
 
A panel of integrins was first analyzed by FACS on a first generation 
batch of HaCaT-Puro, HaCaT-TERT and HaCaT-TERT-HA cells and 
compared with the appropriate isotype controls. The choice of selection 
for this panel was partly the availability in our lab and in Dr. John 
Marshall’s laboratory. Also, the wide range of alpha subunits embraces 
the majority of the receptors formed with the integrin β1 in human 
keratinocytes.  
 
In this preliminary experiment (figure 18), HaCaT showed positivity for 
the integrin subunits α2, α3, α6 and for integrin αvβ6, the receptor for 
fibronectin and tenascin. Particularly interesting was the case of the 
integrin subunit α6, which expression was almost double in HaCaT-TERT 
and HaCaT-TERT-HA compared to HaCaT-Puro. The expression on the cell 
5.1 Integrin expression on the cell surface of HaCaT 
 
153 
surface in the other subunits was not affected by the overexpression of 
TERT and TERT-HA in HaCaT. 
 
The expression analysis on the cell surface of the subunit α6 was 
therefore repeated together with the subunits α4, β1 and β4 in a second 
batch of HaCaT-Puro, HaCaT-TERT, HaCaT-TERT-HA, and HaCaT-DnTERT. 
The second batch of HaCaT lines were transduced with the retroviral 
constructs independently from the first batch but showed a similar level 
of protection against anoikis by the TERT constructs (see section 4.4). 
The experiment was repeated three times to increase the statistical 
significance (figure 19). Even allowing for the big variability in the 
percentage of cells positive for integrin α6 in the three experiments, the 
TERT-dependent increase in expression of this subunit was not confirmed 
with the new population of cells. The other two subunits which were 
positively expressed on the cell surface of HaCaT were β1 and β4. 
However, no significant difference in the expression of these subunits on 
the cell surface of HaCaT due to TERT overexpression could be detected.  
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c) 
Integrins 
Fold mean intensity of cell surface integrins 
expression 
 HaCaT-Puro HaCaT-TERT HaCaT-TERT-HA 
α1 20.37 19.89 11.17 
α2 145.54 126.98 128.82 
α3 99.90 95.57 102.82 
α5 18.57 18.47 18.49 
α6 136.69 254.16 244.33 
α9β1 17.14 18.00 17.73 
αvβ6 36.79 35.51 38.70 
αvβ5 17.85 17.21 18.77 
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d) 
Integrins 
Fold mean positivity of cell surface integrins 
expression normalized to isotype controls 
 HaCaT-Puro HaCaT-TERT HaCaT-TERT-HA 
α1 3998.88 2066.67 4139.08 
α2 11197.75 8763.16 11471.26 
α3 11151.69 8718.42 11440.23 
α5 686.52 581.58 870.11 
α6 9493.33 6706.04 12043.37 
α9β1 511.24 516.67 571.26 
αvβ6 10364.04 8221.05 10968.97 
 
e) 
controls 
Fold mean intensity of isotype controls 
expression normalized to unstained cells 
 HaCaT-Puro HaCaT-TERT HaCaT-TERT-HA 
unstained 100.00 100.00 100.00 
IgG1 111.38 107.78 107.77 
IgG2 103.09 101.76 106.21 
 
Figure 18: Preliminary analysis of the effect of TERT 
overexpression in regulating the expression of integrins on the 
cell surface of HaCaT 
 
Graph a) and table c): analysis of the intensity of integrins expression on 
cell surface. Expression in HaCaT overexpressing TERT and TERT-HA 
were compared with expression of the same subunits in HaCaT-Puro. The 
downregulation of integrin α1 in HaCaT-TERT-HA was not further 
investigated because the positivity for this integrin is not particularly 
elevated in any of the three cell lines. The only striking increase is shown 
in the case of integrin α6, which is overexpressed in HaCaT-TERT and 
HaCaT-TERT-HA.  
Graph b) and table d): analysis of the positivity of integrins expression on 
cell surface. Positivity was compared between HaCaT-Puro, HaCaT-TERT 
and HaCaT-TERT-HA after independent normalization with the 
appropriate isotype controls. HaCaT showed positivity for the integrin 
subunits α2, α3, α6 and for integrin αvβ6, even with great variability 
amongst the cell lines. 
Table e): control analysis for the negativity of the appropriate isotype 
controls compared with unstained HaCaT. 
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c) 
Integrins 
Fold mean intensity of cell surface integrins 
expression 
 
HaCaT-Puro 
 
HaCaT-TERT 
 
HaCaT-
TERT-HA 
HaCaT-
DnTERT 
β1 67.76 52.64 61.80 57.97 
β4 92.92 83.00 81.18 120.85 
α4 20.18 18.78 20.26 20.26 
α6 231.30 185.09 254.56 234.87 
 
Integrins Standard deviation 
 
HaCaT-Puro 
 
HaCaT-TERT 
 
HaCaT-
TERT-HA 
HaCaT-
DnTERT 
β1 29.64 17.39 21.06 6.85 
β4 61.01 47.12 48.23 89.74 
α4 2.32 1.50 1.27 1.05 
α6 85.45 99.98 155.69 176.80 
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d) 
Integrins 
Fold mean positivity of cell surface integrins 
expression normalized to isotype controls 
 
HaCaT-Puro 
 
HaCaT-TERT 
 
HaCaT-
TERT-HA 
HaCaT-
DnTERT 
β1 18574.95 10561.26 13589.66 7484.29 
β4 18106.38 10488.55 13456.78 7546.90 
α4 3145.59 1421.59 3096.50 1726.89 
α6 18605.49 20496.84 12169.56 8863.30 
 
Integrins Standard deviation 
 
HaCaT-Puro 
 
HaCaT-TERT 
 
HaCaT-
TERT-HA 
HaCaT-
DnTERT 
β1 20579.23 8243.32 11257.63 5682.44 
β4 19752.26 7924.20 10913.67 5698.28 
α4 2301.98 340.41 1944.88 977.18 
α6 20800.02 23291.85 9923.51 8119.16 
 
e) 
controls 
Fold mean intensity of isotype controls expression 
normalized to unstained cells 
 
HaCaT-Puro 
 
HaCaT-TERT 
 
HaCaT-
TERT-HA 
HaCaT-
DnTERT 
unstained 100.00 100.00 100.00 100.00 
IgG1 100.75 94.48 100.96 100.78 
IgG2 100.98 129.00 105.17 101.98 
 
controls Standard deviation 
 
HaCaT-Puro 
 
HaCaT-TERT 
 
HaCaT-
TERT-HA 
HaCaT-
DnTERT 
unstained 0.00 0.00 0.00 0.00 
IgG1 15.85 17.74 16.23 16.28 
IgG2 14.57 17.16 18.79 16.62 
 
Figure 19: Analysis of the effect of TERT overexpression in 
regulating the expression of integrins on the cell surface of HaCaT 
 
Graph a) and table c): analysis of the intensity of integrins expression on 
cell surface. Expression in HaCaT overexpressing TERT and TERT-HA 
were compared with expression of the same subunits in HaCaT-Puro. The 
downregulation of integrin α1 in HaCaT-TERT-HA was not further 
investigated because the positivity for this integrin is not particularly 
elevated in any of the three cell lines. The only striking increase is shown 
in the case of integrin α6, which is overexpressed in HaCaT-TERT and 
HaCaT-TERT-HA.  
 
Graph b) and table d): analysis of the positivity of integrins expression on 
cell surface. Positivity was compared between HaCaT-Puro, HaCaT-TERT 
and HaCaT-TERT-HA after independent normalization with the 
appropriate isotype controls. HaCaT showed positivity for the integrin 
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subunits α2, α3, α6 and for integrin αvβ6, even with great variability 
amongst the cell lines. 
 
Table e): control analysis for the negativity of the appropriate isotype 
controls compared with unstained HaCaT. 
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5.2 Analysis of integrin expression in whole cell extracts after 
TERT and TERT-HA overexpression in cell culture and during 
anoikis 
 
 
To analyze the total amount of integrin expressed in the entire cell, both 
immature in the cells and when the integrins cluster together to form a 
mature receptor on the surface of the cells, western blot analysis of 
various integrin subunits was performed. Western blot with integrins is a 
problematic procedure, due to the different forms of these proteins which 
are glycosylated in the Golgi apparatus before moving to the cell surface.  
Therefore, a wider panel of integrin antibodies was studied at first, but 
the inefficiency of the antibodies and their low signal to background ratio 
restricted the panel to the subunits αv, β1, β4, and β6.  
 
The lysates were taken from HaCaT-Puro, HaCaT-TERT and HaCaT-TERT-
HA at 0 hr, after 20 hrs culture in suspension (anoikis assay) and after 20 
hrs in a cell culture control dish (growing adherent) for integrin αv and 
integrin β6, and at 0 hr and 20 hrs in suspension for integrins β1 and β4.  
Controls were represented by cell lysates form NHEK and SCC-25, where 
possible, and expression was normalized to GAPDH expression. 
Expression of β-actin was first contemplated as a good housekeeping 
control, but the variability of its expression during cells in apoptosis 
excludes the possibility of using the expression of this protein as an 
internal control (figure 20, a).  
 
The expression of integrin αv (figure 20, a) is regulated by the presence 
of TERT at the control times: HaCaT cells containing the empty vector 
express lower amount of this integrin compared to HaCaT-TERT-HA and 
even less if compared to HaCaT-TERT. Furthermore, when HaCaT-Puro 
undergo anoikis, no difference in the αv integrin expression is seen; 
however, in HaCaT overexpressing TERT and TERT-HA, anoikis is 
correlated with a more than two fold decrease in αv integrin expression. 
 
On the other hand, integrin β6 expression is not regulated by TERT 
overexpression at control times (figure 20, a) and does not vary when 
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the cells undergo anoikis compared to normal culture conditions at the 
same time point or to the control time point. However, a shift from the 
non glycosylated (non mature) form to the glycosylated (mature) form of 
the integrin is shown when all the three cell lines undergo anoikis. 
 
Integrin β1 expression does not appear to significantly vary at controls 
time between the three cell lines. A slight decrease of expression may be 
seen in HaCaT-TERT and TERT-HA, but the experiment should be 
repeated to confirm the significance of the result; however, there is an 
evident regulation in the expression of the glycosylated form of this 
subunit when the cell lines undergo anoikis among the three cell lines. 
Also in this case, it is not possible to estimate if the small decrease in 
expression of this subunit in TERT and TERT-HA overexpressing cells is 
significant.  
  
Interestingly, while expression of integrin β4 is not significantly affected 
by the presence of TERT or TERT-HA at control times, it decreases when 
the cells are cultured in suspension for 20 hrs and undergo anoikis (figure 
20, c). The expression of the integrin β4 appears to be strongly affected 
during anoikis by the overexpression of TERT and TERT-HA. 
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Figure 20: Western blot analysis of the regulation of integrin 
expression in whole cell after TERT and TERT-HA overexpression 
in cell culture and during anoikis 
 
a): panel of integrin and their expression in HaCaT-Puro, HaCaT-TERT 
and HaCaT-TERT-HA at time 0 hr, after 20 hrs of conventional cell culture 
in adherence on tissue culture dishes, and after 20 hrs in suspension 
(anoikis assay). The expression was normalized to the expression of the 
housekeeping protein GAPDH, since β-actin expression is not stable when 
cells undergo anoikis. At control times, expression of integrin αv is 
increased in TERT and TERT-HA overexpressing HaCaT compared to the 
control. When cells undergo anoikis, the expression of the integrin does 
not vary in HaCaT-Puro, but it is reduced about two fold in HaCaT-TERT 
and HaCaT-TERT-HA. Expression of integrin β6 does not vary with TERT 
presence, but a shift to the glycosylated (higher molecular weight) form 
can be seen when all the three experimental group undergo anoikis. 
b): Integrin β1 is expressed in two forms, glycosylated (upper band) and 
unglycosylated. At 0 hr, TERT and TERT-HA expression is correlated with 
a slight decrease in the expression of the glycosylated form, but the 
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difference may not be significant and would need further confirmation. 
When the cells, independently from TERT overexpression, undergo 
anoikis, there is a shift in the expression of the glycosylated form in all 
the three cell lines. In this case, a moderate downregulation is shown in 
HaCaT-TERT and HaCaT-TERT-HA compared to HaCaT-Puro at 20 hrs in 
suspension.  
c): the expression of integrin β4 is stable in the three cell lines at time 0 
hr, suggesting there is no regulation due to TERT or TERT-HA 
overexpression during normal cell culture. However, when the cells 
undergo anoikis, the expression of this protein significantly decreases in 
the three cell lines, and the decrease appears to be greater in cells 
expressing TERT or TERT-HA.  
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5.3 The ability of TERT to block anoikis is independent of the β1-
integrin 
 
 
As discussed before, the role of β1 integrin has been proven to be 
essential in the regulation of cell death due to anchorage deprivation. The 
specificity of the function of this integrin has been shown with different 
methods, such as by coating dishes with an β1-integrin antibody 
(Meredith, Fazeli et al. 1993) or by adding a neutralizing antibody against 
this integrin to the cultures (Adams and Watt 1990).   
 
To determine a possible involvement of integrin β1 in the anoikis model, I 
therefore utilized a neutralizing antibody against β1 integrin. Firstly, 
analysis of the cell attachment time was investigated by treating HaCaT-
Puro cells growing on cell culture dishes coated with fibronectin with the 
antibody diluted 1:250 in serum free medium, and comparing with 
untreated cells growing on the same type of coated dishes. Cells were 
grown at confluency and subconfluency before the experiment, as I have 
previously demonstrated that these variables strongly influence the 
ability of TERT to mute anoikis (see section 4.4). 
As shown in figure 21, the antibody was more effective when cell were 
kept in subconfluent culture compared to complete confluence prior to 
trypsinization and plating on the coated dishes. In particular, at the 70% 
confluence that was chosen for the anoikis assay, the β1 neutralizing 
antibody could increase the time required for maximal attachment of 
HaCaT Puro by more than two fold and increased the number of 
unattached cells at 30 minutes by two fold.  This showed that the dose of 
neutralizing antibody used was effective against HaCaT cells.  
 
The second step was to determine the involvement of integrin β1 in the 
resistance to anoikis was to repeat the assay in the presence of the 
antibody in the four cell lines HaCaT-Puro, HaCaT-TERT, HaCaT-TERT-HA 
and HaCaT-DnTERT, and to compare resistance to anoikis with the 
untreated cells. In all our cell lines, blocking the function of the β1 
integrin increased the percentage of apoptotic cells, especially in our 
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control cells (figure 22). However, there was no difference in the pattern 
when compared to the untreated cells undergoing anoikis. 
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b) Attachment time of HaCaT-Puro on fibronectin coated dishes 
% floating cells in the fibronectin dish 
70% confluence 100% confluence 
time (min) 
 
 control  β1 blocking ab control  β1 blocking ab 
0 100.00 100.00 100.00 100.00 
25 - - 20.90 28.35 
30 24.19 52.51 - - 
45 - - 18.00 31.20 
50 18.20 36.19 - - 
65 - - 30.00 40.82 
70 18.09 24.79 - - 
 
Figure 21: Attachment time is reduced when cells are treated with 
an antibody blocking β1-integrin 
 
Figure a) and table b): HaCaT-Puro were grown to two different levels of 
confluence (70% and 100%) before trypsinisation and plating into 
fibronectin coated dishes.  Time of adhesion to the cell surface was 
analyzed by measuring the percentage of floating cells after defined time 
points after treatment with a β1-integrin neutralizing antibody. The 
antibody resulted in more efficient blocking of adhesion of the cell to the 
coated dish surface when cells were previously grown to subconfluence 
(squared blue line) compared to when they were grown to complete 
confluence (crossed orange line). 
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b)  
Cell lines 
Average  (%) of apoptotic cell death after 
20 hrs in suspension 
 
Without β1 blocking 
antibody 
With β1 blocking 
antibody 
HaCaT-Puro 26.86 40.43 
HaCaT-TERT 16.20 24.74 
HaCaT-TERT-HA 16.32 22.81 
HaCaT-DnTERT 20.71 27.68 
 
Cell lines Standard deviation 
 
Without β1 blocking 
antibody 
With β1 blocking 
antibody 
HaCaT-Puro 5.97 15.45 
HaCaT-TERT 2.90 10.29 
HaCaT-TERT-HA 0.36 7.22 
HaCaT-DnTERT 3.46 4.02 
 
Figure 22: Effect of disruption of cell-matrix interactions on 
phenotypic features of apoptosis by Hoechst staining of nuclei 
after treatment with a neutralizing antibody against integrin β1 
 
Figure a) and table b): HaCaT cells (approx 2 million cells) were plated 
onto petri dishes which had been coated with polyHEMA and after 20hrs 
hallmarks of apoptosis in the nucleus were detected in the fixed cells and 
compared the same cells treated with a blocking antibody raised against 
integrin β1 (dilution 1:250). 
 
In all the cell lines, treatment with the antibody increased the rate of 
apoptotic cells but did not change the pattern of the results, as HaCaT 
cells overexpressing the different TERT transcripts still showed a reduced 
level of anoikis. This suggests that some ECM ligands for integrin β1, 
such as fibronectin and collagen are produced by HaCaT cells in 
suspension to mute anoikis but also that the TERT transgenes do not 
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work by increasing the expression of these ligands or integrin receptors 
containing the β1 subunit. This is consistent with the FACS and western 
blot data presented in sections 5.1 and 5.2. The result also suggests that 
TERT mutes anoikis independently of the β1 subunit at point downstream 
of integrins. 
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5.4 Summary of results part 3 
 
 
HaCaT cells overexpressing TERT and TERT-HA show resistance to anoikis 
when compared to their empty vector controls.  However, the 
mechanisms through which TERT operates to promote this resistance are 
not yet understood.  
 
The ability of TERT to mute anoikis may partially explain how it augments 
papilloma formation in mice treated with TPA and DMBA, and it is 
essential to understand the pathway involved in this resistance. As 
explained in the introduction, section 1.4.1, and in the chapter 4, the 
importance in anoikis held by integrins, HRAS, Src, FAK and all the other 
kinases involved in the cascade, together with the final effector caspases, 
has been shown by numerous papers. I therefore first investigated the 
role of integrins in the anoikis resistance due to TERT overexpression to 
determine the specific point of regulation of TERT in the anoikis death 
pathway. 
 
As discussed in the introduction of this result chapter, for many cell 
types, including keratinocytes, cell survival depends on intracellular 
signals triggered by integrins. Attachment to the ECM via integrins 
promotes proliferation and cell survival; on the other hand, when cell lose 
their contact with the ECM, the apoptotic form of anoikis will be 
triggered.  
 
Several papers emphasize the role of the integrin subunit β1, therefore I 
focused my study especially on this particular protein. FACS analysis of 
cells cultured under normal culture conditions not only showed that there 
is no contribution of TERT in the expression of integrin β1 in the surface 
of HaCaT cells, but also didn’t show any difference in the expression of 
any of the other considered integrins.  
 
Western blot analysis of HaCaT cells under normal culture conditions and 
when induced to undergo anoikis showed no difference in the density of 
5.4 Summary of results part 3 
 
170 
integrins αvβ6 and αvβ5 in surface culture after ectopic TERT/TERT-HA 
expression and there was no difference in the number of HaCaT cells 
over-expressing the integrins in the different groups. However, ectopic 
TERT/TERT-HA expression did result in an apparent increase in the level 
of αv protein as detected by western blotting compared to the empty 
vector controls at zero time but the levels still fell after the induction of 
anoikis in a similar manner to the empty vector controls.  This result is 
significant when one considers that avβ5 and avβ6 have been reported to 
have antagonistic roles in regulating anoikis, with avβ5 inducing anoikis 
and avβ6 inhibiting in a malignant oral SCC line (Janes and Watt 2004) . 
However, the data I have assembled so far does not support the idea 
that ectopic TERT/TERT-HA expression mutes anoikis by either 
downregulating avβ5 or upregulating avβ6. β1 integrin showed both 
glycosylated and non glycosylated forms in the control times, and an 
increase in the higher molecular weight glycosylated form when the cells 
undergo anoikis. However, the possible regulation of this integrin 
expression by TERT is not certain, and western blot analysis needs to be 
repeated to have more confident results. 
 
Interestingly, however, I could see a strong downregulation of β4 integrin 
expression in whole lysates when HaCaT-TERT and HaCaT-TERT-HA 
undergo anoikis. This downregulation seems to be correlated with the 
overexpression of TERT and TERT-HA in the cell lines model, and 
therefore it could be hypothesised that expression of β4 integrin is 
regulated during anoikis by TERT, independently from the canonical 
function of this enzyme. α6β4 integrin is been shown to have both pro 
and anti-apoptotic functions, depending on the cell type and the status of 
p53 (Bachelder, Ribick et al. 1999). In particular, a study showed that 
α6β4 carries an AKT/PKB–dependent anti-apoptotic function, in p53-
deficient carcinoma cells, while in cells expressing wild-type p53, 
apoptosis by α6β4 is promoted by activation of the caspase-3 pathway 
(Bachelder, Ribick et al. 1999).  
 
Treating the cells with an antibody blocking the functions of β1 integrin 
could allow an insight into the mechanisms by which TERT acts to 
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promote the anoikis. When HaCaT cells were treated with this antibody 
before inducing them to undergo anoikis, the same resistance pattern in 
HaCaT overexpressing TERT, TERT-HA and DnTERT was shown, indicating 
that TERT acts downstream of β1 integrin in the resistant phenotype. 
 
A further study would include the analysis by FACS of the expression on 
the cell surface of the same integrins, or at least of the one positive for 
the expression in HaCaT, and including integrin β4, in the four 
experimental cells at time 0 hr and after 20 hrs in suspension. Therefore 
it would be possible to analyze if a modulation in the integrin expression 
can be seen dependently from TERT expression just when the cells are 
undergoing the apoptotic phenotype. However, it wasn’t possible at the 
time of the writing to perform such an experiment, because of the 
numerous variables of the experiment (cell confluence, elevated number 
of cells to be plated, amount of reagent needed) which need to be 
considered and will constitute a long-term experiment. 
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The main function of telomerase (also known as the canonical function) 
can be been defined as the maintenance of telomere length throughout 
multiple cell cycles. However, other phenotypes, which are independent 
from telomere lengthening, have been investigated and correlated with 
the catalytic component of telomerase TERT, leading to new non-
canonical functions (NC) of this protein.  Type I NC functions are 
dependent on the presence of the RNA component TERC and have been 
correlated with some forms of neoplasia, while type II NC functions are 
independent from TERC and have not been associated with 
carcinogenesis yet (Parkinson, Fitchett et al. 2008). It has been 
hypothesized that TERT can promote epithelial stem cell self-renewal and 
functional maintenance without inducing neoplasia. Inhibition of anoikis 
by telomerase may contribute to this phenotype allowing the self-renewal 
of the stem cells that are migrating out of the niche (Flores, Cayuela et 
al. 2005; Sarin, Cheung et al. 2005).  To support this hypothesis, the 
inhibition of apoptosis by telomerase has been shown (Fu, Begley et al. 
1999) and telomerase downregulation has been correlated with 
keratinocyte differentiation in vivo or ECM detachment in vitro (Crowe, 
Nguyen et al. 2005). 
 
The aim of my project was the determination of the mechanism through 
which telomerase promotes papilloma formation in the two stage mouse 
model of epidermal tumourigenesis of squamous cell carcinoma and by 
inference its human counterpart. I hypothesized that the catalytic 
component of telomerase TERT could regulate cell survival in skin 
keratinocytes, in particular by promoting resistance to a particular form 
of apoptosis induced by anchorage-deprivation, defined as anoikis, to the 
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cells. Having established this I went on to test whether the ability of TERT 
to antagonise anoikis was independent from the canonical function of 
telomerase (telomere elongation) and the catalytic activity of the 
enzyme.  
 
Squamous cell carcinoma is one of the most frequent human 
malignancies, affecting the epidermis and therefore the cells composing 
it, the keratinocytes. Generally, the formation of this tumour starts from 
hyperplastic lesions, which progress in the human to dysplasias of 
increasing grade and finally malignant SCCs (Califano, Westra et al. 
2000). In the mouse, hyperplastic lesions progress into papillomas, a 
fraction of which eventually can evolve into the malignant SCCs (Yuspa 
1998).  
 
In vitro, the study of SCC is more complex due to the limitations in the 
culture of normal epidermal keratinocytes, which undergo senescence 
after few population doublings and are constantly changing with passage 
(Rheinwald and Green 1975). Normal keratinocytes are also hard to 
transfect making many experiments difficult, so for the preliminary steps 
of the investigation I used one of the more characterized keratinocytes 
cell lines, HaCaT, an immortalized keratinocyte line derived from normal 
human skin (Boukamp, Petrussevska et al. 1988). The advantage of 
using this cell line compared to normal keratinocytes is the lack of 
senescence and the similar differentiation pattern to skin keratinocytes 
that can be seen during cell culture (Boukamp, Petrussevska et al. 1988). 
 
On the other hand, the pathways involved in the formation and 
progression of SCC are now well characterized and studied in vivo after 
the development of a two-stages carcinogenesis mouse model. In this 
system, the mutation of the oncogene ras is the most distinctive feature 
of the initial stage on the tumour formation (Quintanilla, Brown et al. 
1986), but other mechanisms can participate to this event and to the 
subsequent growth and progression of the cancer, such as the 
overexpression of cyclin D (Robles and Conti 1995), the activation of the 
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oncogene fos (Greenhalgh, Welty et al. 1990) and the increased 
expression of the integrin α6β4 (Tennenbaum, Weiner et al. 1993). 
 
The involvement of the enzyme telomerase in the tumour formation was 
also found by several groups. High telomerase activity is detected in skin 
carcinoma derived from TPA-treated mice, and the enzymatic activity 
correlates with progression and the genomic instability of the papillomas 
(Bednarek, Budunova et al. 1995). The activity of the telomerase 
requires both the components of the enzyme TERT (catalytic component) 
and TERC (RNA component), as demonstrated by several studies 
performed on mouse models (Gonzalez-Suarez, Samper et al. 2000; 
Gonzalez-Suarez, Samper et al. 2001; Cayuela, Flores et al. 2005). 
 
This particular function of telomerase in promoting neoplasia is in line 
with evidence showing that telomerase does not just elongate the 
telomere (defined as canonical function of telomerase) but covers many 
other non-canonical functions (Parkinson, Fitchett et al. 2008). Some of 
these require the presence of both TERT and TERC (defined as NC I), 
while some others don’t require the presence of the RNA component 
(defined as NC II). 
 
To create a good system that allows the identification of non canonical 
functions of telomerase, I decided to use as a model HaCaTs 
overexpressing the following constructs: wild type TERT, the flagged 
TERT-HA, which has telomerase activity in vitro but cannot lengthen 
telomeres in vivo, the catalytically dead dominant-negative TERT mutant, 
DnTERT, which has neither catalytic activity nor the ability to lengthen 
telomeres, and as a control HaCaT carrying an empty vector.  
 
The ability of telomerase to elongate telomeres in HaCaT was firstly 
investigated by Professor Petra Boukamp’s group, and I carried out the 
characterization of HaCaT with the different constructs by the 
investigation of the activity of the enzyme in vitro and the level of 
expression of the two main components TERT and TERC.  In addition, as 
the splice variants of TERT have been reported to regulate telomerase 
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activity (Ulaner, Hu et al. 1998; Colgin, Wilkinson et al. 2000; Cerezo, 
Kalthoff et al. 2002), I investigated the three most common forms, the α 
variant, the β variant and the αβ variant. I characterized in this way all 
the experimental groups at control times (0 hr) and after 20 hrs of 
growth in suspension after anchorage deprivation. 
 
Firstly, the work from Professor Petra Boukamp’s group proved that 
HaCaT-TERT-HA, where TERT-HA is a modification of wild-type TERT by 
attachment of a haemagglutinin tag at the C-terminal of the protein, is 
an effective system to study non-canonical functions of telomerase. The 
cells carrying this construct, in fact, cannot elongate telomeres in cell 
cultured for 5 weeks in vitro, even if the telomerase complex is active in 
vitro, as I later demonstrated. However, the reasons for TERT-HA 
inability to elongate the telomere are not known yet (Counter, Hahn et al. 
1998). 
 
From my first set of results, I could confirm previous studies showing a 
particular pattern of expression of the components of telomerase in the 
skin. In those studies, TERT is expressed both in the basal and in the 
suprabasal layers of epidermis (Nakano, Watney et al. 1998), where cells 
start the differentiation process and lack contact from the extracellular 
matrix and the dermis. TERT expression follows a gradient which 
progressively decreases to the upper layers of the epidermis, where cells 
lose the nuclei and start keratinisation (Fuchs 1995). This was confirmed 
by my detection of TERT expression by real-time qPCR in HaCaT, both at 
control times, when cells grow attached to a surface, and after 20 hrs in 
suspension, when they are deprived from the anchorage. In the control 
HaCaT, no drop in TERT mRNA expression was detected after 20 hrs, 
while in TERT and TERT-HA overexpressing HaCaTs, the amount of TERT 
mRNA expression at 20 hrs decreased but was not less than the control 
time and that HaCaT-Puro at time 0. These data not only confirm the 
presence of TERT at two different stages of keratinocyte differentiation, 
but also support the arguement that this system is a good model to 
investigate the effect of TERT overexpression in the two different time 
points and when the cells are subjected to anchorage deprivation. 
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Similarly, the expression of TERC detected by the abovementioned study 
was detected both at basal and suprabasal layers of the epidermis, with a 
strong in situ hybridization signal that did not show any gradient in the 
expression (Nakano, Watney et al. 1998). From my results, TERC is 
expressed both at the control time and after 20 hrs of growth in 
suspension. Differently from TERT mRNA expression, there is no drop in 
the expression of TERC when the cells are deprived from the anchorage; 
instead, there is a massive increase of the expression. This could be 
explained by a previous study showing that the half-life of TERC is very 
long, and can be further stabilized by the presence of TERT (Yi, Tesmer et 
al. 1999).  
 
The presence of both TERT and TERC in the basal and suprabasal layers 
of the epidermis would lead us to believe that the telomerase 
holoenzyme is active in the same region of skin. However, a previous 
study showed that the suprabasal layers lack telomerase activity (Harle-
Bachor and Boukamp 1996). Telomerase is active just in the basal layer 
of the epidermis, where keratinocytes show high proliferation rate and 
contribute to the continuous regeneration and proliferation of the skin 
and it is not needed when the cells start differentiating (Flores, Cayuela 
et al. 2005). I could confirm these observations by the detection of 
telomerase activity in HaCaTs at control times and after 20 hrs growth in 
suspension. In fact, the modest telomerase activity of HaCaT dramatically 
drops when the cells are deprived from the anchorage, and at 20 hrs the 
activity is almost undetectable. This pattern of expression in reproducible 
also in the presence of exogenous TERT and TERT-HA, even if the activity 
is not annulled at 20 hrs because of the very high activity already 
detected at time 0. These results are in partial disagreement with a 
previous study from Crowe, who detected a reduction in TERT mRNA in 
anchorage-deprived keratinocytes (Crowe, Nguyen et al. 2005). 
However, my results are in line with the in situ hybridization studies from 
Nakano (Nakano, Watney et al. 1998) and more coherent with the 
differentiation pattern of the skin keratinocytes, that wouldn’t justify the 
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need of telomerase activity described by Crowe in the upper layers of the 
epidermis. 
 
Since the localization of telomerase activity does not correspond to the 
expression pattern of TERT and TERC, there should be a mechanism for 
the regulation of the activity of the enzyme. TERC but mostly TERT are 
finely regulated by numerous factors, leading to transcriptional regulation 
and, in the case of TERT, to post-translational regulation (see section 
1.1.5 of the introduction for further details).  
 
I considered one of the possible regulatory mechanisms of telomerase 
activity, which is the preferred expression of one of the numerous 
inactive or dominant-negative splice variants of TERT rather than the 
wild-type. After careful review of the previous studies for the detection of 
TERT splice variants using different techniques, I adopted the work done 
by Lincz et al., who use independent primer sets for each of the three 
most characterized splice variants, alpha, beta, and alpha/beta (Lincz, 
Mudge et al. 2008). I quantified the expression of the three splice 
variants both at 0 hrs and in suspension, considering a previous study 
that correlated the presence of the beta variant with regulation of 
telomerase activity in HaCaT (Cerezo, Kalthoff et al. 2002). From my 
results, the two main splice variants alpha and beta are expressed at low 
levels in all the HaCaT cells, and, particularly in HaCaT-Puro, they 
represent less than 6% of the total TERT mRNA. The increase of the 
amount of beta splice variant when the cells are deprived from anchorage 
from the ECM is not significant, in my opinion, since the level of 
expression is still very low compared to the amount of full-length TERT 
and unlikely to be sufficient to produce any effect on telomerase 
regulation.  
 
From the characterization of the components of telomerase in the HaCaT 
for my model, I could ensure that any phenotype that is shown when 
cells get deprived from anchorage is associated not only with the 
presence of an active form of TERT, but also permit the classification of 
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any new function of TERT associated with the phenotype in canonical or 
non-canonical function, thanks to the availability of HaCaT-TERT-HA. 
 
Since TERT expression decreases with cell differentiation (Cerezo, Stark 
et al. 2003), and differentiation of skin keratinocytes is regulated by the  
attachment with the cell matrix (Crowe, Nguyen et al. 2005), it is 
possible to hypothesise an association between TERT expression and the 
ECM. In addition, it is well known that epithelial cells undergo a specific 
form of apoptosis called anoikis when they are deprived from the ECM 
(Frisch and Francis 1994). Therefore, in neoplastic cells, I can 
hypothesise that TERT confers an advantage to neoplastic keratinocytes 
by promoting resistance to anoikis itself, making the cells able to grow 
independently from the attachment with the ECM.   
 
To test this hypothesis, I studied the behaviour of HaCaT in a situation of 
anchorage deprivation in the presence or absence of exogenous TERT.  
 
While control HaCaT at time zero show less than 1% of apoptosis, 
possibly due to the response to the trypsin treatment, I could detect up 
to 45% of apoptotic nuclei in control HaCaT after 20 hrs in suspension, by 
morphological staining of the nuclei; with FACS analysis, the percentage 
of apoptotic nuclei in the same experimental group was lower, 
corresponding to 14% of the total cell nuclei.  Those two percentages are 
not as elevated as the one reported by the first study on anoikis (Frisch 
and Francis 1994), where 60% of apoptotic nuclei where detected in 
HaCaT by analysis of DNA laddering, but this may be due to the 
difference in the detection techniques.  
 
When TERT is overexpressed in HaCaT, I could detect an almost two-fold 
significant protection towards apoptosis in the cell lines at 20 hrs after 
anchorage-deprivation. The same level of protection was detected when 
HaCaTs overexpress TERT-HA, therefore this indicates that the phenotype 
that I detected is directly associated with the presence of TERT but it is 
independent from its canonical function of telomere elongation.  
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Later, I confirmed that the apoptotic phenotype observed in the cells 
when deprived of their anchorage with ECM, and characterized by several 
changes in the cell structure and in the nucleus morphology, is not a 
general form of apoptosis, but can be defined as anoikis. In fact, the 
pattern of resistance of HaCaT carrying TERT and TERT-HA is not 
repeated when cells are treated with cisplatin, a general inducer of 
apoptosis (Gonzalez, Fuertes et al. 2001), rather than being placed in 
suspension. 
 
In addition, when HaCaTs carry a construct with a dominant-negative 
form of TERT, DnTERT, the cells, which show very low levels of 
telomerase activity, as explained above, carry a mixed phenotype, 
showing a level of resistance to apoptosis that is bigger than the control 
HaCaTs, but smaller than TERT/TERT-HA overexpressing HaCaT. This 
may suggest that catalytic activity is still required for the observed 
phenotype even TERT does not elongate telomeres. In a previous study, 
regulation of anoikis by TERT in motor neurons was shown not to require 
the catalytic activity of the enzyme (Lee, Sung et al. 2008), but it is 
possible that changes in the response towards anoikis is not sufficient to 
promote the formation of papillomas in the two-stage carcinogenesis 
system, and to augment wound healing; and this is consistent with the 
requirement for TERC to produce these two phenotypes (Rudolph, Chang 
et al. 1999; Gonzalez-Suarez, Samper et al. 2001).  
 
In conclusion, from my data I could confirm the hypothesis that a 
catalytically active TERT confers an advantage to the immortalized HaCaT 
cells by promoting resistance towards anoikis, and this phenomenon is 
due to a new non-canonical function of telomerase. This may explain why 
pre-malignant dysplasias (Edington, Loughran et al. 1995) and malignant 
SCC (Rheinwald and Beckett 1980; Tiberio, Marconi et al. 2002), and 
therefore have an advantage in the formation and progression of the 
tumour.  
 
Several proteins are involved in the mechanism of anoikis, therefore 
characterizing a mechanism through which TERT confers resistance to the 
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cells towards this form of cell death can be difficult. Anoikis for definition 
involves the receptors of the ECM components, integrins. When the cells 
are attached to the matrix, different signalling pathways are triggered 
from the activated integrins, and, after activation of the Src/FAK, involve 
the Ras-Raf-Erk pathway or the PI3K-Akt pathway. Both these pathways 
can lead to the transcription of anti-apoptotic factors and block the 
caspase-induced death signal (Frisch and Ruoslahti 1997; Frisch and 
Screaton 2001; Stupack and Cheresh 2002).  
 
To investigate the point of intervention of TERT in the apoptotic 
machinery, I analyzed changes in expression of the integrin subunits in 
whole cell lysates and on the cell surfaces. 
 
On the integrin subunits that I took into consideration, FACS analysis of 
HaCaTs cultured under normal culture conditions did not show any 
contribution of TERT in the expression of integrins on the cell surface. In 
particular, I couldn’t detect any difference in the expression of the 
integrin β1, which is been previously involved in the keratinocytes 
terminal differentiation by several studies (Adams and Watt 1989; Watt, 
Kubler et al. 1993; Hotchin, Gandarillas et al. 1995) 
 
The expression of integrin αv has been shown to be involved in the 
metastatic stage of different malignancies (Desgrosellier and Cheresh 
2010). From my results on total cell lysates, however, overexpression of 
TERT and TERT-HA in HaCaT is correlated with a with a more than two 
fold decrease in αv integrin expression when the cells are growing in 
suspension, but even at time 0 the overexpression of TERT/TERT-HA is 
associated with an upregulation of this integrin subunit compared to the 
control HaCaTs. Therefore protection against anoikis by TERT may is 
unlikely to be mediated by the upregulation of this integrin. 
 
The analysis if integrin β6 expression showed a shift from the non 
glycosylated (immature) form to the glycosylated (mature) form of the 
integrin when the cells lines grow in suspension for 20 hrs, but this 
change is not muted by the expression of TERT or TERT-HA. A similar 
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patter of glycosylation is shown by the integrin β1, which is expressed in 
both the mature and immature forms at time 0, but only the mature form 
is expressed after 20 hrs in suspension.  
 
It is therefore likely that in our system TERT protects against anoikis by 
intervening downstream of integrin signalling. I could also confirm the 
independence from this particular integrin subunit by analysing the 
response to anoikis after the blockage of the integrin with a specific anti- 
β1 antibody. The pattern of resistance among the cell lines didn’t vary in 
presence of this antibody, therefore excluding the possible regulation of 
this receptor or any of is ligands in the apoptotic phenotype. 
 
The only relevant difference in the expression of integrins when HaCaT 
are grown detached from the matrix for 20 hrs concerns the subunit β4, 
which is donwregulated in TERT/TERT-HA overexpressing HaCaTs after 20 
hrs compared to HaCaT-Puro and with all the groups at control time. This 
result could be consistent with previous studies that showed a p-53 
status dependent pro- and anti-apoptotic functions of α6β4 integrin 
(Bachelder, Ribick et al. 1999). 
 
In addition, I’ve observed that the resistant phenotype is modulated by 
the status of confluence of the cell culture before they are deprived from 
the anchorage and undergo anoikis. This has introduced the possibility of 
the involvement of β–catenin and the Wnt pathway in the TERT-induced 
resistance to anoikis, confirming recent studies that showed an interplay 
between TERT and this pathway (Sarin, Cheung et al. 2005; Choi, 
Southworth et al. 2008; Park, Venteicher et al. 2009).  
 
As β–catenin nuclear signalling is down regulated when epithelial cells 
form stable junctions (Kuphal and Behrens 2006) my results may be 
explained by TERT delaying the the induction of the anoikis programme, 
which is known to be dependent on cell-cell contacts (Frisch and Francis 
1994).  TERT might achieve this by its recently described ability to 
increase Wnt and β–catenin nuclear signalling through its interaction with 
BRG (Park, Venteicher et al. 2009) (see figure 23).  BRG is a chromatin-
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remodeling factor that is recruited by β–catenin in the activation of the 
transcription factor TCF/LEF and the transcription of Wnt target genes 
(Barker, Hurlstone et al. 2001). The interaction with TERT would also be 
consistent with the ability of DnTERT to partially mimic the wild-type. The 
model of interaction and interplay between TERT and β–catenin is 
explained in detail in figure 24.  
 
TERT has been shown to be essential for an adequate DNA damage 
response and its absence sensitises cells to DNA damage and also 
provokes premature senescence (Masutomi, Possemato et al. 2005).  It 
has also been shown that TERT enters the mitochondria and protects 
mitochondrial DNA from damage and the organelle itself from oxidative 
stress (Zhang, Chan et al. 2003). However, these phenotypes require the 
catalytic activity of TERT and hence the presence of TERC, whereas my 
results indicated that the catalytic activity of TERT was largely 
indispensable for its ability to mute anoikis. 
 
More recently, it has been shown that TERT can generate micro RNAs 
(miRNAs) by interacting with the RNA component of mitochondrial RNA 
processing endoribonuclease (RMRP) (Maida, Yasukawa et al. 2009) but 
the relevance of this to TERT’s ability to mute anoikis is not yet known. 
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Figure 23: The possible role of TERT in the regulation of Wnt and 
β–catenin nuclear signalling 
 
In absence of Wnt signalling, β–catenin can bind to cadherin to form 
adherent junctions, fundamental for intercellular adhesion or, if bound to 
the protein axin, it is subjected to phosphorylation by GSK3 and 
subsequent proteasomal degradation. In presence of Wnt ligand, the 
active receptor for Wnt, frizzled, activate dishevelled (Dvl). Dvl prevents 
the phosphorylation of β–catenin by inhibition of GSK3, letting β–catenin 
enter the nucleus. In the nucleus, β–catenin recruits the chromatin-
remodeling factor Brg-1 and interacts with the transcription factors 
LEF/TCF to permit the transcription of Wnt target genes. Since TERT has 
been shown to interact with Brg-1, it could act as a coactivator or 
transcription of Wnt target genes under the presence of Wnt signal and 
when β–catenin is not totally occupied in the formation of adherent 
junctions. 
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Nuclear β-Catenin ↑↑↑
β-Catenin/TCF activity ↑↑
Nuclear β-Catenin ↑↑
β-Catenin/TCF activity ↑↑↑
Nuclear β-Catenin ↑↑
β-Catenin/TCF activity ↑↑
Nuclear β-Catenin ↑
β-Catenin/TCF activity ↑
Nuclear β-Catenin ↑
↑ : level of β-Catenin or transcriptional activity
 
6. Discussion 
 
186 
Figure 24: Possible regulation of the anoikis programming of 
HaCaT by TERT overexpression 
 
As seen in Figure 23, the amount of β–catenin free to enter the nucleus 
and initiate transcription is dependent of the total amount of 
β–catenin, which can also be engaged in the formation of adherent 
junctions. In HaCaT-Puro, the amount of nuclear β–catenin decreases 
with the cell confluence because of the cell-cell junctions, which 
increase in number and stability in parallel with the cell confluence. 
Therefore, in the situation of higher confluence, the transcriptional 
activity regulated by nuclear β–catenin gradually decreases. If the the 
cells are influenced in their apoptotic programme by the transcription 
of specific Wnt/β–catenin target genes, then elevated transcriptional 
activity at lower confluence would inhibit anoikis. In our model, the 
elevated levels of TERT in the nucleus in HaCaT-TERT, by its proposed 
interaction with BRG would keep levels of β–catenin transcriptional 
activity high even when levels of β–catenin are not as elevated, such in a 
situation of sublconfluence. Therefore, at this state of 70% cell 
confluence, the anoikis programme would still be weak compared to the 
corresponding control cells. In summary it is proposed that TERT  
may affect anoikis programming rather than the process of anoikis itself. 
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6.1 Conclusion 
 
 
The catalytic subunit of telomerase, TERT, can cover canonical and non-
canonical functions. Non-canonical functions encompass every role that in 
independent from telomere elongation; however, some of these non-
canonical functions still require the presence of the RNA component TERC 
and therefore the catalytic activity of the enzyme.  
 
I have characterized in this study a new non-canonical function of 
telomerase, requiring the catalytic activity of the enzyme, which confers 
protection against cell death to immortal skin keratinocytes during 
anchorage-deprivation. This particular from of cell death is defined 
anoikis, and the resistance towards it would represent a major advantage 
in the growth and proliferation of malignant cells in a tissue, since it 
would render the cells less dependent from the contact with the 
extracellular matrix. 
 
Furthermore, this resistance to anoikis could be a mechanism through 
which TERT, overexpressed in both dysplasia and SCC cell lines and 
tissues, as well as mouse papillomas and SCCs, could promote the 
formation of these tumours. The exact point in the apoptotic pathway 
that is regulated by TERT has not been identified yet. In adherent cells, 
several pathways are triggered from activated integrins that binds to the 
ECM and converge to the blockage of caspases through the transcription 
of anti-apoptotic factors. From my study, I could not detect a significant 
change in the expression of integrins, thus I hypothesize that TERT acts 
downstream of these receptors to regulate anoikis in HaCaT cell lines, or 
alternatively influences the programming of anoikis potential when the 
cells are attached. 
 
It would be interesting to test if the TERT-induced resistance to anoikis 
happens also in normal human keratinocytes, because this would have 
relevance to normal stem cell function and wound repair, as well as 
neoplasia. In addition, the use of organotypic cultures with HaCaT cells 
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could give a further inside of the role of TERT overexpression in the 
keratinocytes differentiation, in a system that is more directly 
comparable with the in vivo situation. 
 
To underpin the mechanisms involved in the regulation of anoikis, a 
systematic study of the most important proteins involved in apoptosis, in 
the integrin signalling pathways, and in the Wnt/β-catenin pathway 
should be carried out, so that any change of expression could give a 
further insight of the exact point of action of TERT. It would also be 
interesting to test the role of miRNAs in the TERT-induced resistance to 
anoikis by knocking down DICER, the enzyme responsible for much 
miRNA generation. 
 
These and other experiments will be required to establish the mechanism 
of TERT-induced resistance to anoikis.  Understanding the manner by 
which TERT operates to influence an array of biological processes, 
independently of telomere length, will be critical in finding appropriate 
ways to manipulate telomere function both positively and negatively, for 
the purposes of tissue regeneration and cancer therapy, respectively. 
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